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Summary 
Toll-like receptors (TLR) are pattern recognition receptors (PRR) by which macrophages 
(MØ) sense pathogen-associated molecular patterns (PAMPs). The recognition of 
lipopolysaccharide (LPS), the PAMP of gram negative bacteria, by TLR4 triggers signaling 
cascades and leads to the pro-inflammatory activation of the cells. A recent quantitative and 
kinetic analysis of the phosphoproteome of LPS-activated primary macrophages highlighted 
the cytoskeleton as a cell compartment with an enriched protein phosphorylation. In total 44 
cytoskeleton-associated proteins were regulated by this post-translational modification and 
thus might be involved in the control and regulation of key macrophage functions like 
spreading, motility and phagocytosis.  
To investigate the control of cytoskeleton-associated cell functions by TLR4 activation, we 
first developed a method to quantitatively measure the spreading response of bone marrow 
MØ after stimulation with LPS. Fluorescence microscopy was used for cell imaging and 
visualisation of the MØ contact area. In collaboration with the Fraunhofer Institute Erlangen, 
we developed and validated a software tool for the semi-automated segmentation and 
quantitation of MØ fluorescence microscopy data, which allowed fast, robust and objective 
image analysis. Using this method, we observed that LPS caused time-dependent spreading, 
which was detectable after 1-2 h and maximal after 24 h. Next, the impact of genetic or 
pharmacological inhibition of known TLR signaling components was investigated. Deficiency 
in the adapter protein MYD88 strongly reduced spreading activity at the late time points, but 
had no impact early after LPS-stimulation. A similar effect was observed upon 
pharmacological inhibition of ERK1/2 signaling, indicating that ERK1/2 mediates MYD88-
dependent MØ spreading. In contrast, MØ lacking the MAPK p38 were impaired in the initial 
spreading response but responded normally 8-24 h after stimulation. The genetic deletion of 
the MAPK phosphatases DUSP1 and DUSP16 resulted in impaired late spreading, 
corroborating the essential role for functional MAPK signaling in TLR4-driven MØ 
spreading.  
To identify the contribution of other cytoskeletal phosphoproteins to MØ spreading, siRNA 
knockdown of selected candidate genes in primary murine MØ was employed and combined 
with automated quantitative image analysis. These experiments revealed a functional role for 
the Myosins MYO1e and MYO1f in MØ spreading. These motor proteins are strongly 
phosphorylated in LPS-activated MØ. Because of their ability to simultaneously bind to actin 
filaments and cell membrane or other proteins, we investigated their role in phagocytosis, 
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cytokine production and antigen presentation. Phagocytosis and killing of bacteria were not 
affected in Myo1e-/- macrophages. However, MYO1e plays a role in chemokine secretion and 
antigen presentation processes. MCP1 (CCL2) release was selectively increased in Myo1e-
deficient MØ and dendritic cells (DC), while cytokine secretion was unaffected. Furthermore, 
macrophages and DCs lacking MYO1e showed lower levels of MHC-II on the cell surface. 
However, mRNA levels of CCL2 and of MHC-II were unaltered. These data suggest a role 
for MYO1e in the transport of selected chemokines and of MHC-II molecules to the cell 
surface. MHC-II-restricted antigen presentation assays revealed an impaired capacity of 
macrophages and DC lacking MYO1e to stimulate antigen-specific T cells, suggesting that 
the reduced MHC-II expression is functionally relevant. 
Taken together, in this study first a quantitative image analysis method was developed which 
allows the unbiased, robust and efficient investigation of the macrophage spreading response. 
Combination of this method with siRNA knockdown of selected cytoskeleton-associated 
phosphoproteins led to the identification of MYO1e and MYO1f as regulators of macrophage 
spreading. Furthermore, we identified MYO1e in MØ and DC to be essential for the 
intracellular transport of CCL2 and MHC-II to the cell surface and for optimal stimulation of 
antigen-specific CD4 T cells. 
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Zusammenfassung 
Toll-like Rezeptoren (TLR) sind Mustererkennungsrezeptoren (PRR) durch die Makrophagen 
(MØ) pathogen-assoziierte molekulare Muster (PAMPs) erkennen. Die Erkennung von 
Lipopolysacchariden (LPS), dem PAMP gramnegativer Bakterien, durch TLR4 löst 
Signalkaskaden aus, die zu einer pro-inflammatorischen Aktivierung der Zellen führen. Eine 
quantitative und kinetische Analyse des Phosphoproteoms LPS-aktivierter primärer 
Makrophagen identifizierte das Zytoskelett als ein Zellkompartiment mit gesteigerter 
Proteinphosphorylierung. Insgesamt wurden 44 Zytoskelett-assoziierte Proteine identifiziert, 
die durch diese post-translationale Modifikation reguliert wurden und demzufolge an der 
Regulation wichtiger Zellfunktionen von Makrophagen wie Spreading, Motilität und 
Phagozytose beteiligt sein könnten.  
Um die Kontrolle Zytoskelett-vermittelter Zellfunktionen nach TLR4 Aktivierung zu 
untersuchen, entwickelten wir zunächst eine Methode zur quantitativen Messung der 
Spreadingantwort von Knochenmarksmakrophagen nach LPS Stimulation. Die Visualisierung 
der Zellen sowie ihrer Kontaktfläche erfolgte hierbei mittels Fluoreszenzmikroskopie. Für 
eine schnelle, robuste und objektive Analyse der Fluoreszenzaufnahmen entwickelten und 
validierten wir in Kollaboration mit dem Fraunhofer Institut in Erlangen eine Software zur 
halbautomatischen Segmentierung und Quantifizierung der Kontaktfläche. Unter Verwendung 
dieser Methode konnte eine zeitabhängige LPS-induzierte Zunahme der Zellkontaktfläche 
beobachtet werden, die nach 1-2 Stunden detektierbar war und ein Maximum nach  
24 Stunden erreichte. Durch den Einsatz pharmakologischer Inhibitoren sowie genetisch 
veränderter Zellen wurde anschließend der Einfluss bekannter TLR4-Signalwegkomponenten 
untersucht. Die genetische Defizienz des Adapterproteins MYD88 führte hierbei zu einer 
stark reduzierten Spreadingaktivität der Zellen während der späten LPS Stimulationsphase, 
wohingegen das initiale Spreading nicht beeinflusst wurde. Ein vergleichbarer Effekt konnte 
unter Verwendung eines pharmakologischen Inhibitors zur Hemmung des ERK1/2 
Signalweges identifiziert werden. Diese Beobachtungen deuten darauf hin, dass ERK1/2 für 
die Weiterleitung des MYD88 vermittelten Spreading notwendig ist. Im Gegensatz dazu 
wurde in p38-defizienten Makrophagen ein beeinträchtigtes initiales Spreading beobachtet, 
wohingegen das späte Spreading nach 8 – 24 Stunden nicht beeinflusst war. Die genetische 
Deletion der MAPK Phosphatasen DUSP1 und DUSP16 resultierte ebenfalls in einer 
Minderung des späten Spreadings, ebenfalls ein Hinweis auf die essentielle Rolle 
funktioneller MAPK Signalwege.  
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Um die Beteiligung weiter Zytoskelett-Phosphoproteine am Zellspreading zu identifizieren, 
wurde die Expression ausgewählter Kandidatengene in primären Makrophagen mittels 
spezifischer siRNA unterdrückt und das Zellspreading mit Hilfe der entwickelten Software 
quantifiziert. Diese Versuche zeigten eine funktionelle Rolle der Myosine MYO1e und 
MYO1f. Diese Motorproteine weisen ebenfalls eine starke Phosphorylierung nach LPS 
Stimulation auf. Aufgrund ihrer Eigenschaft simultan mit Aktinfilamenten und 
Zellmembranen sowie anderen Proteinen zu interagieren, untersuchten wir ihre Rolle während 
der Phagozytose, Zytokinfreisetzung und Antigenpräsentation. Obwohl Myo1e defiziente 
Makrophagen keine Beeinträchtigung der Phagozytose oder Abtötung von Bakterien 
aufwiesen, spielte das Motorprotein eine wichtige Rolle in der Chemokinfreisetzung und 
Antigenpräsentation. Interessanterweise war die Sekretion des Chemokins MCP1 (CCL2) in 
Myo1e-defizienten Makrophagen und dendritischen Zellen (DC) selektiv erhöht, während die 
Zytokinfreisetzung unbeeinträchtigt war. Des Weiteren wiesen Myo1e KO Makrophagen und 
DC eine reduzierte MHC-II Oberflächen-Expression auf, obwohl die MHC-II als auch die 
CCL2 Transkription auf mRNA Ebene nicht beeinflusst war. Diese Daten legen nahe, dass 
MYO1e während des Transports bestimmter Chemokine, sowie von MHC-II zur 
Zelloberfläche eine wichtige Rolle spielt. Zudem zeigten Myo1e KO Makrophagen und DC in 
einem MHC-II-abhängigen Antigenpräsentationsassay eine abgeschwächte Fähigkeit zur 
Antigen-spezifischen T-Zell Aktivierung, was die funktionelle Relevanz der reduzierten 
Expression von MHC-II nahelegt. 
Zusammenfassend wurde in dieser Studie zunächst eine Methode zur quantitativen 
Bildanalyse entwickelt, welche eine unvoreingenommene, robuste und effiziente 
Untersuchung des Spreadings von Makrophagen erlaubte. Die Kombination dieser Methode 
mit dem spezifischen siRNA Knockdown ausgewählter Zytoskelett-assoziierter 
Phosphoproteine führte zur Identifizierung von MYO1e und MYO1f als wichtige Regulatoren 
dieser Zellfunktion. Darüber hinaus konnte in Makrophagen und DC eine essentielle Rolle für 
MYO1e im intrazellulären Transport von CCL2 und MHC-II an die Zelloberfläche 
identifiziert werden, sowie dessen Notwendigkeit für eine vollständige Aktivierung  
antigen-spezifischer CD4 T Zellen. 
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1 Introduction 
1.1 The immune system 
The immune system is a complex, sensible and well-rehearsed system developed during 
evolution to protect multicellular organisms from infection with pathogens like bacteria, 
viruses, parasites or fungi. The first defense line against foreign organisms for instance are the 
skin and the mucosal surface of the respiratory, gastrointestinal and urogenital tracts [1]. Once 
the invaders overcome these barriers they are immediately recognized by resident or recruited 
cells of the innate immune system. This non-specific part of the immune system engage cells 
like macrophages, dendritic cells, neutrophils, eosinophils, natural killer (NK) cells, 
basophils, mast cells, gamma/delta (γδ) T-cells and epithelial cells, which are continually 
disposed to rapidly act against pathogens. Upon activation, innate immune cells mediate the 
response to prime cells of the adaptive immune system and thereby activate a pathogen 
specific immunity. This protection is arranged by B- and T-cells which finally induce a 
spectrum of specific effector mechanisms to eliminate the pathogen [2]. 
1.2 Macrophages and dendritic cells 
Macrophages (MØ) were first recognized and described as “big-eaters” by Ilya Metchnikoff 
more than 130 years ago [3]. Blood circulating monocytes, which themselves develop from 
hematopoietic stem cells of the bone marrow are the progenitor cells, competent to 
differentiate into macrophages. In response to a wide range of stimuli, including chemokines 
and cytokines, monocytes transmigrate from the blood vessels into the peripheral tissue and 
differentiate into macrophages [2]. Dependent on the colonized tissue, MØ can differentiate 
into a specialized phenotype termed as Kupffer cells in the liver, microglia in brain, 
osteoclasts on bones or alveolar MØ in the lung. In general macrophages serve as scavenger 
cells by uptake and clearance of apoptotic cells and cell debris or wound healing to maintain 
tissue homeostasis [4]. Beside their role in homeostasis, they have important functions in 
immune response. These relatively long-living cells are able to phagocytose and degrade 
foreign materials like invading pathogens and other macromolecular agents. This process 
causes a phenotypical switch from the “silent” to the pro-inflammatory state, resulting in the 
release of cytokines and chemokines to activate surrounding cells, interfere with the threat 
and induce an adaptive immune response [2]. 
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Dendritic cells (DCs) belong to the myeloid cell linage and originate from hematopoietic 
progenitor cells. DCs exhibit long dendrite extensions resulting in their nomenclature. 
Compared to macrophages, DCs also exist in different tissues resulting in phenotypical 
difference and therefore termed Langerhans cells in the skin or lamina propria DCs in the 
intestine [4]. Immature DCs migrate through the blood vessels and the tissue, while tacking 
up pathogenic material and additionally extracellular liquids with their dissolved substances 
by phagocytosis and macropinocytosis. Their main task in the immune response is the 
activation of T-lymphocytes after recognition of pathogenic material. Both cell types are 
essential in the induction and mediation of an inflammation to trigger a successful immune 
response [2]. 
1.2.1 Immunological functions of macrophages and DCs 
In response to invading pathogens and tissue injury MØ and DCs are necessary to avoid 
immunopathology and to tissue repair. Both cell types are found under homeostatic condition 
in several organs and share certain functions such as recognition of pathogens, phagocytosis 
and antigen presentation via the major histocompatibility complex (MHC) [2, 5]. Upon 
recognition of infectious material immature DCs and resident tissue macrophages undergo a 
genetic reprogramming resulting in a change of their activation state and expression of a 
broad repertoire of anti-microbial agents and functions. Maturated DCs lose their 
phagocytosis capacity and actively migrate from the tissue to the lymph nodes and the spleen 
to activate T-cells by antigen presentation. Macrophages switch to a pro-inflammatory “M1” 
phenotype responsible for a local host defense within the affected tissue [5]. M1-macrophages 
and mature DCs express several pro-inflammatory cytokines like TNFα, IL-1, IL-6 or IL-12 
and chemokines like CCL2, CCL3 or CCL4 which are released for an intercellular 
communication. Upon biosynthesis, these produced molecules are guided through the 
cytoplasm towards the cell membrane by a complex trafficking machinery including 
cytoskeleton structures and are finally released in a controlled manner [6-10]. In response to 
these secreted mediators, endothelial cells from peripheral vessels become activated resulting 
in an up-regulation of adhesion molecules and loosening of cell-cell junctions to enable 
immune cell invasion towards chemokine gradients into the tissue. To initiate tissue 
infiltration, immune cells attach by integrin binding to the vessel walls and migrate through 
the endothelium accompanied by morphological changes. Subsequent to transmigration the 
adherence and spreading of immune cells, facilitated and affected through controlled 
cytoskeleton dynamics, is essential to accumulate cells at the site of infection. Among a broad 
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spectrum of immune cells including neutrophils, NK-cells, B- and T-cells also monocytes 
migrate to the site of infection. Dependent on the cytokine signal the monocytes can further 
differentiate into tissue macrophages or into DCs. To restore homeostatic tissue conditions 
MØ and DCs also produce suppressive cytokines and balance the immune response [2]. Anti-
inflammatory macrophages, described as “M2” phenotype excessively phagocytose apoptotic 
neutrophils and secret the cytokines IL-10 and TGF-β [5, 11]. Both molecules are able to 
down-regulate TNFα, IL-1, IL-6 and MHC expression, thus leading to a reduction in immune 
response. Aside IL-10 and TGF-β tissue DCs produce pentraxin-3, a protein able to block 
adhesion molecules on endothelial cells, which prevent further immune cell recruitment into 
the tissue [5, 12]. 
1.2.1.1 Phagocytosis and killing of intracellular pathogens 
Recognition and binding of pathogens to surface receptors of immature DCs and resident 
tissue macrophages like Fcγ-, scavenger-, mannose- and glucose- or lipid receptors stimulates 
an engulfment of the foreign organism. This uptake, called phagocytosis, leads to formation 
of intracellular vesicles known as phagosomes [2, 13]. The whole internalization process is 
caused by active deformation of the cell membrane triggered in response to the surface 
receptor activation. The forces required for this mechanism are produced by the underlying 
actin cytoskeleton, involving a variety of proteins known from analysis on phagocytes [14, 
15]. The maturation of the phagosomes and the subsequent fusion with acidic and protease 
containing lysosomes form the phagolysosomes, responsible for intracellular pathogens 
killing [16]. Furthermore, the V-ATPase proton pump lowers the pH to 4-5, toxic substances 
for instance nitric oxide (NO) are produced by the inducible nitric oxide synthase (iNOS) and 
reactive oxygen species (ROS) are generated by a membrane associated nicotinamide adenine 
dinucleotide phosphate  (NADPH) oxidase in the cytoplasm and diffuse across the membrane 
[17]. These mechanisms inhibit bacterial replication and kill most of the pathogens 
1.2.1.2 Antigen presentation via MHC-II 
An important capability of MØ and DCs to induce an adaptive immune response is the 
antigen presentation via MHC. Two different classes of this molecule are expressed in 
vertebrates [2]. While MHC-I is responsible to present antigens (AG) from intracellular 
origins such as virus, MHC-II expressed by MØ, DCs and B-cells present AG from 
exogenous origin like bacteria. Antigens presented by MHC-I are recognized by cytotoxic 
CD8 T-cells, which in turn induce a programmed cell death of the infected cell and thus 
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mediate cellular immunity to primary combat intracellular pathogens. In contrast, MHC-II-
presented antigens are recognized by CD4 helper T-cells to mediate a humoral immunity. B-
cells primed by activated T helper cells produce specific antibodies and thus allows an 
adapted defense against extracellular pathogens [2, 18]. Prior to MHC-II restricted AG-
presentation the proteins of phagocytosed pathogens need to be processed into smaller 
peptides by proteolytical cleavage within the phagolysosomes. Subsequently the peptides are 
loaded onto MHC-II molecules which in turn are transported by the cytoskeleton machinery 
to the cell surface and present the AG to CD4 T cells [19]. The AG-loaded MHC-II alone is 
not sufficient to induce an effective T-cell activation. Thus, a second antigen nonspecific 
signal is provided by co-stimulatory molecules required to become fully activated T-cells. In 
addition to MHC-II, these molecules like CD40, CD68 and CD80 are up-regulated on the 
surface of DCs and MØ in response to their activation [2, 5]. 
 
1.3 Recognition of pathogens 
Recognition of pathogens occurs via pattern recognition receptors (PRR) expressed on cells of 
the innate immune system, allows them to discriminate between self and non-self material and 
if necessary to induce an adequate immune response. These receptors specifically bind to 
conserved microbial structures described as pathogen associated molecular patterns (PAMP). 
Dependent on their structure and cellular localization the PRR are classified into different 
families including transmembrane C-type lectins (CLRs), and Toll-like receptors (TLRs) on 
the cell surface and cytosolic retinoic acid inducible gene I (Rig-I)-like helicases (RLRs) and 
nucleotide-binding leucine-rich receptors (NLRs). Interaction of these PRRs with their 
specific ligands induces an activation of MØ and DCs, resulting in phagocytosis, expression 
of cytokines and chemokines, antigen presentation and co-stimulatory molecules, cell 
migration and maturation [2, 20, 21]. 
1.3.1 TLRs and their ligands 
Toll-like receptors (TLRs) are an evolutionary old pattern recognition and signaling system 
which was first described in development of Drosophila melanogaster. Later TLRs were 
identified to play an important role in immunity in adult flies [22]. Today 10 and 12 
functional TLRs are known in human and mice, but only TLR1-9 are conserved in both 
organisms. However, murine TLR10 is not functional because of a retroviral insertion and 
human TLR11-13 have been lost from the genome. Each TLR recognizes a specific PAMP 
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derived from bacteria, virus, parasites and fungi and induces a rapid and massive 
transcriptional response of the stimulated cell [23]. TLRs are transmembrane receptors which 
consist of an extracellular domain with leucin-rich repeat motifs (LRR) and an intracellular 
Toll/IL-1R homology (TIR) domain. The TIR domain is also found in members of IL-1 
receptor family like IL-1R, IL-18R and IL-33R and is necessary to recruit intracellular TIR-
containing adapter molecules to induce signaling [24, 25]. On the one hand, TLR1, TLR2, 
TLR4, TLR5, TLR6 and TLR11 are expressed on cell surfaces and mainly recognize 
microbial membrane components like lipids, lipoproteins and proteins. For instance 
lipoteichoic acid from Gram positive bacteria (LTA) is bound by a heterodimer of TLR2/6, 
flagellin of flagellated bacteria is recognized by TLR5 and lipopolysaccharide from Gram 
negative bacteria (LPS) is bound by a complex of TLR4/CD14/MD-2. On the other hand, 
TLR3, TLR7, TLR8 and TLR9 are only expressed intracellularly on vesicular structures like 
endosomes, lysosomes or endolysosomes where they recognize microbial nucleic acids after 
degradation of the pathogens. TLR9 binds to unmethylated CpG motifs within bacterial and 
viral DNA while TLR3 interacts with viral dsRNA. In contrast TLR7 and TLR8 become 
activated in response to viral ssRNA [2, 23, 26].   
1.3.2 TLR4-induced intracellular signaling 
Activation of TLR4-driven signaling (Fig. 1) requires oligomerization of several proteins 
including LPS binding protein (LBP), CD14 and MD-2. The soluble shuttle protein LBP 
directly binds to LPS and facilitates the interaction with CD14. This membrane-anchored 
protein transfers LPS to TLR4 which interacts with the soluble protein MD-2 [27]. 
Subsequent to the receptor complex formation and ligand binding, TLR4 dimerizes and 
undergoes conformational changes on its cytoplasmic TIR domain, required for the 
recruitment of downstream signaling molecules. An essential adaptor molecule in  
TLR-mediated signaling pathways is the myeloid differentiation primary-response protein 88 
(MYD88). MYD88 contains a C-terminal TIR domain and an N-terminal death domain (DD). 
TLR4/MYD88 TIR-TIR domain interactions subsequently recruit and activate the DD domain 
containing IL-1 receptor-associated kinase-4 (IRAK-4). Phosphorylated IRAK4 recruits 
tumor-necrosis factor (TNF)-receptor-associated factor 6 (TRAF6) followed by the activation 
of the transforming growth factor-β-activated kinase 1 (TAK1). TAK1 in turn stimulates 
mitogen-activated protein kinase (MAPK) pathways and mediates the activation of NF-κB 
and AP-1. The transcription factor NF-kB kept inactive under basal conditions by its inhibitor 
IκB, is essential to induce a pro-inflammatory immune response through expression of target 
Introduction  6 
 
genes [2, 24, 27]. In addition to the MYD88-dependent pathways a MYD88-independent 
signal transduction in MØ and DCs exists. TLR4 engages the TIR-domain-containing 
adapter-inducing interferon-β (TRIF) pathway to induce MAPK and NF-κB activation as well 
as IFN-β expression through IRF3 activation. However, both signaling pathways are required 
for a rapid and full pro-inflammatory immune response to LPS. Experiments with MYD88-
deficient mice revealed a reduced and delayed LPS response compared to wild-type mice  
[26, 28]. Activation of TLR4 finally results in expression of pro-inflammatory cytokines, up-
regulation of co-stimulatory molecules and DC maturation [2, 29, 30]. 
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Figure 1. TLR4 signaling. Schematic 
illustration of intracellular signaling 
triggered by LPS induced TLR4 
activation. For details, see text.  
Cell membrane (CM), cytoplasm (CP), 
nucleus (N), TRL4 (red), CD14 (green), 
LBP (yellow), MD-2 (dark purple), LPS 
(bright purple), MYD88 (bright brown), 
TRIF (dark brown), IRAK4 (grey), 
TRAF6 (bright blue), TAK1 (green), 
TBK1 (dark blue), MAPKs (oval 
symbols), NF-κB inhibitor (rhomb), 
transcription factors (hexagons). 
Intracellular regulation of MAPK 
activity by DUSPs (red box) described 
in chapter 1.3.3.  
1.3.3 Regulation of MAPK signaling by dual-specificity phosphatases (DUSP) 
A major role in TLR4-driven signal transduction is played by mitogen-activated protein 
kinases (MAPK) including the extracellular signal-regulated kinase (ERK), c-jun N-terminal 
or stress-activated protein kinase (JNK) and the p38 group of protein kinases (p38). These 
serine/threonine kinases are activated through rapid threonine/tyrosine phosphorylation by 
their upstream kinases. In response to receptor activation MAPKs activate specific substrate 
proteins, e.g. transcription factors leading to pro-inflammatory gene expression. However, 
MAPKs are responsible in regulation of many other cell functions like differentiation, 
proliferation and apoptosis, cell repair, as well as chemotaxis and actin organization [31-33]. 
To avoid an over-response, MAPK activity has to be controlled and regulated by 
dephosphorylation of the threonine-X-tyrosine motif. Eukaryotic cells express a variety of 
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MAKP phosphatases including dual-specificity phosphatases (DUSP) as endogenous 
regulators (Fig. 1). DUSP MAPK phosphatases possess a MAPK-binding domain mediating 
selective binding with individual MAPK family members. Interaction of the catalytical DUSP 
domain with phosphorylated threonine/thyrosine residues on MAPK mediates the 
dephosphorylation [34]. DUSPs differ in their tissue distribution, substrate specificity, cellular 
localization and inducibility by extracellular stimuli [35]. One important family member is 
DUSP1, expressed in response to TLR stimulation through the MYD88-dependent or -
independent pathway and additionally enhanced in response to anti-inflammatory IL-10 [36]. 
Increased expression of DUSP1 leads to a deactivation of MAPK in order p38 > JNK >>ERK 
and thus decrease the amount of released IL-6 and TNF [37]. DUSP1 knock out (KO) MØ 
cultured in medium containing 10% fetal bovine serum (FBS) showed defects in spreading 
and an impaired ERK activation. Furthermore, a reduced MØ migration into the peritoneum 
was observed after injection of KO mice with thioglycolate [38]. DUSP16, an additional 
MAPK phosphatase functional in mouse, dephosphorylates JNK and p38 [39], and its stability 
is controlled by ERK-dependent phosphorylation [40]. Mice lacking DUSP16 died shortly 
after birth and their bone marrow cells poorly proliferate in response to GM-CSF [41]. 
Macrophages deficient in DUSP16 produce increased amounts of the pro-inflammatory 
cytokine TNF and IL-12 [41]. Hence, this MAPK phosphatase plays an important role in 
myeloid cell differentiation and effector function.  
 
1.4 The cytoskeleton 
The cytoskeleton is a system of intracellular filaments with scaffolding properties present in 
all pro- and eukaryotic cells [42]. This cell organelle together with its specific associated 
proteins is organized in microtubules, intermediate filaments and microfilaments, which are 
distributed through the whole cell and differ in their molecular composition and function. 
Research on the cytoskeleton revealed its involvement in almost all immune system functions, 
starting from immune cell maturation, to cell recruitment, inter- and intracellular signaling 
and transport processes as well as activation triggered by of innate and adaptive immune 
receptors. Defects in this sensible and complex system can cause immune deficiencies like the 
Wiskott-Aldrich syndrome (WAS) induced by mutations within the WAS-protein [43, 44]. 
Furthermore, even bacterial and viral pathogens developed strategies to manipulate the 
cytoskeleton and subvert immune cells [45-47]. For a better understanding of this complex 
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system it is essential to further investigate which cytoskeletal processes and components 
contribute to the control and regulation of immune cell responses. 
1.4.1 Microtubules and intermediate filaments 
Microtubules are essential cytoskeletal polymers forming hollow tubes with approximately  
25 nm in diameter. These structures participate in distribution of organelles during cell 
division and affect cell shape, motility and other intracellular transport processes. 
Microtubules are highly dynamic and build by heterodimerization of the small monomers  
α- and β-tubulin forming the functional α-/β-tubulin [48, 49]. The regulation of the 
microtubule system occurs by transcription of different tubulin isotypes, folding of α-/β-
tubulin heterodimers and post-translational modification of tubulin. The microtubule dynamic 
is based on binding and hydrolysis of guanosine triphosphate (GTP) by tubulin subunits 
inducing microtubule assembly and disassembly [48, 50]. From resident peritoneal 
macrophages it is known that IFNγ/LPS stimulation stabilizes microtubules via the CLIP-170 
protein resulting in an enhanced cell spreading and FcγR-mediated phagocytosis [51]. Recent 
studies on primary bone-marrow macrophages (BMM) revealed the requirement of 
microtubules in IFNγ/LPS induced matrix metalloproteinase (MMP)-9 secretion. Vesicles 
loaded with the proteinase were selectively guided through the cell by the motor protein 
kinesin along stabilized and acetylated microtubules [52]. In the microtubule system the 
proteins kinesin and dynein are well described essential motors for a directional cargo 
transport [49, 53]. 
Intermediate filaments are found in the nucleo- and the cytoplasm of metazoan cells [54]; they 
are built by fibrous proteins which consist of long, un-interrupted segments forming 
multistranded coils. This protein family consist of ~65 distinct proteins which assemble in 
very flexible filaments approximately 10 nm in diameter. Intermediate filaments are the 
“stress-buffering” elements of the cytoskeleton becoming more viscoelastic under shear stress 
compared to microtubules and microfilaments, thus they play an important role e.g. in 
migration processes. [55-57]. The best described proteins of this superfamily are the nuclear 
lamin, with an important role in nuclear membrane stabilization during mitosis and keratin as 
well as vimentin [55]. In circulating human CD4
+
 T-lymphocytes vimentin forms an 
intracellular cage that provides protection against deformation. Upon activation of the cells by 
the chemokine C-X-C motif ligand (CXCL)12, the vimentin cage collapses and facilitates 
transendothelial migration [58]. Furthermore, the expression of vimentin during myeloid cell 
maturation seems to be important for the differentiation into fully active macrophage-like 
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cells. Vimentin knockdown experiments with phorbol 12-myristate 13-acetate (PMA) - 
treated BM2 cells resulted in macrophage-like cells with a suppressed phagocytosis capability 
and ROS production [59]. In addition to microtubules and intermediate filaments, the actin 
cytoskeleton is required to complete the function of this complex cell compartment. 
1.4.2 Cytoskeleton and actin dynamic 
Microfilaments are also known as actin cytoskeleton composed of superfine filamentous actin  
(F-actin) structures with 7-9 nm in diameter. It builds a dense layer in the cortical region of 
the cell but is also found distributed in the cytoplasm and even localized within the nucleus 
[60, 61]. This highly dynamic filament system with its related proteins contributes e.g. in the 
cell cycle, membrane deformation during endo- and exocytosis, intracellular transport, signal 
transduction, regulation of cell shape, motility and spreading as well as in chromatin 
remodeling and gene expression [60, 62-66]. F-actin is build by polymerized monomers of 
globular actin (G-actin), while its adenosine triphosphate (ATP)-dependent assembling and 
disassembling is controlled by actin polymerization and depolymerization factors which 
themselves are regulated by many associated proteins [65, 67, 68]. Actin filaments are highly 
dynamic structures undergoing constant changes described as dendritic nucleation or treadmill 
model (Fig. 2). An actin filament can be subdivided in a polymerizing barbed end and a 
depolymerizing pointed end. This filament polarity allows a directed elongation of actin 
filaments inducing e.g. membrane deformations. ATP-bound G-actin is recruited by an 
activated polymerization factor to a free barbed end or already existing actin filament and 
biochemically linked to initiate filament growth and elongation. To control the direction of 
filament assembling capping-proteins interact with dispensable filaments and terminate its 
elongation. Filaments mature by hydrolysis of ATP bound to each actin subunits and are 
disassembled by depolymerization factors at the pointed end. Released ADP-bound G-actin 
gets subsequently reloaded with ATP by nucleotide exchange factors to be re-used for F-actin 
assembling. Under steady state conditions these changes occurs slowly but cells can 
accelerate this process very quickly by activation of various surface receptors in response to 
extracellular stimuli [64, 65, 68]. The fast reorganization of microfilaments in macrophages 
within 1-6 min upon LPS stimulation was already described in 1991 [69]. This process as well 
as the functionality of the actin cytoskeleton is regulated by associated proteins, which are 
focus of the next chapter. 
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Figure 2. Dendritic nucleation / treadmill model for membrane protrusion. (1) Activation of 
surface receptor (blue) by extracellular stimuli (purple). (2) Recruitment and activation of 
cytoskeletal signal mediators (orange). (3) Interaction of signal mediators (orange) with actin 
polymerization factors (green) induces (4) binding to monomeric ATP coupled G-actin (white circle). 
(5) The activated complex attaches to preexisting filaments and induce a rapid growth at the barbed 
end of the new branch, pushing the membrane forward. (6) Capping proteins terminate filament 
elongation (red). (7) Actin filaments age by hydrolysis of ATP bound to each actin subunit (white 
circles > grey). Actin depolymerization factors (yellow) dissect ADP-actin filaments and facilitate 
dissociation of ADP-actin (grey circles). (8) Nucleotide exchange factors (dark purple) recycles ATP 
loading of monomeric G-actin (grey circles > white) to provide a new pool of monomeric ATP-actin 
for F-actin assembling. Modified scheme from Pollard, TD et al. Cell 2003 [64] 
1.4.2.1 Signal transduction and cytoskeleton-associated proteins 
Dynamic and function of the actin cytoskeleton are controlled by a large group of associated 
proteins. More than 150 are already identified containing actin binding domains [66]. They 
control the monomer-polymer balance of actin and its organization, which is regulated 
through a number of co- and post-translational modifications e.g. acetylation, 
phosphorylation, ubiquitinylation, methylation and oxidation [70-72]. Trigger-induced actin 
modifications are mediated by cytoskeletal proteins which themselves requires activation in 
response to extracellular stimuli. One essential mechanism is protein phosphorylation. In a 
quantitative phosphoproteome analysis of LPS activated primary macrophages our group 
identified the cytoskeleton as a hotspot of TLR4-induced protein modification. A group of 44 
cytoskeletal associated proteins were detected, including e.g. signal mediators like PXN, 
LSP1, MSN, EPS8; the actin polymerization factor subunit ARP3; the formins FHOD1 and 
FMN1; the capping protein CAPZB and motor proteins like MYO1e, MYO1f and MYO9b 
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[30]. These results are supported by investigations on the macrophage cell line J774 [73]. The 
researchers identified LPS triggered cell motility and assembly of actin filaments leading to 
the formation of a lamella protrusion and accumulation of phosphorylated actin–regulatory 
proteins paxillin (PXN) and N-WASP at the leading edge. This whole process was 
accompanied by a redistribution and transient co-localization of TLR4 and CD14 at the 
leading lamella where the receptors triggered local enrichment of actin filaments and transient 
phosphorylation of paxillin on tyrosine 118 and N-WASP on serine 484/485 within 30 min 
[73]. A comparable actin-dependent receptor clustering is also described in RAW 264.7 cells 
[74]. The mutual control of TLR4 signaling and the actin cytoskeleton in immune response 
has become a focus of investigations. Several studies described a cytoskeletal-dependent 
regulation of the transcription factor NF-κB in response to LPS. In myelomonocytic cell lines 
and human monocytes the inhibition of actin polymerization through Cytochalasin D (CyotD) 
induces a significant activation of NF-κB through an IKK-dependent pathway [75, 76]. In 
J774 cells a TLR4-driven transient phosphorylation of paxillin and N-WASP is followed by 
phosphorylation of the NF-κB inhibitor IκB on Ser32/35 (30-60 min) mediated by Src kinase 
[73]. However, CytoD does not affect LPS induced NF-κB activation in murine macrophages, 
but is critical for a post-translational regulation of iNOS and ROS production [77]. To 
understand the cause of the events, the identification of responsible signal cascades is 
essential. Many cytoskeletal signal pathways are regulated by small GTPases of the RHO, 
RAS, RAC and ARF family in response to TLR4 stimulation [78]. Dynamics in  
TLR4-induced B-cell polarization and migration are dependent on MYD88 and correlates 
with enhanced RAC activation, but were independent on ERK1/2 and p38 [79]. In 
macrophages the RHO GTPases RAC1 and CDC42 contribute to LPS-induced lamellipodia 
and fillopodia formation and are essential for intracellular TNF trafficking to the membrane 
[80]. Furthermore, in RAW cells a MYD88-independent TLR4 activation of CDC42 and 
RAC1 was shown. Stimulation of both kinases was induced through actin polymerization 
itself, with an important role in phagocytosis [81]. Further studies also link the classical 
MAPK ERK1/2 and p38 to the regulation of actin cytoskeletal cell functions. In M-CSF-
stimulated macrophages the p21-activated kinase (PAK1) affects lamellipodial dynamics by 
regulating ERK1/2 activity. MØ lacking PAK1 showed an enhanced spreading in response to 
adherence, forming less stable lamellipodia [82], and in smooth muscle cells p38 is involved 
in lamellipodia formation [83]. Literature analysis of cytoskeletal phospho-proteins detected 
in our own study [30] partially linked them to known TLR4-associated signal pathways or 
rather to important immunological cell functions while their regulation is still unclear. The 
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actin polymerization factor FHOD1, a formin responsible to build bundled actin structures 
important in stress fibers and fillopodia formation [84, 85], was described to specifically 
interact with RAF-1 and ERK but not with p38 and JNK [86]. The phosphorylation of 
FHOD1 on C-terminal residues S1131, S1137 and T1141 in endothelial cells is necessary for 
stress fiber formation [87]. The best described actin polymerization factor ARP2/3, a multi 
protein complex composed of seven subunits including ARP2, ARP3 and ARPC1-5 is 
responsible for formation of actin filament branches, and is regulated through interaction with 
nucleation-promoting factors (NPFs) of the WASP and WAVE family [88]. In Drosophila 
and Dictyostelium cells binding of NPFs to ARP2/3 is not sufficient for its activation. Mass 
spectrometry analysis and experiments with ARP2 phospho-mutant constructs identified an 
important role of ARP2 phosphorylation on Y200 and T235/6 in membrane protrusion and 
cAMP chemotaxis [89, 90]. Furthermore, ARP2/3 is indirectly regulated by ERK through the 
activation of the NPF WAVE2 by this MAPK in human epithelial cells [91]. In addition, the 
phosphosite S77 within the ARPC5 subunit in human neutrophils was identified as a p38-
mediated MK2 substrate [92]. An additional example is LSP1, the lymphocyte-specific 
protein 1 expressed in human and murine myeloid and lymphoid cell lines [93]. The signal 
transducer with actin binding capacity was shown to be a substrate of p38/MK2 in human 
neutrophils [94]. Furthermore, LSP1 was identified to target MAPK scaffold proteins KSR, 
MEK1 and ERK2 to the actin cytoskeleton [95].  
Interestingly, 18 of 44 LPS regulated cytoskeletal phosphoproteins detected in our own 
phosphoproteome analysis contain phosphorylation sites with a MAPK sequence motif 
(Tab.1), identifying them as probable kinase substrates regulated by these essential pathways. 
Literature knowledge in combination with our results highlights the essential role of 
cytoskeletal reorganization as well as a mutual control of TLR4-induced signaling. 
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Cytoskeletal phosphoproteins containing MAPK substrate motifs 
Add1       (Alpha-adducin 1) 
Epb4.1/1 (erythrocyte protein band 4.1- protein 1) 
Fhod1     (formin homology 2 domain containing protein 1) 
Flna        (Filamin-A) 
Frmd4b  (FERM domain containing protein 4B) 
Hdac6     (Histone deacetylase 6) 
Lima1     (LIM domain and actin-binding protein 1) 
Lsp1        (Lymphocyte specific protein 1) 
Marcks   (Myristoylated alanine-rich C-kinase substrate) 
Mkl1       (megakaryoblastic leukemia/myocardin-like 1) 
Mprip     (Myosin phosphatases Rho interacting protein) 
Mtss1      (Metastasis suppressor 1) 
Myo9b    (Myosin-9b) 
Plec1       (Plectin-1) 
Pxn         (Paxillin) 
Snta1      (Alpha-1-syntrophin) 
Spnb2     (Spectrin beta 2) 
Svil          (Supervillin) 
Table 1. Cytoskeletal phosphoproteins with MAPK substrate motifs. Cytoskeletal 
phosphoproteins with LPS-induced phosphorylation of one or more sites within a MAPK 
substrate motifs, detected in phosphoproteome analysis of primary macrophages [30].  
 
1.4.3 Myosins 
Myosins are actin-based motor proteins functional in cell migration and adhesion, signal 
transduction, membrane traffic, vesicle transport as well as protein, RNA and organelle 
localization [96, 97]. Phylogenetic analysis of these molecular motors from different 
organisms divided this superfamily into 35 classes [98, 99]. These molecules can 
heterodimerize through interaction of one or two heavy chains and a variable number of light 
chains, resulting in formation of two-headed or single-headed motors [96, 98]. The heavy 
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chain can be divided in the motor, the neck and the tail domains. The neck domain consists of 
a isoleucine/glutamine (IQ) motifs, allows binding of light chains and functions as lever arm 
which enables motor domain movement [96, 98, 100]. Myosin light chains play an important 
role in the regulation of ATPase and contractile activity of the motor protein [101]. They are 
controlled by phosphorylation through myosin light chain phosphates [102] and Ca
2+
 
dependent interaction with calmodulin [103, 104]. The myosin tail harbors domains 
responsible for interaction with proteins, membranes or other cargos (Fig. 3a). The motor 
domain allows attachment and detachment to actin filaments through binding and hydrolysis 
of ATP, resulting in a movement along actin tracks and production of mechanical forces 
through conformational changes (Fig. 3b). Differences in motor properties of myosins define 
their specific intracellular function. Important characteristics are the force which is produced 
during an ATPase cycle as well as the velocity and direction of the movement along actin 
filaments [96]. A further critical aspect is the duty ratio of these molecular motors. It is 
defined as the fraction of the ATPase cycle that a motor spends strongly attached to a 
filament, resulting in low-duty-ratio or high-duty-ration classification. The main factors 
controlling the kinetic of the ATPase cycle is the rate of inorganic phosphate (Pi) or ADP 
release [105, 106] (Fig. 3c). Myosins with high-duty-ratio, called processive motors, are 
thought to act as effective cargo transporters because of the minimal risk of detaching and 
falling off the actin track. In contrast, low-duty-ratio motors are presumably better to induce 
rapid contraction or participate in signal transduction [96, 99, 106]. The direction of myosin 
movement is given by the structure of actin filaments resulting in the discrimination as plus-
end-directed (towards the barbed end) or minus-end-directed (towards the pointed end) motor 
[96]. 
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Figure 3. Scheme of myosin structure and actin-based movement. (a) Illustration of single- and 
double-head myosin built by heterodimerization of two heavy chains (blue) with its distinct domains. 
(1) Head- or motor-domain containing actin- and nucleotide-binding-pocket. (2) Neck region with 
bound light chains (yellow). (3) Tail region with cargo binding domain (square). (b) Directed 
movement of myosin along actin filament by hydrolysis of ATP (1-4 ATPase cycle). (1) ADP bound 
myosin is coupled to actin filament. (2) Binding of ATP leads to dissociation from actin polymer.  
(3) Hydrolysis of ATP into ADP + Pi induce a +end directed conformational change of the myosin.  
(4) Dissociation of Pi is followed by myosin head binding to a new filament site and rearrangement of 
the initial conformation. Repetition of ATPase cycle can occur. (c) Duty ratio is a measure how long a 
myosin is attached to actin filaments during an ATPase cycle. Useful to estimate myosin function and 
mechanism.  Duty ratio = timeon/(timeon+timeoff) [99, 105, 106]. 
1.4.3.1 Class I myosins 
Class I myosins (MYO1) are monomeric and single-headed myosins expressed in many 
species from yeast to human, in a molecular weight range of 110-130 kDa [107]. In humans 
and mice this myosin class is represented by eight members MYO1a-h, subdivided with 
regard to differences in the tail domain. They all share the common myosin structure 
expressing an N-terminal motor domain, the neck domain containing several regulatory light 
chain binding sites and the C-terminal tail domain. The tail regions comprise tail homology 
(TH)1 domains responsible for membrane interaction and a pleckstrin homology (PH) domain 
which is a putative lipid-binding motif. MYO1e and MYO1f are termed ‘long-tail’ myosins 
according to the expression of an additional TH2 and SRC homology (SH)3 domain (Fig.4) 
TH2 mediates an ATP independent actin interaction and SH3 a direct interaction with other 
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proteins [99, 108]. The functional activity and subcellular localization of the proteins depends 
on the regulation of these domains. Related investigations have been mainly done in lower 
eukaryotes like yeasts, Acanthamoeba, Dictyostelium, or Aspergillus. Here, ATPase activity 
of the motor region is stimulated through a kinase induced phosphorylation of conserved 
phospho-sites within the catalytic myosin I heads, called ‘TEDS rule’ (threonine or serine, 
aspartyl or glutamyl residues). Higher eukaryotes do not require TEDS phosphorylation 
because they have a negatively charged aspartate or a glutamate at this site, which seems to be 
important for the activity of this region [103, 109]. In addition to heavy chain 
phosphorylation, the change in Mg
2+
 ion concentration regulates MYO1 motor activity [110]. 
IQ motifs of the neck region have a higher affinity to Ca
2+
 free calmodulin (CaM), assumed to 
have a function in controlling the length of the myosin lever arm and regulation of the power 
stroke. Interaction with Ca
2+
 bound calmodulin inhibits myosin 1 kinase activity and seems to 
prevent lever arm movement [103, 104, 111, 112]. The tail region with its binding domains is 
responsible for the subcelluar distribution and function of the respective MYO1 [103]. 
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Motor IQ TH1 PH TH2 SH3
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Figure 4 Schematic overview of the 
class I myosin family with respective 
domain structure. Based on tail 
domain comparison this group is 
subdivided into 8 members. MYO1e 
and f are called ‘long-tailed’ myosins 
regarding the expression of an 
additional TH2 and SH3 domain. The 
other members termed ‘short-tail’ 
myosins. The N-terminal motor domain 
(blue) is followed by the neck-region 
containing 1-6 regulatory CaM light 
chain binding sites (yellow) and ending 
in the C-terminal tail domain (red). 
Modified scheme from McConnell et al. 
Trends Cell Biol 2010 [99]. 
 
These myosins are described as membrane – cytoskeleton crosslinkers and thus may 
contribute in the control of plasma membrane tension, vesicle shedding and transport as well 
as endo- and exocytosis [99]. The role of this myosin class in vertebrate cells, especially 
immune cells, has moved into the focus of research. In macrophages, phagocytosis of foreign 
material is a very important mechanism which depends on cytoskeletal rearrangements. A 
recruitment of MYO1c in primary MØ [113] and MYO1g in J774 cells was observed in Fcγ-
receptor mediated phagocytosis. The recruitment of MYO1g to the phagocytic cup and even 
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the whole engulfment process downstream of Fcγ-receptor was dependent on its PH domain 
[114].  
In B-cells MYO1c is necessary for cell spreading and also accumulates within the 
immunological synapse. Cells lacking MYO1c lost the ability to cluster MHC-II molecules on 
their surface resulting in an impaired T-cell activation [115, 116]. Furthermore, MYO1g was 
shown to regulate B-cell migration, endo- and exocytosis as well as cytoskeletal plasticity  
[116, 117]. 
1.4.3.2 Myosin1e and Myosin1f 
MYO1e and MYO1f are termed ‘long-tailed’ myosins because of the expression of an 
additional C-terminal TH2 and SH3 domain. Sequence alignments of both proteins show a 
71% homology on amino acid level, and a strikingly high sequence analogy of 94-96% 
between mice and human species. Both myosins are differently expressed in cells of the 
innate and adaptive immune system. While MYO1f is predominantly expressed in immune 
cells, MYO1e can be found ubiquitously [98, 118]. Long-tailed myosins are plus-end 
directed, low-duty ratio motor molecules which accumulate in actin rich regions, mainly 
known from investigations of their homologues in lower eukaryotes [106, 109, 119]. They are 
able to crosslink actin filaments via their TH2 domain, and even an interaction with 
microtubules by TH1-TH2 domain binding was observed [109, 120]. In vertebrate cells the 
TH2 domain is important for myosin1 recruitment to endocytic structures [121, 122]. In rat 
liver cells, an auto-inhibition of the long-tailed myosin I (MYR3) by its own tail domain and 
by Ca
2+
 binding to its light chain calmodulin is described. Experiments with MYR3 tail 
domain mutant constructs revealed an intramolecular self binding of the SH3 domain to 
prolin-rich motifs present in MYR3 and thereby inhibit the ATPase activity [120]. 
First immunologically relevant observations for MYO1f were obtained from neutrophils 
lacking this long-tailed myosin. The cells exhibited a reduced motility and increased adhesion 
to fibronection and ICAM-1, resulting from an enhanced exocytosis of β2-integrin (CD18) 
containing granules. Localization of MYO1f in the cortical region of neutrophils was 
observed by fluorescence microscopy [118]. Experiments with a human neutrophils cell line 
(HL-60) revealed a PIP3-mediated MYO1f recruitment to the plasma membrane in response 
to chemoattractant fMLP. Substitution of the positively charged lysine (position 770) and 
arginine (position 780) residues to alanine within the TH1 domain prevented the PIP3 binding 
and the MYO1f recruitment [123]. Comparable results were obtained from experiments with 
human T-lymphocyte cell lines (Jurkat cells) were MYO1f also localized at the plasma 
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membrane [124]. These results suggest a possible role for long-tailed myosins in exocytosis 
processes. The closely related MYO1e was found to interact via its SH3 domain with the 
prolin-rich proteins dynamin and synaptojanin-1, known for their contribution in clathrin-
mediated endocytosis. However, removal of the TH1 and TH2 domain suppressed localization 
to clathrin-coated vesicles indicated that the interaction of the SH3 domain alone was not 
sufficient [121]. Further investigations identified an additional nonspecific electrostatic 
interaction of the MYO1e tail with vesicles containing negatively charged phospholipids and 
thus confirmed a contribution of long-tailed myosins in endocytosis [125, 126]. An important 
role of MYO1e in regulation of granules exocytosis was detected by experiments with 
Xenopus oocytes. Here, the localization of MYO1e to the surface of lectin-containing granules 
in the cortex of PMA treated cells was observed. Interfering with either overexpression or 
inhibition of MYO1e influenced the lectin secretion [127-129]. Furthermore, recent studies on 
fibroblasts provide evidence for a role of MYO1e in coordination of actin assembly during 
clathrin-mediated endocytosis. It was shown that MYO1e interacts via its SH3 domain with 
actin-regulatory and -binding proteins WIP/WIRE and N-WASP and target them to the 
endocytic site for ARP2/3 complex activation and formation of vesicles [122]. Gupta and co-
workers could show an active movement of MYO1e to the tips of active lamellipodia as well 
as a SH3 domain dependent co-localization with CARMIL, FHOD1, ARP3 and β3-integrins. 
Deletion of SH3 resulted in a decreased stable adhesion of the cells [130]. The knowledge 
about the regulation and functionality of MYO1e in primary immune cells is more limited. 
The class I myosin seems to be important during B-lymphocyte development and is expressed 
as one target of the Bruton’s tyrosine kinase (Btk) during differentiation [131]. In human DCs 
MYO1e was shown to control movement of MHC-II vesicles along actin filaments. Here the 
MHC-II transport was regulated by the GTPase ARF7 which interacts with MYO1e via its 
effector protein ARF7EP [19, 132]. Furthermore, MYO1e was also found to be expressed in 
podocytes of the kidney where it plays an important role in the formation of cell-cell junctions 
and is crucial for the filter function of the blood-urine barrier [133-135]. 
1.4.4 Integrins  
Integrins are important molecules responsible to link the extracellular matrix (ECM) to the 
actin cytoskeleton and transmit biochemical signals across the cell membrane [136]. These 
transmembrane receptors are essential for cell attachment, spreading, phagocytosis, signal 
transduction, cell-cell interaction, cell shape, motility and regulation of actin dynamics. Each 
integrin is build by a non-covalent heterodimerization of a α- and β-subunit. 8 α-subunit and 8 
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β-subunit are known in vertebrates characterized to form 24 different integrins partially 
specific or redundant in their ligand interaction [137]. Not all of these molecules are 
constitutively active and thus require an activation by an inside-out signaling mediated in 
response to other receptors e.g. chemokine receptors, T- or- B-cell receptors or activation of 
TLRs. The activation by an inside-out signal leads to a conformational change of the integrin 
and allows binding to extracellular ligand. In contrast the ligand binding generates an  
outside-in signal of the integrin which in turn induces intracellular signal cascades to regulate 
required cell functions [138]. An important β2-subunit expressed on MØ is CD18 which forms 
the functional integrin Mac-1 through interaction with αM-subunit CD11b or by interaction 
with αL-subunit CD11a the integrin LFA-1. Both heterodimers play essential roles in MØ 
immunity. In J774.A1 cells it was found that LPS activated CD11b/CD18 via MYD88, IRAK, 
p38 and RAP1 GTPase signaling is responsible for effective cell spreading. Furthermore, the 
RAP1 GTPase mediated activation of the αMβ2-integrin after LPS stimulation was required 
to effectively phagocytose C3bi-opsonized target [139, 140]. Inhibition of integrin signaling 
or culturing RAW cells in low-adherence plates reduced TLR4-driven ERK and JNK 
phosphorylation and resulted in a decreased TNF production. This demonstrates that TLR4 
requires the cooperation of integrin receptors for a full response [136]. Moreover it was 
shown that TLR4 rapidly activated CD11b through inside-out signaling via PI3K, RAPL 
GTPase pathway in murine macrophages and subsequently down-regulated the TLR4 
response via outside-in signaling through SRC and SYK. Activation of these tyrosine kinases 
leads to degradation of phosphorylated MYD88 and TRIF to dampen the TLR4 signaling and 
prevent a hyper-response [141]. 
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2 Aim of the Study 
The cytoskeleton is a highly dynamic structure of intracellular filaments present in all pro- 
and eukaryotic cells [42]. This cell compartment and its specific associated proteins possess 
scaffolding properties and serve as important regulators in immune cell functions starting 
from cell maturation, to cell recruitment and adherence, inter- and intracellular signaling and 
transport processes. Defects in this sensible and complex system can cause immune 
deficiencies like the Wiskott-Aldrich syndrome (WAS) induced by mutations within the 
WAS-protein [43, 44]. Furthermore, bacterial and viral pathogens developed strategies to 
manipulate the cytoskeleton and subvert immune cells [45-47]. Thus, for a better 
understanding of this structure it is essential to further investigate which cytoskeletal 
processes and components contribute to the control and regulation of immune cell responses.  
 
The regulation of the cytoskeleton, as well as of individual cytoskeletal proteins, are well 
described in fibroblasts, stable cell lines and lower eukaryotes, but less is known about their 
function and regulation in primary cells of the immune system. The starting point for this 
study was a phosphoproteome analysis of TLR4-activated bone-marrow derived 
macrophages, which highlighted the cytoskeleton as a hotspot of LPS-induced protein 
phosphorylation [30]. This finding stressed the potential impact of TLR activation on the 
cytoskeleton and associated macrophage functions like phagocytosis and motility. In addition, 
the identification of a large number of cytoskeletal proteins with LPS-regulated 
phosphorylation provides molecular candidates whose individual regulation and contribution 
to TLR-induced macrophage responses are yet mostly unknown.  
 
To investigate these questions generates a need to measure and manipulate cytoskeleton-
dependent macrophage functions in a quantitative manner. We therefore first aimed to 
develop and validate a microscopy-based quantitative method to determine the macrophage 
spreading response as a readout system with potential to apply as high or middle throughput 
screen. Furthermore, through utilization of specific KO mice, pharmacological inhibitors and 
specific siRNA knockdown the role of known TLR4 signal components and newly identified 
phosphoproteins should be revealed in this context. As a consequence of the screen interesting 
and contributing candidate proteins should became the focus of more detailed investigations 
to reveal further involvement and regulation of important TLR4-driven immune cell 
functions. 
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3 Material and Methods 
3.1 Material 
3.1.1 Chemicals and reagents 
Acetic acid glacial (C2H4O2)     # 3738.1 Roth 
Acrylamide/Bis-acrylamide Gel 40 %, Rotiphorese  # A515.1 Roth 
Ammoniumchloride (NH4Cl)    # 1.01145 Merck 
Ammoniumpersulfate (APS, (NH4)2S2O8)   # 31117 Fluka 
Bovine Serum Albumin (BSA)    # K45-001 PAA 
Bromphenol blue (C19H9Br4NaO5S)    # B-5525 Sigma-Aldrich 
Carboxyfluorescein succinimidyl ester (CFSE)  # 422701 BioLedgend 
Chloroform (CHCl3)      # 102445 Sigma-Aldrich 
Deoxycholic acid (C24H40O4)    # D6750 Sigma-Aldrich 
DEPC water (PCR grade)     # T143.3 Roth 
Dimethylsulfoxide (DMSO, C2H6OS)   # D-5879 Sigma-Aldrich 
Ethidiumbromide solution (C21H20BrN3)   # E15-10 Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA) disodium salt # 8043-2 Roth 
Ethanol (for analysis, denatured, C2H6O)   # 1.00974 Merck 
β-glycerophosphate disodium salt (C3H7Na2O6P)  # 35675 Calbiochem 
Glycine (C8H9NO3)      # 3790.3 Roth 
Glycerine (C3H8O3)      # 49767 Fluka 
Glycogen ((C6H12O6)n=7-11)     # AM9510 Ambion 
Hydrochloric acid (HCl)     # 6331.3 Roth 
[
3
H]-Thymidin      PerkinElmer, Rodgau, Germany 
β-mercaptoethanol (C2H6OS)    # M-7154 Sigma-Aldrich 
Methanol (MeOH, CH4O)     # 20847.307 VWR 
Mounting medium (DAPI containing)    # SCR-38448 Dianova 
Phosphate buffered saline (PBS)    # 1.15925 Biochrom & in house 
Phosphoric acid (H3PO4)     # 21510-4 Sigma-Aldrich 
Polybrene (Hexadimethrine bromide, 6 mg/ml in PBS) # 107689 Sigma-Aldrich 
Ponceau S C22H16N4Na4O13S4)    # P-3504 Sigma-Aldrich 
2-propanol (C3H7OH)     # 109634 Merck 
FProtease inhibitor cocktail cOmplete   # 11697498001 Roche 
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Sodium chloride (NaCl)      # 3957.1 Roth 
Sodium fluoride (NaF)     # S7920 Sigma-Aldrich 
Sodium hydroxide (NaOH)     # 1.06498 Merck 
Sodium nitrite (NaNO2)     # 1065490100 Merck 
Sodium orthovanadate (Na3VO4)    # S6508 Sigma-Aldrich 
Substrate for ELISA, OptiEIA    # 555214 BD Biosciences 
Substrate for WB, Immobilon Western   # WBKLS0500 BD Biosciences 
Sulfanilamide (4-aminobenzenesulfonamide, C6H8N2O2S) # 86060 Fluka 
Sulphuric acid (H2SO4)     # 4623.4 Roth 
Tetramethylethylenediamine (TEMED, C6H16N2)  # 87689 Fluka 
Trifast        # 30-2030 Peqlab 
Tris base (C4H11NO3)      # 5429.2 Roth 
Trypan blue (C34H28N6O14S4)    # T-8154 Sigma-Aldrich 
Tween 20 (Polysorbat 20, C58H114O26)   # 8.22184 Merck 
 
3.1.2 Kits and enzymes 
Accutase       # L11-007 PAA 
DuoSet ELISA Development System     R&D 
 TNF-α       # DY410 
 IL-10       # DY417 
 IL-12p40      # DY499 
IL-6       # DY406 
IL-2       # DY402 
IFN-γ       # DY485 
CCL3       # DY450 
CCL4       # DY451 
IP-10       # DY466 
ELISA MAX
TM
 Standard Set      BioLedgend 
CCL2/MCP-1      #432703 
High Capacity cDNA Reverse Transcription Kit  # 4368813 Applied Biosystems 
peqGold dNTP Mix (10 mM each nucleotide)  # 20-3011 Peqlab 
peqGold Taq DNA-Polymerase ‘all inclusive’  # 0191411-1 Peqlab 
RNeasy Micro Kit      # 74004 Quiagen 
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3.1.3 Western blot antibodies and protein ladder 
3.1.3.1 Western blot antibodies 
All antibodies (Table 2) required for protein detection by Western blot (WB) analysis were 
diluted in 3%BSA in TBS-T. The respective secondary horseradish peroxidase (HRP)-
conjugated anti- antibodies were purchased from Jackson ImmunoResearch (#711-036-152, 
#115-036-068) and applied in a 1:10.000 dilution. To determine protein size the PageRuler 
Prestained protein ladder purchased from Fermentas (# 26616) was utilized. 
 
Table 2. Primary antibodies (recognizing mouse proteins) for WB 
Antibody Source Dilution 
Expected 
band size 
Catalog 
number 
Company 
anti-ERK1/2 Rabbit 1:1000 42/44 kDa # 4695 Cell Signaling 
anti-pERK 
(Thr202/Tyr204) 
Rabbit 1:2000 42/44 kDa # 4370 Cell signalling 
anti-p38 Rabbit 1:1000 43 kDa # 9212 Cell signalling 
anti-pp38 
(Thr180/Tyr182) 
Rabbit 1:1000 43 kDa # 9211 Cell signalling 
anti-GRB2 Mouse 1:10.000 24 kDa # 610112 BD 
anti-pMK2 (Thr334) Rabbit 1:1000 49 kDa # 3007 Cell Signaling 
anti- MYO1e Rabbit 1:800 127 kDa 
17768-1-
AP 
Proteintech 
Europe 
 
3.1.4 Primers and probes 
Genotyping of mice was done by Barbara Bodendorfer. In case of Myo1e KO mice the screen 
was done by Sharon Chase (Department Cell and Developmental Biology, SUNY Upstate 
Medical University, Syracuse, NY, USA). Conditional p38 KO mice [142] were screened and 
obtained after polyI:C treatment from the group of Jean Pierre David in Erlangen.  
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Table 3. Genotyping primers 
Tagret Name Primer pairs Band size 
Dusp1-/- 
RL 300 caggtactgtgtgtcggtggtgctaatg 
300 & 301 : wt ~300 bp 
302 & 301 : ko ~250 bp RL 301 ctatatcctcctggcacaatcctcctag 
RL 302 aaatgtgtcagtttcatagcctgaagaacg 
Dusp16-/- 
(gene trap) 
RL 528 cgctcttaccaaagggcaaaccc 
536 & 535 : wt ~450 bp 
528 & 535 : ko ~650 bp 
RL 535 ccatctcatggcagaggagtgact 
RL 536 gacctgtgcataactggccctactac 
Myd88-/- 
RL 665 
 
agacaggctgagtgcaaacttgtgctg 
 
665 & 667 : wt ~1000 bp 
666 & 667 : ko ~1000 bp RL 666 
 
agcctctacacccttctcttctccaca 
 RL 667 atcgccttctatcgccttcttgacgag 
Myo1e-/- 
#1 ttccgcttacggtggaaatg 
#1 & #3: - wt --, ko ~250bp 
#3 & #4: -wt ~150bp, ko -- 
#3 tcatgtgtagcccaagctcacc 
#4 actcattctgtcatctgactccacc 
Rag1-/- 
RL984 gaggttccgctacgactctg 
984 & 985 : wt 474bp 
985 &986 : ko 530bp 
RL985 ccggacaagtttttcatcgt 
RL986 tggatgtggaatgtgtgcgag 
 
The quantitative Real-time polymerase chain reaction (qRT-PCR) analysis to determine gene 
expression was performed using specific primers and probes (Table 4) designed by the 
Universal ProbeLibrary (UPL, Roche) and employment of the FastStart Universal Probe 
Mastermix (Roche). 
 
Table 4. Primer and probe combinations used for quantitative Real-time PCR  
Gene of interest Primer number primer sequence UPL 
Actr3 
(ARP3) 
RL1049 gactttggacgtcgtttgc 
# 64 
RL1050 catcaataggcttgggcttc 
Ccl2/Mcp-1 
RL473 tcactgaagccagctctctct 
# 22 
RL474 gtggggcgttaactgcat 
Ciita 
(CIITA) 
RL822 gatgtggaagacctggatcg 
# 110 
RL823 tgcatcttctgaggggtttc 
Coro1b 
RL1055 ttcagccgcatgagtgaac 
# 17 
RL1056 gtagagccccattgcttgaa 
Eps8 
RL1053 cactgggagatagttgggtga 
# 108 
RL1054 ggacgtaaggtgggatgaac 
Fhod1 
RL1043 gctctgcaccgactcctg 
# 78 
RL1044 atccggagggagacacttg 
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Fmn1 
RL1045 ttccacattgctgttcatcc 
# 4 
RL1046 cagcgggaaaacactcttgt 
Hprt RL415 tcctcctcagaccgctttt # 95 
RL416 cctggttcatcatcgctaatc 
Lsp1 
RL1220 acccacaccgaagacacc 
# 75 
RL1221 ttcctcgtcttcttctctcca 
I-Ab1 
(MHC-II) 
RL824 gtggtgctgatggtgctg 
# 26 
RL825 ccatgaactggtacacgaaatg 
Mtss1 
RL1222 cttcataaacaaagccggaaa 
# 33 
RL1223 gctgctgctactactgttgtcc 
Myo1e 
RL1183 ccaaggagcgcacagtatgag RL1228 
(5’-FAM-3’BHQ) 
acccgcctcatatctatgccct
tgctg 
RL1184 tctctgtcgatcgatcatgtttctgta 
Myo1f 
RL1017 cctacataccatccctcacca 
# 53 
RL1018 tccactctgcttcacgttgt 
All primers were purchased from Metabion. Myo1e probe and primer were designed by SDS 
2.4.1 software from Applied Biosystems and ordered from Metabion. 
3.1.5 siRNA 
Small interfering RNA oligonucleotides (siRNA) for selective gene silencing were purchased 
from Dharmacon (Thermo Fisher Scientific) using Dharmacon’s pre-validated  
ON-TARGETplus siRNA database. Each specific siRNA set composed of a pool of four 
specifically directed siRNAs. Lyophilized siRNAs samples were resuspend in 1-fold siRNA 
buffer from Dharmacon to a final concentration of 20 µM, heated for 1 min to 90°C and 
incubate at 37°C for 60 min on a thermo shaker. Dissolved samples were stored in aliquots at 
-80°C. 
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Table 5. siRNAs for selected gene silencing 
Target gene Gene ID siRNA catalog number 
Actr3 (Arp3) 74117 # L-046642-01-0005 
Coro1b 23789 # L-048421-01-0005 
Eps8 13860 # L-045154-01-0005 
Fhod1 234686 # L-057380-01-0005 
Fmn1 14260 # L-042798-01-0005 
Lsp1 NM_019391 # L-043955-01-0005 
Mtss1 211401 # L-041040-01-0005 
Myo1f 17916 # L-050897-01-0005 
non-silencing siRNA (nsRNA) 
(control) 
--- # D-001810-01-20 
3.1.6 Antibodies for immunofluorescence analysis 
Antibodies for FACS analysis and fluorescence microscopy imaging (Table 6) were diluted in 
0,2%BSA/PBS. Stained FACS samples were stored up to 5 days in 2% PFA/PBS at 4°C. 
Specimens for fluorescence microscopy were covered with DAPI containing mounting 
medium (Dianova SCR-38448), sealed with nail polish and stored at 4°C.  
 
Table 6. Conjugated primary antibodies for immunofluorescence 
Antibody 
Conjugated 
fluorophore 
Dilution Clone 
Catalog 
number 
Company 
B220 PE 1:400 RA3-6B2 553089 BD 
CD11a PerCP 1:400 M17/4 46-0111-82 eBioscience 
CD11b Violet421 1:400 M1/70 101235 BioLegend 
CD11b APC 1:400 M1/70 101212 BioLegend 
CD11c PE-Cy7 1:400 N418 25-0114-82 eBioscience 
CD16/CD32 
(Fc-block) 
- 1:1000 93 14-0161-86 eBioscience 
CD18 PE 1:400 M18/2 12-0181-81 eBioscience 
CD19 PE 1:400 6D5 115508 BioLegend 
CD29 APC 1:200 eBioHMb1-1 17-0291-80 eBioscience 
CD3 PerCP 1:100 145-2C11 100326 BioLegend 
CD4 FITC 1:800 GK1.5 100406 BioLegend 
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CD40 APC 1:400 3/23 558695 BD 
CD45.1 APC 1:300 A20 110720 BioLegend 
CD61 FITC 1:200 2C9.G3 11-0611-81 eBioscience 
CD8a eFluor450 1:400 53-6.7 48-0081-82 eBioscience 
CD80 PE 1:200 16-10A1 104707 BioLegend 
CD86 FITC 1:200 B7-2 (GL1) 553691 BD 
F4/80 FITC 1:200 BM8 123108 BioLegend 
Ly6C FITC 1:400 AL-21 553104 BD 
Ly6G PE 1:400 1A8 551461 BD 
MHC-II 
(I-A/I-E) 
PerCP 1:1000 M5/114.15.2 107623 BioLegend 
MHC-II 
(I-A/I-E) 
eFluor450 1:400 M5/114.15.2 48-5321-82 eBioscience 
NK1.1 PE-Cy7 1:100 PK136 25-5941-82 eBioscience 
PDCA PE 1:400 eBio927 12-3172-81 eBioscience 
3.1.7 Buffers 
Buffers and water-soluble reagents were prepared with high-purity water (HPW) from the in-
house Milli-Q purification system. 
3.1.7.1 ELISA 
Buffers listed in Table 7 were used for Enzyme-linked-Immunosorbent Assay (ELISA). 
Table 7. Buffers for ELISA 
Coating buffer  
(only for CCL2 ELISA BioLedgend) 
8,4 g sodium bicarbonate (NaHCO3); 3,56 g sodium 
carbonate (Na2CO3), pH9,5 in 1L HPW 
(according to manufacturer’s instructions) 
Blocking buffer 1% BSA in 1x PBS 
Stop solution 2 N sulphuric acid (H2SO4) in HPW 
Wash buffer 0.05% Tween 20 in 1x PBS 
3.1.7.2 SDS Page and Western Blot 
Recipes for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) buffers 
and Western blot are shown in Table 8. 
In all cases, 10% SDS gels were prepared for protein separation as described in Table 8. 
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Table 8. Buffers for SDS-PAGE and Western blot 
Buffer Compostion 
4x Lämmli 
6.25 ml 1 M Tris base/HCl (pH 6.8; 62,5 mM final)); 2 g SDS (2% final); 
20 ml glycerol (20% final); 400 µl 0.5 M EDTA (2 mM); 
100 mg Bromphenol blue; add HPW to a final volume of 100 ml. 
Add 70 µl β-mercaptoethanol to 1 ml Lämmli buffer freshly before use. 
Ponceau 
staining 
0.5 g Ponceau S (0.1 %) dissolved in 500 ml 5 % glacial acetic acid. 
Ripa 
Add to 150 ml 1x PBS (keep order as listed): 
2 g sodium deoxycholate (25.5 mM final); 2 ml 10% SDS (0.1% final); 
0.8 ml 0.5 M EDTA (2 mM final); 0.42 g sodium fluoride (50 mM); 
2 ml NP40 (1 % final); add 1x PBS to a final volume of 200 ml. 
Add freshly before use: 
1:50 sodium fluoride (0.5 M); 1:50 Roche Complete (1 tablet in 1 ml); 
1:100 β-glycerophosphate (1 M); 1:200 sodium orthovanadate (200 mM) 
4x Resolving 
gel 
36,3 g Tris base (1.5 M) in 200 ml HPW adjust to pH 8.8 with HCl, 
store at 4°C 
4x Stacking gel 
12 g Tris base (0.5 M) in 200 ml HPW adjust to pH 6.8 with HCl, 
store at 4°C 
Stripping 0.2 N NaOH in HPW 
10x Tank 
60.56 g Tris base (250 mM); 288 g glycine (1.9 M); 
200 ml 10% SDS (1%) 
Adjust to a final volume of 2 l with HPW, store at RT 
1x Tank Dilute 10x tank buffer 1:10 with HPW. 
10x TBS 
48.4 g Tris base (200 mM); 160 g sodium chloride (1.4 M) 
Adjust to pH 7.6 with HCl and add HPW to a final volume of 2 l. 
TBS-T Dilute 10x TBS 1:10 and add 0.1% Tween 20. 
10x Transfer 
48.4 g Tris base (200 mM); 216.4 g glycine (1.44 M); 
100 ml 10% SDS (0.5 %) 
Adjust to a final volume of 2 L with HPW, store at RT. 
1x Transfer 
1x transfer buffer consists of 
10x transfer buffer (1:10) and 10% Methanol in HPW 
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Table 9. SDS-PAGE gel composition  
Calculated for two 20 cm x 10 cm gels, *add directly before casting 
Reagents 
Resolving gel 
10% 
Stacking gel 
4% 
Acrylamide 12.6 ml 1.5 ml 
Resolving gel buffer 12.6 ml - 
Stacking gel buffer - 4 ml 
10 % SDS 0.5 ml 160 µl 
HPW 24.4 ml 10.4 ml 
10 % APS* 300 µl 80 µl 
TEMED* 70 µl 16 µl 
 
3.1.7.3 Cell culture 
Buffers applied for cell culture: 
Table 10. Buffers for cell culture 
Erylysis buffer 
9.1 g ammonium chloride (0.17 N) in 1 L HPW 
+ 20 ml 1 M Hepes in HPW (20 mM final); ~pH 7.0 
pH is not adjusted, sterile filtered, store at RT 
PBS 
37 mM NaCl; 2.7 mM KCl; 80 mM Na2HPO4 
pH 7.4, autoclave, store at 4°C 
Trypan blue 0.04% in PBS 
 
3.1.8 Bacteria and medium 
E.coli (E550 ATCC 25922) was stored in glycerol stocks at -80°C. 24 h prior to intra 
peritoneal (i.p.) injection into mice the bacteria were cultured at 37°C in autoclaved lysogeny 
broth (LB) media (without antibiotics). LB media contains 5 g/l yeast extract, 10 g/l tryptone 
and 10 g/l NaCl (pH 7.0). Bacteria number was adjusted to 4*10
8
/ml by measurement of the 
optical density (OD600) and dilution in sterile PBS. E.coli were inactivated by incubation at 
65°C for 20 minutes.  
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3.1.9 Cell culture media, supplements and stimulatory agents 
3.1.9.1 Media 
Dulbeco’s modified Eagle’s Medium (DMEM) 
High Glucose (4.5 g/l)     # E15-810 PAA 
RPMI 1640        # E15-840 PAA 
Opti-MEM        # 11058-021 Invitrogen 
3.1.9.2 Supplements 
β-mercaptoethanol       # M-7522 Sigma-Aldrich 
(10 mM Stock in 1x PBS, sterile filtered, stored at 4 °C, 50 µM final) 
Penicillin/Streptomycin (100x)    # P11-010 PAA 
Foetal Bovine Serum (FBS)     # F7524 Sigma  
Foetal Bovine Serum (FBS)     # S0115 Biochrome 
Donor Horse Serum (HRS)     # S-HEU03-I CellConcepts 
Non-essential amino acids      # M7145 Sigma-Aldrich 
Hank's Balanced Salt Solution (HBSS)   # H15-008 PAA 
 
3.1.9.3 Complete DMEM (cDMEM) and complete RPMI (cRPMI) 
Preparation of complete cell culture media DMEM High glucose or RPMI was done by 
supplementation with 10% FBS, 1x Penicilin (100 U/ml) / Streptomycin (1 mg/ml), 2,5 ml  
β-Mercaptoethanol (0.05 mM). Medium for macrophage differentiation in hydrophobic 
Teflon bags were complete by addition of 10% FBS, 5% HRS, 2,5 ml β-Mercaptoethanol 
(0.05 mM), 1:100 non-essential amino acids (Sigma, M7145, stock 100x). 
3.1.9.4 Stimulatory agents 
LPS (E. coli 055:B5)      # L-6529 Sigma-Aldrich 
 Stock 10 µg/ml in media (4°C), final 100 ng/ml  
Interferon γ (murine, recombinant, source: E. coli)  # 315-05 Peprotech 
 Stock 1 mg/ml in PBS (-20°C), Stock 1 µg/ml in media (4°C), 50 ng/ml final 
OVA (Albumin from chicken egg white)   # A5503 Sigma-Aldrich 
 Stock 100 mg/ml in PBS (-20°C), 2 mg/ml final 
DQ-OVA (OVA; heavily labeled with BODIPY
® 
dye) #D12053 Lifetechnologies 
 Stock 1 mg/ml in PBS (-20°C), 20 µg/ml final 
3.1.9.5 Inhibitors  
Cytochalasin D      # C8273 Sigma-Aldrich 
 Stock 4mM in DMSO (-20°C), final 5µM  
PD184352 (MEK1 inhibitor)     #S1020  Selleck Chemicals. 
 Stock 10 mM in DMSO (-20°C), final 10 µM  
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3.1.10 Consumable items 
Blotting paper       # GB-40 Hartenstein 
Cell culture dishes 
 Nunclon delta (Ø 10 cm)    # 150350 Nunc 
 Tissue culture polystyrene dish, 150 x 25 mm style # 353025 BD Falcon 
Cell culture plates 
 96-well Nunclon (F bottom)    # 167008 Nunc 
 24-well Nunclon     # 662160 Greiner bio-one 
12-well Nunclon     # 3512  Costar 
CD4 (L3T4) MicroBeads, mouse     #130-049-201 MiltenyBiotec 
CD45R (B220) MicroBeads, mouse    #130-049-501 MiltenyBiotec 
Cell Strainer 70 µM      # 352350 BD Falcon 
Cryotube Vials (1 ml)     # 366656 Nunc 
ELISA plates MaxiSorp     # 442404 Nunce 
Electroporation chambers     # 71-2030 Peqlab 
MACSiMAG Seperator     #130-092-168 MiltenyBiotec 
MACS Separation columns (LS)    #130-042-401 MiltenyBiotec 
Needles (sterile) 
 27G x ¾’’, Nr. 20 (0.4 mm x 19 mm)  # 302200 BD Microlance 3 
 22G x 1 ¼’’, Nr. 12 (0.7 mm x 30 mm)  # 300900 BD Microlance 3 
 14G x 2’’, IV indwelling cannula (2.2 x 50 mm) # 4252217B Henke Sass Wolf 
Nitrocellulose transfer membrane Protran   # 10 401 396 Whatman 
Petri Dishes       # 82.1473.001 Sarstedt 
Permanox chamber slides     # 177445 Nagle Nunc 
Pipets Stripette (5 ml / 10 ml / 25 ml)   # 4487/88/89 Costar 
Pipet tips 
0.1 - 20 µl, epT.I.P.S     # 022492012 Eppendorf 
2 - 200 µl, epT.I.P.S     # 0030000.870Eppendorf 
200 - 1000 µl,      # 729065 Biozym 
2.5 ml (PD-tips, multistep pipet)   # 702388 Plastibrandrand 
5 ml (PD-tips, multistep pipet)   # 702390 Plastibrandrand 
Filter tips 
0.5 – 20 µl, Biosphere filter tips   # 70.1116.210 Sarstedt 
20 µl, Biosphere filter tips    # 70.760.213 Sarstedt 
2 – 200 µl, Biosphere filter tips   # 70.760.211 Sarstedt 
100 - 1000 µl, Biosphere filter tips   # 70.762.211 Sarstedt 
Polypropylene Conical Tubes 15 ml    # 352096 BD Falcon 
Polypropylene Conical Tubes 50 ml    # 352070 BD Falcon 
Reaction plates 
 384 well reaction plate    # 4343370 Applied Biosystems 
Reaction plate covers 
 QPCR adhesive clear seal    # 4ti-0560 4titude 
Reaction tubes 
 PCR tubes, 0.5 ml     # 0030124537 Eppendorf 
 Safe-lock, 1.5 ml      # 0030120.086 Eppendorf 
 Safe-lock, 2.0 ml     # 0030120.094 Eppendorf 
 1.5 ml PP      # 421-800 J. Peske GmbH 
Steritop filter 0.22 µm     # SCGPT05RE Millipore 
Syringes 
 1 ml, Soft-JECT  Tuberculin   # 5010-200V0 Braun 
Material and Methods  32 
 
 10 ml, Discartid     # 309110 BD Biosciences 
 50 ml       # 300866 BD Plastipak 
Teflon foil for bag preparation DuPont, purchased via Cadillac 
Plastic, Karlsruhe, Germany 
3.1.11 Laboratory equipment 
1450 microplate scintillation counter    Wallac, Turku, Finland 
Analytical Balance Acculab (max. 210 g)    Satorius group 
AxioCam MRm camera      Carl Zeiss Microscopy 
Balance Scout Pro (max. 600 g)     Ohaus 
Biophotometer       Eppendorf 
Bioruptor        Diagenode 
Centrifuge Heraeus Pico 17      Thermo Scientific 
Centrifuge Heraeus Fresco 17     Thermo Scientific 
Centrifuge Heraeus Multifuge 3SR+     Thermo Scientific 
ChemiLux Imager, incl. CCD camera (WB documentation) INTAS 
Electrophoresis Power Supply EV261 / EV243   Peqlab 
SPECTRAmax 340PC ELISA Reader    Molecular Devices 
Flow Cytometer FACS Canto II     BD 
Freezer (-20°C)        Liebherr 
Freezer (-80°C)       Thermo Scientific 
Fridge (4°C)        Liebherr / Siemens 
GenePulser Xcell       Bio-Rad 
Ice machine        Ziegra Eismaschienen 
IH-110 harvester for 96-well deep unifilter plates   Inotech 
Incubator Hera Cell 240      Thermo Scientific 
Laboratory Water Bath Aqualine AL12    LAUDA 
Laminar Flow HeraSafe      Thermo Scientific 
Liquid Nitrogen Tank (N2), 35VHC     Union Carbide 
Microscope Axiovert 40C      Zeiss 
Microwave        Severin 
Milli-Q Biocel, Q-Guard2, Ultrapure Organex Cartridge (# QTUM000EX) Millipore 
Multichannel pipets Finnpipette (5-50 µl / 50-300 µl)  Thermo Scientific 
Multistep pipet Handystep S       Brand 
Neubauer counting chamber Improved    Brand 
PerfectBlue Gelsystem Mini S & Mini L    Peqlab 
 Just Cast (adjustable casting chamber)   Peqlab 
Perfect Blue Tank Electroblotter Web M    Peqlab 
 Fiber mat       Peqlab 
Perfect Blue Doppelgelsystem Twin ExW S   Peqlab 
Pipetboy acu        Integra Biosciences 
Pipets (1000 µl, 200 µl, 20 µl, 10 µl, 2 µl)    Gilson 
Rocking Platform (RT)      VWR 
Shaker Polymax 2040 (4°C)      Heidolph Instruments 
Spectrophotometer Nanodrop 1000     Peqlab 
Taqman 7900 HT Fast Real-Time PCR System   Applied Biosystems 
Thermocycler T3000       Biometra 
Thermocycler TGradient      Biometra 
Thermomixer compact / comfort     Eppendorf 
Vacuum pump BVC21      Vacuubrand 
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Vortex-Genie 2       Scientific Industries 
Zeiss AxioVert 200M      Carl Zeiss Microscopy 
3.1.12 Software 
Adobe Acrobat Reader X       Adobe Systems 
Adobe Photoshop CS2 / CS5      Adobe Systems 
AxioVision Rel 4.8       Zeiss 
Endnote X4        Thomson Reuters 
ChemoStar Imager V.0.1.25      INTAS 
FACSDiva Software V6.12      BD 
FlowJo 7.6.5        TreeStar, Inc 
Gel documentation system GDS V3.28    INTAS 
Graph Pad Prism 4       Graph Pad Software 
MS Office Professional Plus 2010 Version 14.0.6106.5005 Microsoft 
NanoDrop ND1000 Version 3.6.0     Thermo Scientific 
Probe finder         Roche Applied Science 
SDS RQ Manager 1.2      Applied Biosystems 
Sequence Detection System 7900 HT SDS 2.3   Applied Biosystems 
SoftMax Pro 5.4        Molecular Device 
VectroNTI 9.1.0       Invitrogen  
 
3.2 Methods 
3.2.1 Molecular biology 
3.2.1.1 RNA isolation 
The isolation of RNA from cell lysates was mainly performed by a phenol/choroform 
extraction method. 5*10
5
 – 1*106 stimulated or unstimulated cells were directly lysed by 
adding 500µl TriFast
TM
 to each well and RNA preparation was performed according to the 
manufacture’s protocol. Subsequently the RNA pellet was resuspended in 15µl PCR-grade 
water. In case of siRNA treatment 2*10
5
 cells were used for RNA extraction and RNA 
isolation was performed using RNeasy Mini Kit (Qiagen) according to the manufacture’s 
protocol. The RNA concentration and purity was determined by using the Nanodrop ND-1000 
UV/Vis-spectrophotometer. Finally the extracted RNA was stored at -20°C or directly 
prepared for cDNA synthesis. 
3.2.1.2 cDNA synthesis 
Conversion of extracted RNA into random-primed single-stranded cDNA for qRT-PCR was 
performed by using the High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems) according to the manufacture’s protocol. For reverse transcription 200 ng - 1 µg 
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total RNA was add in 10 µl RNAse free water and complete with 10 µl master mix to a total 
reaction volume of 20 µl. The master mix composition and the used thermocycler program are 
shown in Table 11. 
Table 11. cDNA synthesis master mix and program 
cDNA synthesis master mix 
cDNA synthesis program 
Component Volume 
10x RT buffer 2 µl  Temperature Time 
10x Random Primers 2 µl Step 1 25 °C 10 min. 
25x dNTPs (10 mM) 0.8 µl Step 2 37 °C 120 min. 
Reverse Transcriptase 1 µl Step 3 85 °C 5 min. 
PCR grade water 4.2 µl Step 4 4 °C ∞ 
3.2.1.3 Quantitative real-time PCR and calculation of fold changes 
To identify the relative expression levels of different genes a quantitative real-time PCR 
(qRT-PCR) was performed based on the Universal ProbeLibrary System from Roche. The 
primer-probe combinations required for specific mRNA detection were designed by an online 
software provided on the Roche homepage. An intron-spanning assay was applied to 
minimize the risk of false positive signals arise from genomic DNA contamination in the 
RNA samples. The following PCR reactions occurred in a total volume of 12 µl (5µl cDNA 
dilution plus 7µl mastermix) and were performed in 384-well plates (15-50 ng cDNA per 
well) on the 7900HT Fast Real-Time PCR System. For the mastermix recipe see Table 12. 
To allow the comparison of target gene expression between different samples the 
deltadeltaCT (ΔΔCT) method was utilized to calculate the fold changes [143]. Therefore, the 
CT value (number of PCR cycles required to rise the fluorescence intensity significantly 
above the background signal) from the gene of interest was normalized to the CT value of the 
house-keeping gene Hprt and subsequently calculated to the untreated control used as 
calibrator. In case of siRNA treatment the unstimulated and non-targeting siRNA (nsRNA) 
challenged condition was used as calibrator.  
ΔCT   =  CTHprt – CTgene of interest 
  ΔΔCT   =  ΔCTtreated sample – ΔCTuntreated sample (average) 
  fold change  = 2
ΔΔCT 
Each condition was analyzed as single biological sample and each sample was assayed in 
technical duplicates. 
Material and Methods  35 
 
Table 12. Mastermix for qRT-PCR 
Component Volume Final concentration 
FastStart Universal Probe Master (ROX) (2x) 6 µl 1 x 
Forward / reverse primer (100 µM) 0.1 µl ~ 800 nM 
Probe (10 µM) 0.1 µl ~ 80 nM 
PCR grade water 0.7 µl  
 
Before PCR, the plates were centrifuged for 10 minutes at 900 x g and covered with an 
adhesive seal to avoid evaporation of the sample during PCR reaction (see Table 13). 
 
Table 13. Taqman program for qRT-PCR 
 Temperature Time Cycles 
Step 1 50°C 2 min.  
Step 2 95°C 10 min.  
Step 3 
95°C 15 sec. 
40 
60°C 1 min. 
 
3.2.1.4 Polymerase chain reaction 
The polymerase chain reaction was used to amplify specific DNA sequences for mouse 
genotyping. The peqGOLD Taq-DNA-Ploymerase system from Peqlab was applied with 
respective primers listed in Table 3. Cycling conditions for each PCR reaction were adapted 
to the product size.  
3.2.2 Immunoassays 
3.2.2.1 ELISA 
An enzyme-linked-immunosorbent assay (ELISA) was performed to determine cytokines and 
chemokines in the supernatant of activated macrophages and DCs. The R&D and BioLedgend 
sandwich ELISA were accomplished according to the manufacture’s protocol.  
3.2.3 Biochemical analysis 
Total or phosphorylated proteins in cell lysates were detected by SDS-PAGE and subsequent 
Western blot analysis [144]. 
3.2.3.1 SDS-PAGE 
Buffers and gel preparation was performed according to recipes listed in section 3.1.7.2. At 
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least 1*10
6
 cells were lysed in 150 µl RIPA buffer and mixed with 50 µl Lämmli buffer 
before heated at 95°C for 10 min. A final sonication step was performed to complete the 
protein denaturation. Samples were stored at -20°C or directly loaded onto the polyacrylamide 
gel. To separate the proteins the electrophoresis was done at 100 – 120 mA in 1x Tank buffer.  
3.2.3.2 Western Blot 
Prior to immunovisualization of the proteins their immobilization on a membrane was 
performed by the wet blot method. For this the polyacrylamide gel was applied on a 
nitrocellulose membrane and covered on both sites with Whatman papers and two sponges. 
After assembling the complete setup in the transfer chamber, it was filled up with transfer 
puffer and the blotting was performed at 300 - 500 mA (1.5 mA/cm
2
) for 3h. Afterwards the 
membrane was blocked for 30 min – 1 h in 1x TBS-T with 3% BSA to avoid unspecific 
binding. Incubation with the respective primary antibody (Table 2) occurs at 4°C overnight. 
On the next day the membrane was washed in TBS-T and incubated with the HRP-conjugated 
secondary antibody for 1 – 2 h at room temperature. Finally the proteins were detected using 
Immobilon Western HRP substrate and a ChemoCam Imager.  
3.2.4 Cell culture 
Solutions and buffers required for preparation, culture or stimulation of cells lines or primary 
cells were prepared with LPS-free reagents. Cell culture reagents were tested for endotoxin 
content by the quantitative chromogenic limulus amebocyte (LAL) lysate endpoint assay 
QCL-1000 (# 50-6470, Cambrex). Cells were incubated at 37°C, 85% humidity and 5% CO2. 
Centrifugation of cells was performed at 1,400 rpm for 5 minutes at 4 °C.  
3.2.4.1 Cell lines 
As a source of macrophage colony stimulating factor (M-CSF) L-cell-conditioned medium 
(LCCM) produced by the mouse fibroblast cell line L929 (ATCC # CCL-1) was used for 
macrophage differentiation. Granulocyte macrophage colony-stimulating factor (GM-CSF) 
required for dendritic cells differentiation was obtained from the murine myeloma cell line 
(X63 Ag8), which contains with the cDNA of granulocyte macrophage-colony stimulating 
factor gene (Csf2) and were generated by Brigitta Stockinger in the lab of David Gray [145].  
3.2.4.2 L-cell conditioned medium (LCCM) 
L-cell-conditioned medium (LCCM) was used as a source of macrophage colony stimulating 
factor (M-CSF). L929 cells (5x10
6
 cells/tube) were cultured on 15 cm cell culture dishes to a 
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nearly confluent stage, trypsinized and splitted 1:5. The M-CSF containing supernatant was 
collected from cells grown again to confluence, fresh cDMEM was added, and the procedure 
was repeated without splitting every other day for three weeks until the cells started 
detaching. The collected LCCM was sterile filtered and stored in 50 mL aliquots at 4 °C. 
3.2.4.3 Preparation of GM-CSF containing media 
To obtain GM-CSF containing supernatant the Csf2 expressing, non-adherent, murine, 
myeloma cell line X63 [145] was cultured in cRPMI with 1 mg/ml G-418 under selective 
pressure. After cell expansion the geneticin was removed and the supernatant was collected 
every five days by centrifugation at 4,000 rpm for 10 minutes at 4°C. Cells were transferred 
back to the culture flask to continue the supernatant production. Collected SNs were sterile 
filtered and aliquoted for storage at – 20°C. 
3.2.4.4 Macrophage differentiation  
Primary macrophages were differentiated from murine bone-marrow. Thus mice were 
sacrificed by cervical dislocation, the skin was disinfected with 70% ethanol and femur and 
tibias were isolated. The bones were opened with sterile scissors under the laminar flow and 
the bone marrow was flushed out with 10 ml ice cold PBS using a 10 ml syringe and a 22-
gauge needle. The bone-marrow was incubated for 5 min in 5ml erylysis buffer at room 
temperature to eliminate co-isolated erythrocytes, centrifuged and subsequently resuspended 
in cDMEM containing 10% LCCM. The cells were incubated overnight in a 10 cm Petri dish 
for fibroblast depletion. Non-adherent cells were collected, counted and replated at a density 
of 5*10
6
 cells per dish in 10 ml cDMEM containing 10% LCCM. At day four, 5 mL of fresh 
cDMEM with 10 % LCCM was added. After six to seven days of differentiation, cultures 
were nearly confluent. Non-adherent cells were removed, the remaining cells washed once 
with 1xPBS and then incubated with 4-5 mL accutase at 37°C for 5 min to detach the cells. 
The accutase was inhibited by adding 5 ml cDMEM. Subsequently cells were counted with a 
Neubauer chamber using tryphan blue do identify death cells, centrifuged and resuspended in 
cDMEM to adjust the required cell concentration. Cells were replated and rest overnight at 
37°C before they were used for experiments. 
Differentiation of macrophages for siRNA knockdown (KD) occurred in hydrophobic Teflon 
bags according to the protocol from Wiese M. et al [146]. 6 to 10 million cells were cultured 
8 days at 37°C, 10% CO2 and 90% humidity in 50 ml cDMEM (described in 3.1.8) containing 
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15% LCCM. Cells were harvested with a 50 ml syringe using a 14-gauge needle and prepared 
for siRNA KD described in 3.2.4.6. 
3.2.4.5 DC differentiation 
Bone-marrow was prepared as described in 3.2.4.4. After erythrocyte lysis 6*10
6
 bone-
marrow cells were plated in 10 cm cell culture dishes in 10 ml cRPMI containing 10 %  
GM-CSF. Every three days the cells were feed by adding 10 ml of fresh medium including 
10% of the differentiation factor. Non-adherent cells were harvested on day 8 and prepared 
for stimulation.  
3.2.4.6 Specific siRNA Knockdown 
Delivery of siRNA into primary MØ was done by electroporation as described in Wiese M. et 
al [146]. Prior to electroporation cells were harvested from Teflon bags, washed once in 10 ml 
of ice cold Opti-MEM, centrifuged and resuspend in Opti-MEM in a concentration of 
2*10
6
cells / 50µl. Afterwards, 20 µl of the 20 µM siRNA stock were transferred into 4-mm 
electroporation chambers and filled up to a volume 50 µl with Opti-MEM. 50 µl of the cell 
suspension were added, incubated 5 min on ice and subsequently pulsed in a GenePulser 
Xcell electroporation device. Pulse conditions were 400 V, 150 µF, and 100 Ω. 
Electroporated cells were diluted in pure RPMI, transferred into required well plates and 
incubated at 37°C. 1-2 hours upon siRNA delivery pure RPMI was aspirated and exchanged 
by addition of cRPMI. Cells were incubated 48h at 37°C, 5% CO2 prior to LPS stimulation. 
The KD efficiency on mRNA level was determined by qRT-PCR as described in 3.2.1.4. 
3.2.4.7 Stimulation of cells 
LPS and IFN-γ stocks were dissolved in the cell culture media. For LPS stimulation  
100 ng/ml was used as final concentrations. In case of IFN-γ 50 ng/ml was applied. 
For stimulation of macrophages and DCs, cell suspensions were usually adjusted to 1 - 2*10
6
 
cells/ml and plated as listed in Table 14. 
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Table 14. Stimulation of macrophages and DCs: cell numbers and assays 
Plate format 
Number of 
cells/well 
Final 
volume/well 
Assay 
8 Well 
chamber slides 
25.000 0,3 ml cell spreading and SN for ELISA 
12 well 1.500.000 1 ml WB (lysis in 150 µl Ripa buffer) 
24 Well 500.000 0,5 ml 
RNA for qRT-PCR of WT and KO cells 
(lysis in 500µl Trifast), SN for ELISA 
48 Well 200.000 0,5 ml 
RNA for qRT-PCR of siRNA treated 
cells (RNA extraction by kit) 
96 Well 300.000 0,2 ml FACS staining for surface molecules 
 
3.2.4.8 Measurement of cell spreading 
To measure TLR4-driven cell spreading 2,5*10
4
 WT and KO cells were transferred to 8-well 
Permanox chamber slides 24 h prior to LPS stimulation. In case of siRNA treatment, cells 
were plated 48 h before activation. Cells were fixed at indicated time points in pre-warmed 
2% PFA/PBS for 20 min, followed by CD11b/APC surface staining. Therefore, the 
fluorochrome conjugated antibody was diluted 1:200 in 0,2% BSA/PBS added to the cells and 
incubated 30 minutes at 4°C. Subsequently samples were washed twice with PBS, covered in 
DAPI containing mounting medium. and stored at 4°C. Fluorescence images were obtained 
using a Zeiss AxioVert 200M (Germany) widefield microscopy. Contact areas of activated 
macrophages were semi-automatically determined with the developed two-step segmentation 
software described in 4.1.1 and Wenzel J. et al 2011[147].  
3.2.4.9 FACS analysis for surface molecule expression 
FACS staining was performed according to standard protocols with antibodies listed in Table 
6. Data were record on a FACSCanto II (BD Bioscience) and analyzed by FACSDiva 
Software V6.12 and FlowJo 7.6.5 software. 
3.2.4.10 OT-II stimulation assay 
Differentiated bone-marrow MØ or DC were cultured for 24 h in the presences or absence of 
2 mg/ml ovalbumin. The APCs were washed at least 5 times with pure RPMI before co-
cultivation with purified CD4+ cells from OT-II mice. Numbers of APCs were titrated from 
1*10
5
 to 1*10
3
 while constant numbers of 3*10
5
 CD4+ T cells were added to the suspension. 
CD4+ T cells were purified from spleen and lymph nodes of OT-II mice by magnetic cell 
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sorting (Miltenyi Biotec) and their purity was determined by FACS to be >93%. Supernatants 
were collected 72 h after co-cultivation and analyzed for the presence of IFNγ and IL-2, as 
described in 3.2.2. To analyze proliferation capacity, cells were subsequently pulsed with 
[
3
H]-thymidine (1 µC/well) for 20 hours. Culture supernatants were harvested onto glassfiber 
filtermates using an ICH-110 harvester and filters were counted in a 1450 microplate 
scintillation counter. 
3.2.4.11 CFSE dilution assay and T-cell activation marker  
Antigen-presenting cells (APCs) and CD4+ T cells were prepared as described in 3.2.4.10. In 
advance to co-cultivation the initial CD4+ T cell population was stained with CFSE according 
to the standard protocol. In separated approaches for 24 h and 72 h time points the cell culture 
was stained for CD4 and CD25. T cell activation and division was determined by FACS 
analysis.  
3.2.4.12 DQ-OVA assay 
To analyze the antigen processing capacity of APCs, 4*10
5
 bone-marrow derived MØ or DC 
were incubated in 24 well plates under presence of 20 µg/ml DQ-OVA. To stop DQ-OVA 
cleavade, cells were washed twice with PBS and fixed in 2% PFA/PBS for at least 30 
minutes. To determine antigen processing increased fluorescence of cleaved DQ-OVA was 
analyzed by FACS. To prevent DQ-OVA endocytosis and processing, control cells were 
incubated at 4°C under constant ovalbumin presence.   
3.2.5 Mice 
All mice were used on a C57BL/6 background and bred under SPF conditions in the animal 
facilities of the ‘FAU Erlangen-Nürnberg’ (‘Franz-Penzholdt-Zentrum’ and 
‘Biotechnologisches Entwicklungszentrum’). Experiments were performed in the animal 
house of the ‘Institut für klinische Mikrobiologie, Immunologie und Hygiene’. All animal 
work was conducted according to relevant national and international guidelines and approved 
by the ‘Regierung von Mittelfranken’. 
Mice lacking Myo1e and respective control animals were maintained at the Department of 
Laboratory Animal Resources, SUNY Upstate Medical University (Syracuse, NY). All 
protocols for animal studies and cell collection using these mice were approved by the SUNY 
Upstate Medical University IACUC. Bone marrow of C57BL/6 and, Myo1e -/- mice was 
controlled deep-frozen in FCS containing 10% DMSO, shipped on dry ice from USA to 
Germany and stored in liquid nitrogen until usage. 
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3.2.5.1 Starins 
C57BL/6 wild-type (wt) mice were purchased from Charles River periodically and bred in the 
barrier area of the FPZ. 
Mice deficient in the myeloid differentiation primary response gene 88 (Myd88-/-, [148]) 
were generated by Osamu Adachi in the lab of Shizuo Akira. Mice deficient in MAPK p38 
were kindly provided by Jean Pierre David [142]. Blastocysts from mice deficient in the dual-
specificity phosphatase 1 (MKP-1; Dusp1-/-) were generated by the R. Bravo laboratory at 
Bristol-Myers Squibb Pharmaceutical Research Institute [149] and kindly provided Andrew 
C.B. Cato [150]. Mice with a gene trap insertion in the locus encoding dual-specificity 
phosphatase 16 (MKP-7; Dusp16tp mice) were generated in the laboratory of Roland Lang 
[41]. Breeding colonies of mice lacking B- and T-cells (RAG1 KO) and mice expressing the 
congenic marker CD45.1 (B6.Ptprc) were maintained at the Franz Penzoldt Center of the 
Medical Faculty at the University Erlangen-Nuremberg. Bone–marrow and mice deficient in 
Myosin1e (Myo1e-/-) were generated and kindly provided by the laboratory of Mira Krendel 
[133]. 
3.2.5.2 Generation of bone marrow chimeras 
Bone-marrow chimeras were generated to examine the MYO1e-dependent immune cell 
recruitment in vivo and its function in B-cells.  
Prior to radiation the mice were pre-treated 7 days with antibiotics (Neomycinsulfat, 
Polymyxin B-sulfat) administered orally by the drinking water. RAG1 KO mice for B-cell 
experiments were sublethally irradiated with a dose of 4 Gray (Gy) and PTPRC mice for in 
vivo immune cell recruitment with a lethal dose of 9 Gy. The reconstitution of mice with 
either WT or Myo1e KO bone marrow occurred 24 h upon treatment. In advance, the deep-
frozen bone marrow from femur and tibias of one mouse per genotype was rapidly thawed at 
37°C, washed in 20 ml ice cold HBSS, centrifuged and resuspended in 2 ml ice cold HBSS. 
Independent of the cell number 200 µl of the bone marrow was injected intravenously (i.v.) 
into each recipient mouse. 6-8 week upon bone-marrow transplantation mice were ready for 
experiments. During the whole process mice were kept under antibiotic treatment. 
3.2.5.3 Utilization of bone-marrow chimeras 
B-cells from RAG1 KO chimeras were isolated from spleen by a B220+ positive selection via 
magnetic cell sorting (MACS). Their purity was determined by FACS to be >93%. 
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Immune cell recruitment to the site of injection was examined in PTPRC chimeras using the 
congenic CD45.1/.2 marker to distinguish between donor and recipient cells. 4*10
7
 heat 
inactivated (20 min, 65°C) E.coli were injected intraperitoneal (i.p.). After 24 h mice were 
sacrificed and cells within the peritoneum were flushed out with 2 ml ice cold PBS. The total 
cell number in the lavage fluid was determined to finally calculate the number of migrated 
immune cell populations. Donor immune cell subsets were discriminate by FACS as CD45.1 
negative and analyzed as listed in Table 15. 
Table 15. FACS staining for immune cell subsets  
immune cell subset marker 
monocytes Ly6G
neg
; Ly6C
pos
; CD11b
pos
 
neutrophils Ly6G
pos
; Ly6C
pos
; CD11b
pos
 
macrophages F4/80
pos
; CD11b
pos
 
pDCs CD11c
pos
; PDCA
pos
; MHC-II
pos
 
NK cells lymphocyte gate; NK1.1
pos
 
B-cells lymphocyte gate; B220
pos
 
CD4 T-cells lymphocyte gate; CD3
pos
; CD4
pos
 
CD8 T-cells lymphocyte gate; CD3
pos
; CD8
pos
 
 
3.2.6 Statistical evaluation 
For statistical evaluation Student’s T test was performed with the parameters “2-tailed” 
(Seiten 2) and “unpaired with heterogeneous variances” (Typ 3). p-values below 0.05 were 
regarded as significant (*), below 0.01 (**) and 0.001 (***) were regarded as highly 
significant.  
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4 Results 
A global and quantitative phosphoproteome analysis of TLR4 activated primary macrophages, 
done in our lab, identified more than 1800 phosphoproteins containing around 7000 
phosphorylation sites. Further bioinformatic analysis pointed out the cytoskeleton as one cell 
organelle with enhanced protein phosphorylation [151]. In total, 44 cytoskeletal or associated 
proteins were reproducibly regulated by this post translational modification after LPS. A 
remarkable fast and strong phosphorylation of the actin polymerization factors ARP3 and 
FHOD1 was detected simultaneously to the regulation of capping and motor proteins like 
CAPZB or MYO18a and MYO1e (Fig. 5). Many of these proteins are described in 
fibroblasts, stable cell lines or model organisms like yeast, but their task in primary immune 
cells is mainly unknown. Based on these data, we started to investigate the role and function 
of TLR4-induced changes in cytoskeleton remodeling and related immune cell responses. 
LPS [100ng/ml] LPS [100ng/ml]
15min 4h 15min 4h
Actr3 (Arp3) 88 95 Msn 1 4
Add1 6 5 Mtss1 9 5
Capzb 10 8 Myh9 1 2
Coro1b 6 0 Myo18a 13 1
Dbn1 11 2 Myo1c 1 1
Epb4.1l1 5 5 Myo1e 10 8
Epb4.1l2 2 1 Myo1f 3 3
Eps8 6 5 Myo5a 2 2
Fhod1 55 10 Myo9b 8 6
Flna 2 8 Palld 6 2
Fmn1 19 0 Phactr4 8 2
Frmd4b 1 2 Plec1 1 2
Hdac6 3 1 Ppp1r9b 10 6
Inf2 1 1 Pxn 3 5
Inppl1 13 0 Snta1 2 1
Lcp1 10 9 Spnb2 1 1
Lima1 17 10 Svil 2 1
Lsp1 24 6 Tln1 2 2
Marcks 6 5 Tmod3 6 9
Mib2 2 1 Twf1 6 0
Mkl1 17 7 Vasp 8 4
Mkl2 15 8 Wipf1 6 3
 
Figure 5. Phosphorylated cytoskeleton-associated proteins detected in the phosphoproteome 
analysis of LPS treated primary MØ. Shown are intensities of the most strongly regulated 
phosphorylation site of each detected protein in response to 15 min and 4 h LPS stimulation 
Intensities are calculated by the ratio of stimulated to unstimulated condition. Listed are only proteins 
with the GO annotation “actin binding” or “cytoskeletal protein binding” and at least a 1,5-fold 
increase in any phosphosite by LPS. Detailed information with respect to multiple phosphorylation 
sites is publicly accessible at www.phosida.com. Numbers indicates the fold induction, additionally 
illustrated as heat map (red = strong; blue = weak induction). 
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4.1 TLR4 induced-cytoskeleton remodeling 
4.1.1 Quantification of LPS-induced macrophage spreading 
In order to investigate the control of TLR4-driven changes in cytoskeleton remodeling a 
quantitative readout system was needed. Therefore, we validated the spreading response of 
primary macrophages as measurable readout. Cell spreading was defined as the change in 
contact area of macrophages to the support material. To define the cell boarders against the 
background of the slide we visualized the cells by fluorescence microscopy. Therefore, 
CD11b staining of the macrophage cell surface was used to define the contact area to the slide 
and combined with DAPI staining of the nuclei to identify individual cells on the microscopy 
image (Fig. 6a-c). The spreading response of macrophages to LPS was examined in a kinetic 
analysis using time points between 1 h and 24 h. The stimulation was performed on Permanox 
slides with 100 ng/ml LPS. A first significant increase of the contact area was already 
observed 1h after cell treatment. The macrophages continued to spread and increased their 
contact size to roughly twice of their initial size after 24h. This was also observed to be the 
maximum in most of the experiments. To confirm that the spreading of primary macrophages 
was dependent on actin cytoskeleton and its LPS induced polymerization we used the actin 
polymerization inhibitor Cytochalasin D (CytoD). The cells were treated 1h prior to 
stimulation with 5 µg/ml of the inhibitor. The inhibitor treatment completely prevented 
macrophage spreading in response to LPS (Fig. 6d, e). These data confirmed that the 
activation of TLR4 by its antagonist LPS induces an actin polymerization-dependent 
remodeling of the cytoskeleton that finally results in macrophage spreading. Furthermore this 
experimental setup provided us the possibility to use the spreading readout for a more detailed 
analysis in order to investigate which of the cytoskeletal phosphoproteins and TLR4 signal 
cascades contributes in this context.  
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Figure 6. LPS induced spreading of primary macrophages. BMM were plated in eight-well 
chamber slides and rested over night before addition of LPS (100 ng/ml) .The inhibitor of actin 
polymerization Cytochalasin D (5 μg/ml) was added 1 h prior to LPS-stimulation. At the indicated 
time points after addition of LPS, slides were processed for staining of CD11b and nuclei, followed by 
fluorescence microscopy. (a-c) Representative images from control, 2 h, 8 h, and 24 h time points. 
Cells were imaged at 20x magnification. Scale bar = 50 µm. (d) Detailed quantification of cell 
spreading by manual annotation of CD11b staining. Each dot represents one single cell per condition. 
Black bars within the scatter plots show median contact area. (e) Comparative spreading 
representation. Shown are mean + SEM of at least 300 cells per condition. Media control (open 
circles), LPS (closed circles) and LPS in the presence of CytoD (red closed squares). Statistical 
significance refers to LPS-treated compared to untreated condition. Representative of 2 independent 
experiments with similar results * p < 0.05, *** p < 0.0001. 
 
Manual annotation of contact areas from the fluorescence microscopy images is a very time 
consuming process. To perform experiments with multiple conditions in a feasible time frame 
and a less biased analysis it was necessary to develop an annotation software. In collaboration 
with the group of PD Dr. Thomas Wittenberg (Fraunhofer Institut Erlangen) a two-step 
segmentation algorithm was established and specifically adapted to this issue [152]. In a first 
step, the software annotates the DAPI stained nuclei of the imported images (Fig. 7a-c) by a 
watershed transform-based segmentation routine [153, 154]. Subsequently, this information is 
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used as an initialization point to annotate in a second step the cell boarder by a gradient 
magnitude based fast marching level set method [154, 155] (Fig. 7d-f). The results of the 
annotated cell boarder are highlighted, allowing quality control and manual editing by the 
user. For most cells the obtained automatic segmentation was found to be correct, but in case 
of overlapping cells some manual editing was required (arrows in Fig. 7e and f).  
To test the accuracy and reliability of the automatic segmentation algorithm, we compared the 
distribution of contact areas of macrophages under resting and LPS-stimulated condition 
using automated tool segmentation versus manual annotation. Comparing image data from 
one single experiment we obtained very similar distribution of contact areas and median 
values in resting and early LPS-stimulated cells. At later time points the segmentation 
algorithm generated smaller values (Fig. 7g). To test whether this “shrinkage effect” was 
generic at later time points we extended the comparison analysis to a series of six experiments 
(Fig. 7h). Contact area values of resting cells and early (2 h) time points showed a 
consistently high agreement between software and manual annotation. At later time points the 
annotation difference got more striking and also “blow-up effects” were observed. Overall we 
observed a good agreement between results obtained by automated segmentation and manual 
annotation. Convinced that we had obtained an annotation software with capacity for high 
throughput analysis we used this system to investigate TLR4 driven macrophage spreading 
and its control by MAPK signaling as well as selected phosphoproteins. 
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Figure 7. Validation of a semi-automatic quantification software. Segmentation and annotation of 
macrophages with two-step segmentation software. Fluorescence microscopy images of CD11b-APC 
and DAPI stained macrophages were uploaded into the software (a), nuclear segmentation (b-c) and 
contact area annotation was performed by the tool (d-e) and finally checked and corrected by the user 
(f). Arrowheads indicate shrinkage and blow-up effects requiring manual editing of the annotation. 
(g) Comparison of cell contact area measured automatically by the tool (T) versus manual annotation 
(M). Data are from one experiment. Each dot represents one cell. Black bars within the scatter blot 
show median contact area (numerical value indicated above). (h) Comparison of data obtained by 
annotation with tool (open circle) versus combination of tool and manual correction (closed circle) 
from six independent experiments. Each dot represents the median of at least 300 annotated cells. 
4.1.2 MyD88 is required for macrophage adhesion after TLR4 activation 
TLR4 requires adapter protein recruitment at its intracellular domain to induce signal 
mediation upon activation. One universal adapter protein is MYD88 that binds to almost all 
TLR family members leading to a change in gene expression and cytokine secretion. We 
employed macrophages with genetic deletions of Myd88 to determine the control of LPS-
induced cell spreading by this molecule. In comparison of Myd88 knockout to heterozygous 
macrophages, we observed that the spreading response at the late 8 and 24 h time points was 
severely impaired in the absence of MYD88 (Fig. 8a) indicating that the adapter protein is 
essential for a late phase spreading response to LPS and to maintain cell shape. However, 
Myd88 KO macrophages respond comparably to heterozygous control cells at the early 2 h 
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time point. This indicates that other signaling molecules (e.g. the adapter TRIF) may play an 
important role in cytoskeletal rearrangement after LPS. The effect of Myd88-deficiency on 
cytokine responses to LPS was examined using supernatants from the cultures used for cell 
spreading analysis. In the absence of MYD88, secretion of the pro-inflammatory cytokines 
TNF, IL-6 and IL-12p40 as well as of anti-inflammatory IL-10 was almost absent (Fig. 8b). 
The results revealed not only the requirement of the adapter protein in TLR4-driven cytokine 
response but also a contribution of MYD88 in LPS induced macrophage spreading.  
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Figure 8. Contribution of MYD88 in MØ spreading and control of LPS induced cytokine 
secretion. (a) Phenotype of Myd88 KO macrophages in cell spreading. Shown are mean and SEM 
from one representative experiment of two performed. LPS (closed symbols), media control (open 
symbol), Myd88± (circles), Myd88−/− (red squares). Statistical significance refers to Myd88± 
compared to Myd88−/− genotypes. (b) Supernatants of the cultures used for macrophage spreading 
analysis were analyzed by ELISA for the presence of the cytokines TNF, IL-6, IL-12p40, and IL-10. 
To normalize for differences between experiments in the absolute amount of cytokines produced, the 
maximum level of the LPS-treated WT or control macrophage in each experiment was set to 100% 
(shown as - - - -). Shown are mean + SD values from two independent experiments.   
ns=not significant;*** p <0.0001   n=2. 
4.1.3 MAPK signaling in early and late phase spreading 
MAPK pathways are some of the major and best described signal cascades in innate immune 
cells. Initiated by adapter protein recruitment to the transmembrane domain of the activated 
cell surface receptor, they mediate the signal in a hierarchical manner from the membrane 
through the cell, resulting in a change in gene expression and substrate protein activation. We 
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used primary macrophages with genetic deletion of p38 and pharmacological inhibition of the 
ERK1/2 kinase MEK1 to examine their role in macrophage spreading. 
A possible contribution of the p38 MAPK was investigated using macrophages derived from 
the bone marrow of conditional p38-flox/flox; Mx-Cre mice [142] treated with poly I:C to 
induce deletion of p38 (Fig. 9b). Deletion of p38 was very efficient in mice expressing Cre, 
p38 was undetectable. The conditional KO of p38 resulted in a strongly reduced 
phosphorylation of MK2, a substrate kinase downstream of p38. Initiation of ERK1/2 
phosphorylation which appears very fast within 1 h after LPS stimulation is not influenced by 
the p38 KO but a prolonged activation of ERK1/2 was apparent (Fig. 9b). The spreading 
response of primary macrophages was only weakly affected by the p38 KO. Deficient 
macrophages showed a significantly, but moderately reduced initial spreading at 2 h after LPS 
stimulation. However, there was no difference detected between p38 WT and KO cells at the 
late spreading phase 8 h and 24 h post stimulation (Fig. 9a). Examination of the TLR4-driven 
cytokine secretion in the supernatant of these cells showed that TNF was secreted 
simultaneous to IL-10 rapidly after LPS-stimulation, while the release of IL-6 and IL-12p40 
was first measurable 8 hours upon macrophage activation. In absence of p38 TNF and IL-10 
levels were decreased 40-60% during the time course, while in contrast IL-12p40 release was 
strongly increased. Secretion of IL-6 was not altered by p38 deletion (Fig. 9c). Taken 
together, the MAPK p38 appeared to be required for maximal initial spreading, but in contrast 
to the strong effects observed for Myd88 deficiency, p38 was not involved at later time points. 
Furthermore, p38 MAPK signaling was necessary for an efficient TNF and IL-10 production 
but inhibited IL-12p40 secretion. 
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Figure 9. Reduced early spreading response and altered cytokine release of p38 KO MØ.  
(a) Phenotype of p38 KO macrophages in cell spreading. Shown are mean and SEM from one 
representative experiment of two performed. LPS (closed symbols), media control (open symbol), p38 
WT (circles), p38−/− (red quares). Statistical significance refers to p38 WT compared to p38 KO 
genotypes. (b) Western blot control for p38 protein levels and phosphorylation of MK2 and ERK1/2. 
Cell lysates were taken at indicated time points (15 min to 4 h) after LPS stimulation (100 ng/ml). 
Grb2: loading control. (c) Supernatants of the cultures used for macrophage spreading analysis were 
analyzed by ELISA for the presence of the cytokines TNF, IL-6, IL-12p40, and IL-10. To normalize 
for differences between experiments in the absolute amount of cytokines produced, the maximum 
level of the LPS-treated WT cells in each experiment was set to 100% (shown as - - - -). Shown are 
mean+SD values from two independent experiments.   ns=not significant;*** p <0.0001  n=2 
 
To address the role of ERK1/2 MAPK signaling in LPS-induced macrophage spreading, the 
second generation MEK1 inhibitor PD184352 was used. It has been reported to have a higher 
specificity than older reagents [156]. The pharmacological inhibitor PD184352 was added one 
hour prior LPS-stimulation to the culture, interfering with the up-stream kinase MEK1 to 
block ERK1/2 phosphorylation and signal mediation via this MAPK. Pretreatment of 
macrophages with PD184352 strongly reduced basal and LPS-induced phosphorylation of 
ERK1/2. An impact on p38 MAPK phosphorylation could not be observed (Fig. 10b). MEK1 
inhibition had no effect on basal macrophage spreading compared to untreated cells, and did 
not show a significant difference in early spreading (2 h) after TLR4 activation. However, the 
further increase in the contact area at 8 h and 24 h time points was prevented (Fig. 10a). We 
also determined the cytokine release of PD184352 treated macrophages, indicating that 
MEK1 inhibition resulted in a 40-50% reduction of TNF and nearly blocked the IL-10 
secretion. Also in the supernatant we determined strongly increased amounts of IL-6 and IL-
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12p40 at the late 24 h time point (Fig. 10c). In summary, blocking ERK1/2 signaling caused a 
reduction of the macrophage spreading 8 h and 24 h after LPS-simulation, similar to the effect 
of Myd88 deficiency, and showed also important contribution in cytokine response of TLR4 
activated macrophages.  
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Figure 10. ERK1/2 signaling is essential for late phase spreading response. (a) Effect of 
pharmacological blockade of ERK1/2 activation on macrophages spreading. Cells were pre-treated 
with MEK1 inhibitor PD184352 (10 µM, squares) or not (circles) 1 h prior to LPS addition (closed 
symbols) or media control (open ymbols). Shown are mean+SEM of at least 300 cells per condition. 
Statistical significance refers to PD184352 treated compared to no inhibitor. (b) Western blot control 
for ERK1/2 and p38 phosphorylation. Cell lysates were taken at indicated time points (15 min to 24 h) 
after LPS stimulation (100 ng/ml). Grb2: loading control. (c) Supernatants of the cultures used for 
macrophage spreading analysis were analyzed by ELISA for the presence of the cytokines TNF, IL-6, 
IL-12p40, and IL-10. To normalize for differences between experiments in the absolute amount of 
cytokines produced, the maximum level of the LPS-treated non inhibitor control macrophage in each 
experiment was set to 100% (shown as - - - -). Shown are mean + SD values from two independent 
experiments.   ns=not significant;*** p <0.0001  n=2. 
4.1.4 DUSP1 and DUSP16 in LPS induced cytoskeleton remodeling  
Dual-specific phosphatases (DUSP) are endogenous negative regulators of intracellular signal 
pathways. Eleven DUSP gene family members are MAPK phosphatases (MKP) because they 
habor a MAPK binding domain allowing them to interact with one or more members of the 
MAPK family (p38, ERK1/2 and JNK) [37, 157]. DUSP1 and DUSP16 are both MKP and 
show preference for binding to and inactivating p38 and JNK, respectively. We previously 
observed an essential and time dependent contribution of ERK1/2 and p38 signaling in 
cytoskeletal remodeling as well as cytokine secretion in TLR4-activated macrophages. 
Whether these processes are possibly regulated by DUSPs has not been studied. To address 
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this issue we employed primary macrophages deficient either for Dusp1 or Dusp16, 
determining the LPS-induced spreading response and cytokine secretion. Both genotypes 
showed a similar TLR4-driven early spreading response (2 h) comparable to the WT and 
control cells. However, KO macrophage spreading was significantly affected throughout the 
late phase, 8 to 24 hours. While Dusp1 as well as Dusp16 KO cells showed a similar 20% 
reduction in the contact areas 8 h after stimulation, the difference was more striking in 
Dusp16 KO macrophages at the 24 h time point (Fig. 11a and c). Compared to WT 
macrophages, Dusp16 KO cells showed a 40-50% decrease in contact size indicating a more 
crucial contribution of DUSP16 in LPS induced spreading (Fig. 11c). Observation on 
cytokine secretion revealed a divergence of both DUSPs in IL-10 and IL-12p40 release. 
Macrophages deficient for Dusp1 showed an increased IL-10 secretion and a severely reduced 
IL-12p40 release in response to TLR4 activation (Fig. 11b). Contrary results were obtained 
under Dusp16 deficient conditions. These macrophages secreted 40% less IL-10, however 
strikingly more IL-12p40 after LPS stimulation (Fig. 11d). In case of TNF and IL-6 secretion 
no difference in the KO cells compared to the WT situation was detected. Taken together, the 
results indicated a contribution of DUSP1 and DUSP16 in TRL4-driven macrophage 
spreading as well as IL-10 and IL-12p40 production, possibly caused by dysregulation of 
MAPKs signaling. 
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4.1.5 Validation of siRNA KD to investigate cytoskeletal phosphoprotein function 
We next were interested to functionally analyze the role of LPS-regulated phosphoproteins 
associated with the cytoskeleton in macrophage spreading. We therefore combined our 
previously developed automatic quantification software with a specific siRNA knock down of 
selected cytoskeletal proteins in primary macrophages. This approach allowed us to determine 
the function of candidate proteins in LPS-induced cytoskeleton remodeling by measuring the 
cell spreading response. Based on three criteria, candidate proteins were selected. First, the 
intensity of the detected phosphorylation in the phosphoproteome analysis, meaning the fold 
induction of a phosphosite after LPS stimulation compared to the unstimulated condition. 
Second, the reproducible detection of a phosphosite in repeated experiments, and third 
whether the detected phosphoproteins have already been described in the literature or not. For 
a first screen we chose seven proteins ACTR3 (ARP3), FMN1, FHOD1, CORO1b, MTSS1, 
LSP1, EPS8 and performed specific siRNA knockdown, with an efficiency of 50 – 85% 
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Figure 11. A role of Dual-specificity phosphatases (DUSP) in MØ spreading and cytokine 
secretion. (a) Phenotype of Dusp1 KO macrophages in cell spreading. Shown are mean and SEM from 
one representative experiment of three performed. LPS (closed symbols), media control (open symbol),  
 Dusp1+/− (circles), Dusp1−/− (red squares). Statistical significance refers to KO compared to Dusp1 
heterozygous genotypes. (b) Supernatants of the cultures used for macrophage spreading analysis were 
analyzed by ELISA for the presence of the cytokines IL-10 and IL-12p40. To normalize for differences 
between experiments in the absolute amount of cytokines produced, the 24h time point of the LPS-
treated control cells in each experiment was set to 100% (shown as - - - -). (c, d) Phenotype of Dusp16 
KO macrophages in cell spreading and cytokine secretion. Legends and statistical analysis as described 
for (a) and (b). ns=not significant; ** p <0.001, *** p <0.0001  n=3. 
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reduction in their mRNA levels. As positive control we used ACTR3 (ARP3) which was 
strongly phosphorylated in response to TLR4 activation. Interacting with ARP2 it builds the 
actin polymerization factor ARP2/3 which is one of the best described in a broad variety of 
cell types. Knockdown (KD) of ACTR3 (ARP3) with an efficiency of 85% on mRNA level 
resulted in an initially smaller contact size between cells and the supported material as well as 
a strikingly reduced spreading throughout the whole time course compared to LPS-stimulated 
macrophages treated with an unspecific non-targeting control RNA (Fig. 12a). KD of FMN1 
and FHOD1, actin polymerization factors of the formin family, did not result in an altered 
spreading phenotype although a good KD efficiency with 85% for FMN1 and 60% for 
FHOD1 were reached (Fig. 12b and c). The Knockdown of the ARP2/3 antagonist CORO1b, 
which induces actin disassembly and inhibition of the ARP2/3 complex known in mast cells, 
fibroblasts and yeast [158-161], resulted in altered and finally increased contact size at the 
very late spreading phase 24 h post LPS addition (Fig. 8d). The KD efficiency reached in this 
case was 50%. The Knockdown of other cytoskeletal phosphoproteins like MTSS1 (KD ~ 
90%), LSP1 (KD ~ 85%) and EPS8 (KD ~ 60%) did not alter LPS-induced macrophage 
spreading in such a severe manner indicating that these proteins do not participate in the cell 
spreading response but may support other cytoskeletal associated cell functions like e.g. endo- 
and exocytosis or migration processes (Fig. 12e-g). 
These knockdown experiments serve as a starting point for a siRNA screen of further selected 
cytoskeletal proteins. Furthermore these techniques provide the possibility to get insight 
which phosphoproteins actually contribute in cytoskeletal rearrangement and adhesion 
processes.  
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Figure 12. siRNA KD of selected cytoskeletal associated phosphoproteins. Spreading phenotype of 
siRNA treated macrophages. Differentiated primary macrophages were electroporated with specific 
siRNA for selected cytoskeletal proteins 48h prior LPS stimulation [100 ng/ml]. Contact area 
quantification of (a) ACTR3 (ARP3), (b) FMN1, (c) FHOD1, (d) CORO1b, (e) MTSS1, (f) LSP1  
(g) EPS8 siRNA treated cells was measured by automatic segmentation software with subsequent 
manual correction. Shown are mean + SEM of at least 300 cells per condition. Media control (open 
symbols), LPS (closed symbols), non-silencing control RNA treated cells (circles), specific siRNA 
treated cells (red squares). Statistical significance refers to nsRNA treated LPS stimulated control cells 
compared to siRNA treated LPS stimulated cells. Knockdown efficiency was determined by qRT-PCR 
shown as KD within the graphs.     ns=not significant; * p <0.05, ** p <0.001, *** p <0.0001 n=1-2. 
4.2 Function of the Class I Myosins MYO1e and MYO1f in macrophages 
and DCs 
Among the group of LPS-regulated cytoskeletal phosphoproteins, several class I myosins 
were identified. These proteins are able to interact simultaneously with actin filament and 
proteins or membranes and thus might play an important role as transport proteins regulating 
TLR4-driven macrophage immune response. Our research was aimed on the role of the two 
“long-tailed” motor proteins myosin1e (MYO1e) and myosin1f (MYO1f), because of their 
strong LPS-induced phosphorylation. In contrast to their other six family members they 
contain an additional SH3 domain at the N-terminus. The phosphosites detected in our 
phosphoproteome analysis were localized in the tail region of the proteins, mainly within the 
TH2 domain apart from a single one within the PH domain. Both myosins possess a similar 
phosphorylation pattern except of an additional phosphorylation at S1023 on MYO1f  
(Fig. 13a). A regulation of the motor proteins by this posttranslational modification occurs 
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very fast within the first 15 minutes after LPS stimulation and was still detectable after 4 h in 
our study of the macrophage phosphoproteome. Comparing both myosins MYO1e revealed a 
stronger phosphorylation within the TH2 domain compared to MYO1f (Fig. 13b). The 
functions of the single phosphorylation sites are still unknown and remain to be clarified. 
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Figure 13. TLR4 activation induces phosphorylation of Myosin 1e and 1f in primary MØ.  
(a) Schematic illustration of MYO1e and MYO1f with single protein domains. Highlighted are the 
LPS-induced phosphorylation sites detected in our own phosphoproteome analysis. (b) Intensity of 
single phosphosites regulated in response to 15 min and 4 h LPS stimulation. Intensities are calculated 
by the ratio of stimulated to unstimulated condition. 
4.2.1 Essential role of MYO1f in macrophage spreading 
To test for a possible contribution of the motor protein MYO1f to TLR4-driven macrophage 
spreading and adhesion, specific siRNA knockdown was performed. Targeting MYO1f by a 
pool of four specific siRNAs, a knockdown efficiency of around 60% compared to control 
cells could be detected in primary macrophages. Macrophages not treated with any siRNA 
exhibited only a weak regulation of Myo1f mRNA expression in response to LPS. A slight 
decrease 2 h after stimulation followed by a subsequent modest increase until 24 h was 
detected. Transfecting siRNA into the cells did not influence the mRNA expression of Myo1f 
confirmed by the use of nsRNA (Fig. 14a). Macrophages expressing lower Myo1f mRNA 
levels showed a significantly decreased basal contact area. While the initial spreading 
occurred, MYO1f KD macrophages failed to increase their contact area throughout continuing 
LPS stimulation until 24h. Comparing the results to the spreading behavior of control cells 
indicated a requirement of MYO1f in this context (Fig. 14b).  
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Figure 14 A role of phosphorylated MYO1f in MØ spreading. Spreading behavior of primary 
macrophages treated with specific siRNA for MYO1f KD in response to LPS [100 ng/ml].  
(a) Differentiated primary macrophages were electroporated with specific siRNA for Myo1f 48 h prior 
LPS stimulation. mRNA expression levels and KD efficiency was determined by qRT-PCR. Gene 
expression was normalized to the expression of the “house-keeping gene” HPRT and fold changes 
were calculated to the unstimulated WT condition. In case of Myo1f KD the fold changes were 
calculated to the nsRNA treated unstimulated control cells. (b) Macrophage spreading was measured 
by automatic segmentation software with subsequent manual correction. Shown are  
mean + SEM of at least 300 cells per condition. Media control (open symbols), LPS (closed symbols), 
non-silencing control RNA treated cells (circles), Myo1f siRNA treated cells (red squares). Statistical 
significance refers to nsRNA treated LPS stimulated control cells compared to siRNA treated LPS 
stimulated cells.     ns=not significant; * p <0.05, ** p <0.001  n=3. 
 
Primary macrophages differentiated from bone marrow of mice with a genetic deletion in 
Myo1e were employed to continue our investigation on how these motor proteins contribute 
to macrophage spreading. Western blot analysis from lysates of Myo1e deficient macrophages 
confirmed the knockout (Fig. 15a). Quantifying the change in contact area Myo1e KO 
macrophages exposed a significant but modest reduction in TLR4-driven cell spreading 
compared to WT cells (Fig. 15b). The protein sequence homology of 71% and the presumably 
similar structure of both murine “long-tailed” class I myosins, redundancy effects could not 
be excluded. Therefore, we applied a Myo1f siRNA knockdown in primary Myo1e knockout 
macrophages to generate “double-deficient” cells. Determination of Myo1e and Myo1f mRNA 
expression by qRT-PCR under this condition did not show a compensatory up-regulation of 
Myo1e and Myo1f, respectively (Fig. 15c). A significant reduction in the basal contact area 
was measured under both conditions. Single-deficient Myo1e KO macrophages induced to 
spread, reaching a contact size similar to the control cells 8 h and 24 h after LPS stimulation. 
However, additional knockdown of Myo1f in Myo1e-deficient bone marrow macrophages 
resulted again in a significantly decreased phenotype throughout LPS stimulation, indicating 
that MYO1f is the major “long-tailed” class I myosin required in TLR4-driven macrophage 
spreading (Fig. 15d). 
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Figure 15. Differential role of Myosin 1e and 1f in MØ spreading. (a) Western blot control for 
Myo1e KO. Cell lysates taken at indicated time points after LPS stimulation [100 ng/ml]. Grb2: 
loading control. (b) Spreading behavior of primary Myo1e KO MØ in response to LPS. (c) Generation 
of “double-deficie t” cells by Myo1f siRNA KD in Myo1e KO macrophages. Expression of mRNA 
levels and KD efficiency was determined by qRT-PCR. Fold changes were calculated to the 
unstimulated WT condition and in case of Myo1f KD to the nsRNA treated unstimulated control cells. 
(d) Spreading be avior of MYO1e single- (green) and MYO1e and 1f double-deficient macrophages 
(red). Spreading was measured by automatic segment tion software with subsequent manual 
correction. Shown are mean+SEM of at least 300 cells per condition. Statistical significance refers to 
WT or nsRNA treated LPS stimulated control cells compared to KO or siRNA treated LPS stimulated 
cells.    ns=not significant; * p <0.05, ** p <0.001, *** p <0.001  n=3. 
 
The spreading process is not exclusively dependent on the actin network. Regulation of this 
mechanism is simultaneously mediated by integrins, building a bridge between the 
extracellular matrix (ECM) and the actin cytoskeleton. Analysis of integrin expression on 
Myo1e KO MØ was performed to identify a possible contribution in this context, as it is 
known for example from MYO1f in β2-integrin surface expression on neutrophils [118]. 
Functional integrins are assembled by interaction of a α- and β-subunit whereas the β-subunit 
constitutes the essential domain. Thus expression of the MØ relevant β-integrins CD18, CD29 
and CD61 was analyzed in response to LPS. CD29 and CD18 expression was up-regulated 
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after TLR4 activation while CD61 were even slightly down regulated. An increase of 40% 
compared to basal condition in CD18 expression was already observed after 8 h and remained 
at this level throughout LPS stimulation. Alterations in β-integrin expression caused by the 
lack of MYO1e were not observed (Fig. 16a). Hence, the expression of the α-integrins 
CD11a, CD11b and CD11c was determined and revealed only a modest TLR4-driven 
increase. All α-integrin subunits were already expressed in remarkable amounts on 
macrophages (Fig. 16b). These results indicate no contribution of MYO1e in surface 
expression of the integrin on primary LPS-stimulated macrophages. 
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Figure 16. LPS induced integrin expression on Myo1e KO MØ. FACS analysis of integrin 
expression on primary WT (closed circles) or Myo1e KO (open circles) macrophages. Cells were 
stimulated with LPS [100 ng/ml] for indicated time points. (a) Expression of β1-3-integrin subunits 
CD29, CD18 and CD61. (b) Expression of αL,M,X-integrin subunits CD11a, CD11b and CD11c. 
To normalize for differences between experiments in the absolute MFI, the 24 h time point of WT 
condition in each experiment was set to 100%. Shown are mean + SEM. n=3    ns = not significant  
4.2.2 MYO1e in in vivo immune cell recruitment 
Based on our observed class I myosin dependent spreading phenotype and the published 
evidence of migration abnormality in Myo1f KO neutrophils, we addressed the question 
whether the Myo1e KO affects the recruitment of immune cells to the site of heat killed  
E. coli injection. Myo1e KO or C57BL/6 control bone marrow cells were used to generate 
radiation chimeras. The CD45.1/2 congenic markers allowed to determine reconstitution 
efficiency and to gate on CD45.1-negative donor-derived cells. As a source of LPS, 4*10
7
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heat inactivated E.coli were injected intraperitoneally into mice and immune cells in the 
peritoneal lavage fluid were analyzed by FACS 24 h post injection. Determination of the total 
cell number revealed a significant increase within the peritoneum of E.coli challenged KO 
chimeras although a difference in untreated mice was not observed (Fig. 17a). Identification 
of cell subsets was done to determine whether the recruitment of specific populations was 
regulated by MYO1e. The major population found at the site of infection after 24h were 
PMNs followed by B-cells and macrophages (Fig. 17b). However, the previously observed 
increase in the total cell number was not caused by a specific immune cell population, 
because the mean numbers of all analyzed cell types were higher in Myo1e KO chimeras, 
even though this difference was significant only for NK cells. 
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Figure 17. Enhanced immune cell recruitment to site of infection (in vivo). Lethally irradiated 
PTPRC mice were reconstituted with WT (closed circles) or Myo1e KO (open circles) BM. 4*10
7
 h.i. 
E.coli were injected i.p. and immune cell population in peritoneal lavage fluid 24h after mice 
treatment analyzed by FACS.(a) Total cell counts in untreated and E.coli treated WT and Myo1e KO 
chimeras. (b) Counts of immune cell populations analyzed by FACS after 24h E.coli challenge. Gated 
on CD45.1 negative cells for pDCs, NK-cells, monocytes, macrophages, PMNs, B-cells, CD4 and 
CD8 T-cells (used cell markers see in material and methods). Dots represent one mouse (4 treated 
mice per genotype). Bars represent MEAN. Statistical significance was determined by student’s t-test. 
* p <0.05,** p <0.001 
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4.2.3 Selectively increased CCL2 secretion in primary Myo1e deficient macrophages 
The cytokine response of activated macrophages is strongly regulated and controlled at 
various levels, starting from the induced mRNA transcription until the point of release from 
the cell surface. Cytokines synthesized in response to TLR4 activation need to be guided from 
the nuclear periphery through the cytoplasm towards the cell membrane where they finally get 
secreted in an organized manner. The cytoskeleton is one important cell organelle which 
allows such an active transport. To address the possible contribution of the motor protein 
MYO1e in this dynamic process, cytokine and chemokine secretion in the supernatants of 
LPS stimulated primary macrophages were analyzed. The pro- and anti-inflammatory 
cytokines TNF and IL-10 were both again secreted rapidly after LPS-stimulation while the 
release of IL-6 and IL-12p40 (data not shown) was first measurable 8 and 24 hours upon 
macrophage activation. The deficiency of MYO1e did not affect their release (Fig. 18a). 
However, extension of the supernatant analysis to the spectrum of chemokines revealed a 
contribution of MYO1e in the secretion system. Primary macrophages of both genotypes 
secreted a constitutive amount of CCL2 in a range of 200 to 800 pg/ml under basal culture 
condition which accounts for approximately 10% of the maximum released in response to 
LPS. Already 8 h after stimulation an increased CCL2 secretion of 50% in Myo1e KO 
macrophages was detected compared to WT cells. Up to 14 ng/ml of CCL2 were detected in 
TLR4-activated Myo1e KO macrophage cultures. The chemoattractant CCL4 was also 
measurable under basal conditions in a magnitude of 300 to 500 pg/ml and already peaked at 
8 h post stimulation with concentrations of 45 to 50 ng/ml, keeping this level constant until  
24 h under WT conditions. In contrast, macrophages lacking the motor protein MYO1e were 
also able to secret high amounts of CCL4 but compared to WT cells in a delayed manner. 
Differences of 25% reduction were detected at 8 h time points whereas 24 h after LPS 
addition KO cells aligned to concentrations detected in WT situations. A significant 
divergence in the secretion of other chemotactic agents like IP-10 (data not shown) was not 
detected in TLR4-activated primary macrophages (Fig. 18b). 
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Figure 18. Alteration of chemokine secretion in activated Myo1e KO macrophages. Supernatants 
of the cultures were analyzed by ELISA for the presence of (a) cytokines and (b) chemokines. To 
normalize for differences between experiments in the absolute amount, the 24h time point of the LPS-
treated control cells in each experiment was set to 100% (shown as - - - -). Shown are mean + SEM.  
ns=not significant; ** p <0.001,*** p <0.0001  n=5-7. 
 
Induction of cytokine and chemokine biosynthesis as well as their release from immune cells 
is controlled by a variety of signaling cascades triggered by the activation of expressed 
receptors. The most prominent and fast-acting TLR4-driven pathways are mediated by MAPK 
like p38 and ERK1/2. Whether the observed change in CCL2 and CCL4 secretion was due to 
an aberrant MAPK signaling as an effect of the Myo1e KO was examined by Western blot 
analysis. Both kinases were constitutively expressed in comparable amounts in WT and KO 
macrophages. Stimulation with LPS induced a typical rapid ERK1/2 and p38 phosphorylation 
within the first 30 min which attenuated already after 1 h until the later time points except of 
p38 which showed re-phosphorylation 24 h post stimulation. Independent from the genotype 
both MAPK pathways were activated to the same extent (Fig. 19). 
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Figure 19. MAPK signaling in activated Myo1e KO macrophages. Western blot for ERK1/2 and 
p38 phosphorylation. Cell lysates were taken at indicated time points (15 min to 24 h) after LPS 
stimulation (100 ng/ml). Grb2: loading control 
 
Furthermore, to investigate whether the increased CCL2 secretion resulted from a change in 
transcriptional levels, we determined its mRNA expression in TLR4 activated macrophages 
by quantitative RT-PCR. Primary macrophages already expressed Ccl2 mRNA in comparable 
amounts to the “house-keeping” gene HPRT, acting as control expression gene independent of 
LPS stimulation. Activation of cultured macrophages induced a 90 - 130 fold increase in the 
mRNA expression of this chemoattractant 8 h post stimulation. This peak of mRNA induction 
was subsequently reduced to a 60 – 70 fold change 24 h after LPS addition compared to 
media control (Fig. 20). The regulation of Ccl2 expression on the transcriptional level was not 
altered by the Myo1e KO, indicating that MYO1e does not participate in signal transduction 
from the activated TLR4 receptor to the nucleus but in transport and secretion processes of 
synthesized chemokines in primary macrophages. 
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Figure 20. Myo1e KO does not influence Ccl2 mRNA 
expression. WT and Myo1e KO MØ were stimulated 
with LPS [100 ng/ml] and Ccl2 mRNA expression was 
determined by qRT-PCR. To normalize for differences 
between experiments in the fold changes, the maximum 
fold change of LPS-treated WT cells in each experiment 
was set to 100% (shown as - - - -). Detection of the house-
keeping gene HPRT occurs at CT values of 22-23 while 
basal Ccl2 expression was measured at CT = 23-24. 
Shown are mean + SEM.  ns = not significant;  n=6. 
4.2.4 Increased CCL2 secretion phenotype in Myo1e KO dendritic cells 
Aside from macrophages a highly important cell type of the innate immune system are 
dendritic cells. Based on the literature, describing the expression of MYO1e also in DCs [118] 
further investigations should identify a possible contribution of the motor protein to 
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chemokine secretion by this cell type. Comparable to primary macrophages, supernatants of 
GM-CSF derived bone marrow DC were analyzed for cytokine and chemokine secretion in 
response to LPS. Dendritic cells were also a very potent source of TLR4-induced cytokines. 
TNF was the only detected cytokine that peaked already 8 h after cell activation in a range of 
4-6 ng/ml which was slightly reduced until 24 h time points. Compared to primary 
macrophages dendritic cells displayed a non-simultaneous release of IL-10 and TNF. Only 
40% of the maximum amount (1,0 - 1,5 ng/ml) was reached after 8 h of the anti-inflammatory 
cytokine IL-10. Interestingly DCs lacking the class I myosin secreted almost doubled amounts 
of IL-6 compared to WT cells; although there were high variations between single 
experiments this difference was still significant indicating an engagement of MYO1e in 
cytokine release by this cell type (Fig. 21a). The CCL2 phenotype detected in MYO1e KO 
macrophages was also observed in DCs with a genetic deletion in Myo1e. LPS stimulated WT 
DCs secreted increasing amounts of the chemokine with prolonged stimulation. However, KO 
DC released constantly almost doubled amounts of CCL2 throughout LPS stimulation at a 
magnitude of 6 ng/ml at 24 h post stimulation. In our experiments MYO1e further affected the 
late CCL3 response to TLR4 activation. Secretion of this chemoattractant was strongly 
induced within the first 8 h upon LPS addition. Up to 8,5 ng/ml under WT condition was 
measurable and subsequently dropped down to 2 ng/ml at 24 h time points. DCs lacking 
MYO1e were not as efficient in down regulation of CCL3 release to the same extent as WT 
cells, because at later time points concentration of 5 ng/ml were still detectable. A 
contribution of MYO1e in CCL4 secretion was not detected in our hands (Fig. 21b). 
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Figure 21. A role of MYO1e in chemokine secretion of activated dendritic cells. . Supernatants of 
the cultures were analyzed by ELISA for the presence of (a) cytokines and (b) chemokines. To 
normalize for differences between experiments in the absolute amount, the 24h time point of the  
LPS-treated control cells in each experiment was set to 100% (shown as - - - -). Shown are  
mean + SEM.   ns=not significant; * p <0.05, *** p <0.0001;  n=3-6.  
 
Comparable to experiments with primary macrophages we next addressed the question 
whether the altered secretion phenotype of TLR4 activated dendritic cells resulted from a 
Myo1e KO caused change in signal transduction. We therefore determined the expression and 
activation of the MAPK ERK1/2 and p38 by immunoblot analysis. Both kinases were 
expressed in comparable amounts in WT and KO DCs. Phosphorylation of ERK1/2 and p38 
in response to LPS stimulation occurs very rapidly already 15 – 30 min after addition of the 
TLR4 ligand and were diminished after 1h until the later time points. Independent from the 
genotype both MAPK pathways were activated to the same extent in DCs (Fig. 22). 
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Figure 22. MAPK signaling in activated Myo1e KO DC. Western blot for ERK1/2 and p38 
phosphorylation. Cell lysates were taken at indicated time points (15 min to 24 h) after LPS 
stimulation (100 ng/ml). Grb2: loading control 
 
Furthermore, to investigate whether the increased CCL2 secretion resulted from a change on 
transcriptional levels we determined its mRNA expression in TLR4 activated DCs by 
quantitative RT-PCR. GM-CSF derived DC already expressed Ccl2 mRNA in higher basal 
amounts compared to the “house-keeping” gene HPRT, acting as control expression gene 
independent of LPS stimulation. Activation of cultured WT DCs induced only a 1.4 - 2 fold 
increase in the mRNA expression of this chemoattractant 8 h post stimulation which was 
strongly down regulated at later time points. The control of Ccl2 expression on transcriptional 
level in Myo1e KO cells displayed a significantly enhanced up-regulation of mRNA to the 
extent of 1.9-3 fold followed again by a subsequent down-regulation (Fig. 23). These 
experiments indicate a possible role of MYO1e not only in transport and secretion processes 
of cytokines and chemokines in DC but also a cell type specific contribution in regulation on 
the transcriptional level. 
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Figure 23. Increased CCL2 mRNA expression in 
Myo1e KO DC. WT and Myo1e KO DC were stimulated 
with LPS [100 ng/ml] and Ccl2 mRNA expression was 
determined by qRT-PCR. To normalize for differences 
between experiments in the fold changes, the maximum 
fold change of LPS-treated WT cells in each experiment 
was set to 100% (shown as - - - -). Detection of the 
house-keeping gene HPRT occurs at CT values of 24-25 
while basal CCL2 expression was measured at CT = 21-
22. Shown are mean+SEM. ns = not significant; * p 
<0.05;  n=4. 
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4.2.5 Reduced MHC-II surface expression on Myo1e deficient antigen presenting cells  
Activation of adaptive immunity in response to invading pathogens is an essential task of the 
innate immune system. To mediate the response macrophages process phagocytozed 
extracellular material into peptides and subsequently present these antigenic structures via the 
MHC-II complex to CD4
+
 T-cells. With respect to the important function and its intracellular 
localization in a membrane engulfed compartment we asked whether MYO1e may contribute 
to MHC-II surface expression on antigen presenting cells. Primary KO macrophages analyzed 
by FACS displayed a significantly reduced 15% lower basal MHC-II surface expression if 
compared to WT cells. Stimulation with LPS induced an increase of surface MHC-II with a 
maximum intensity 8 h after addition and a reduction back to initial expression levels 
measured at later time points. Interestingly, an impaired TLR4-driven up-regulation was 
observed in macrophages lacking MYO1e (Fig. 24a). In contrast, this defect was compensated 
by IFNγ stimulation, resulting in a continuously increased MHC-II expression throughout 
stimulation (Fig. 24b). Investigation on MHC-II mRNA expression argued against the notion 
that the observed phenotype results from a change on the transcriptional level. In qRT-PCR 
analysis both genotypes revealed similar amounts of MHC-II mRNA (CT =21-23) under basal 
conditions. Activation of cultured macrophages induced a 1.5 - 2 fold increase in the mRNA 
expression 8 h post stimulation which was down regulated after 24 hours. Expression of 
CIITa mRNA, the master regulator of MHC-II transcription, was decreased for the duration of 
TLR4 activation without differences between WT and KO condition (Fig. 24c). The results 
indicated that the reduced MHC-II surface expression is due to an intracellular transport 
defect caused by the Myo1e KO and not because of alterations in its biosynthesis. 
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Figure 24. Decreased MHC-II surface expression on activated Myo1e KO MØ. (a, b) WT and 
Myo1e KO MØ were stimulated with LPS [100 ng/ml] or IFNγ [50 ng/ml] and MHC-II surface 
expression was determined by FACS. Left: Histogram overlay of WT cells. Right: MFI normalized for 
differences between experiments, the maximum MFI of treated WT cells in each experiment was set to 
100% (shown as - - -). (c) MHC-II and CIITa mRNA expression of LPS treated MØ. Fold changes 
normalized for differences between experiments, the maximum fold change of LPS-treated WT cells 
in each experiment was set to 100% (shown as - - -).   ns = not significant; ** p <0.001,  
*** p <0.0001. 
 
In addition to antigen presentation the surface expression of co-stimulatory molecules is 
required to activate T-cells. For this reason, the surface expression of CD40, CD80 and CD86 
was examined by FACS analysis on WT and Myo1e KO primary macrophages. In contrary to 
CD80 and CD86 which were already expressed in substantial amounts under basal condition, 
CD40 was detected at low levels on the cell surface. Activation of TLR4 induced only a  
25-30% increase in CD86 expression while CD40 and CD80 were strongly up-regulated in 
response to LPS with a maximum in detection level 24 h after stimulation. However, a modest 
but significant decrease in CD80 expression on Myo1e KO cells was detected at the latest 
time point (Fig. 25a). The stimulation of macrophages with IFNγ also induced a regulation in 
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surface expression of all three co-stimulatory molecules. The decreased amount in CD80 at  
24 h in response to LPS could be restored in Myo1e KO cells activated by IFNγ (Fig. 25b). 
The motor protein not only contributes in LPS-induced MHC-II up-regulation, it also seems 
to be involved in a full CD80 surface expression. 
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Figure 25. Co-stimulatory molecule expression on Myo1e KO MØ. Surface expression of  
co-stimulatory molecules CD40, CD80 and CD86 on (a) LPS [100 ng/ml] or (b) IFNγ [50 ng/ml] 
treated WT or Myo1e KO MØ detected by FACS analysis. MFI normalized for differences between 
experiments, the maximum MFI of treated WT cells in each experiment was set to 100%  
(shown as - - -). Shown are mean + SEM.   ns = not significant. ** p <0.001, *** p <0.0001,  n=4-7. 
 
The most potent antigen presenting cell type of the innate immune system expressing TLR4 
and MYO1e are dendritic cells. These cells already showed strikingly high amounts of surface 
MHC-II under basal conditions and were able to up-regulate the molecule roughly 1.5 fold in 
response to 24 h of TLR4 activation. Although Myo1e KO DCs did not show a difference in 
basal expression and early up-regulation after LPS stimulation, a continuing activation over 
24 h resulted in a significant 20% reduction in MHC-II expression on KO cells (Fig. 26a, b). 
Stimulation of DCs with IFNγ did not affect the surface expression and also did not show an 
altered Myo1e KO phenotype (Fig. 26c). Analysis of the Mhc-II and Ciita mRNA production 
identified an altered expression pattern in response to LPS. DCs lacking MYO1e showed a 
significantly reduced Ciita and a corresponding Mhc-II mRNA expression 8 h after LPS 
stimulation (Fig. 26d), indicating that the Myo1e KO might interfere with the synthesis of the 
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MHC-II master regulator CIITa leading to a reduced Mhc-II mRNA production, which 
subsequently results in the diminished MHC-II surface expression on murine DCs at the later 
time points. Simultaneous measurements of co-stimulatory molecules showed a strong TLR4-
driven up-regulation of CD40, CD80 and CD86 up to a 6-fold increase compared to initial 
condition. Myo1e KO DCs displayed no difference in surface expression patterns of these 
molecules with exception of CD40 with a weak but significant reduction in KO DCs 24 h 
after LPS stimulation (Fig. 26e). 
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Figure 26. Reduced MHC-II mRNA and surface expression in Myo1e KO dendritic cells.  
(a) MHC-II histogram overlay of LPS activated WT DCs. (b) WT and Myo1e KO DCs stimulated 
with LPS [100 ng/ml]. Myo1e KO was confirmed by western blot and surface expression of MHC-II 
analyzed by FACS. n= 5 (c) MHC-II surface expression of IFNγ [50 ng/ml] stimulated DCs. n= 4  
(d) Mhc-II and Ciita mRNA expression of LPS treated DCs. Fold changes normalized for differences 
between experiments, the maximum fold change of LPS-treated WT cells in each was set to 
100%(shown as - - -). Shown are mean + SEM. n= 6 (e) Surface expression of co-stimulatory 
molecules CD40, CD80 and CD86 on LPS treated DCs. MFI were normalized for differences 
between experiments, the maximum MFI of treated WT cells in each experiment was set to 100% 
(shown as - - -). n=5;   ns = not significant; * p <0.05, ** p <0.001. 
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4.2.6 Altered CD4 T-cell activation by Myo1e deficient APCs 
The MHC-II phenotype of Myo1e KO MØ and DCs observed here raised the question 
whether this moderate reduction in surface expression has an impact on T-cell activation. To 
address this issue, we employed an in vitro T-cell stimulation assay where CD4 T-cells 
specific for OVA peptide were isolated from spleen and lymph nodes of OT-II mice and were 
subsequently co-cultured with OVA pre-incubated WT or KO MØ. The MHC-II mediated 
OVA peptide presentation by APCs and its recognition by T-cells expressing the specific 
transgenic TCR induces the activation of CD4 T helper cells. Hence, T-cell proliferation was 
examined by a 
3
H-thymidine incorporation assay. Titrating the number of APCs revealed a 
significantly reduced T-cell proliferation under KO conditions at lower MØ counts. However, 
higher numbers of Myo1e KO MØ were able to induce comparable T-cell proliferation, 
indicating that macrophages lacking MYO1e may have an impaired capacity to activate T 
helper cells (Fig. 27a). FACS analysis of CD25 levels on CD4
+
 cells within the culture 
confirmed the impaired activation after 72 h. T-cells co-incubated with a low number of KO 
MØ up-regulated CD25 to a less extent compared to WT condition (Fig. 27b). Furthermore 
significantly decreased IFNγ levels were measured under KO conditions independent of the 
MØ cell numbers (Fig. 27c). 
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Figure 27. Impaired T helper cell activation through Myo1e KO MØ. In vitro OT-II assay to 
determine MØ MHC-II specific activation of CD4 T-cells. (a) T-cell proliferation measured by  
3
H-thymidine incorporation assay. MØ were pre-incubated with 2 mg/ml OVA over night and 
intensively washed in cRPMI before addition of MACS isolated CD4
+
 T-cells from spleen and LN of 
OT-II mice. MØ numbers we e titrated as indicated above and always 3*1
5
 T-cells were added. 
After 72 h of co-culture 1µCi of 
3
H-thymidine was added and incubated overnight at 37°C before 
measuring. Shown are MEAN+SEM. n=3 (b) OT-II cells were incubated with 3*10
4
 MØ. Gated on 
CD4
+
 cells CD25 expression was determined by FACS at indicated time points. Shown are 
MEAN+SD. (c) Supernatants were analyzed for IFNγ production by ELISA. To normalize for 
differences between experiments in the absolute amounts, the mean of WT condition in each 
experiment was set to 100%. Shown are mean + SEM. n=3; ns = not significant; * p <0.05,  
** p <0.001, *** p <0.001.  
 
The more professional APCs mainly responsible for T-cell activation are dendritic cells. The 
OT-II approach was also utilized to investigate the contribution of MYO1e in MHC-II 
specific T-cell activation mediated by DCs. Low numbers of DCs (1.000 – 10.000) 
independent of the genotype were comparable in their T-cell activation capacity. However, a 
striking change in T–cell proliferation was detected under conditions with high numbers of 
DCs (30.000 – 100.000) which ended up in a significantly decreased T-cell proliferation 
under KO conditions (Fig. 28a). Comparable observations were obtained by CFSE labeling of 
T-cells. Myo1e KO DCs induced a reduced or delayed T-cell proliferation. Started from the 
point of co-incubation each T-cell division cycle can be determined by each peak. Under KO 
conditions the majority of activated T-cells divided two times and a third and fourth cycle 
were detectable. In contrast, under WT condition most of the T-cells were within the third 
division cycle and even a fourth and fifth were measured (Fig. 28b). Activation of CD4
+
 T-
cells dramatically increased until 72 h of co-culturing with DCs measured by up-regulation of 
CD25. However, no difference between WT and Myo1e KO conditions was observed (Fig. 
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28c). Investigation of the T-cell cytokine response revealed an altered IFNγ secretion after co-
incubation with OVA-loaded KO DCs in the majority of the different DC doses (Fig. 28d). 
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Figure 28. Myo1e KO DCs induced alteration in CD4
+
 T helper cell activation. In vitro OT-II 
assay to determine DC MHC-II specific activation of CD4 T-cells. (a) T-cell proliferation measured 
by 
3
H-thymidine incorporation assay. DCs were pre-incubated with 2 mg/ml OVA over night and 
intensively washed in cRPMI before addition of MACS isolated CD4
+
 T-cells from spleen and LN of 
OT-II mice. DC numbers were titrated as indicated above and always 3*10
5
 T-cells were added. After 
72 h of co-culture 1µCi of 
3
H-thymidine was added and incubated overnight at 37°C before 
measuring. Shown are MEAN+SEM. n=3 (b) T-cells were labeled with CFSE before co-incubation 
with 3*10
4
 DCs. After 72h samples were analyzed by FACS. n=1 (c) T helper cells were incubated 
with 3*10
4
 DCs. Gated on CD4
+
 cells CD25 expression was determined by FACS at indicated time 
points. Shown are MEAN+SD. n=1(d) Supernatants were analyzed for IFNγ production by ELISA. 
To normalize for differences between experiments in the absolute amounts, the mean of WT 
condition was set to 100%. Shown are mean + SEM. n=3;  ns = not significant; * p <0.05,  
*** p <0.0001. 
 
Due to the fact that T-cell activation and antigen presentation requires a previous processing 
of the up-taken protein into small peptides and there loading on MHC-II molecules, we finally 
examined whether the altered T-cell activation by Myo1e KO APCs may result from change 
in antigen processing. Thus we applied DQ-OVA on WT and KO MØ as well as DCs. This 
fluorophore labeled OVA with self-quenching capacity can be visualized by increased 
Results  74 
 
fluorescence upon its proteolytical cleavage. FACS analysis of MØ incubated with DQ-OVA 
revealed a very potent processing of the protein, indicated by the fast and strong increase in 
fluorescence signals. Throughout DQ-OVA incubation almost no difference between WT and 
KO MØ was detectable except at the 24h time point (Fig. 29a). Interestingly DCs lacking 
MYO1e showed a significantly enhanced OVA processing during the whole kinetic. Although 
the initial processing does not occur to such an extent as in MØ, after 24h Myo1e KO DCs 
processed relatively equal amounts of OVA compared to WT MØ (Fig. 29b). These results 
indicated contribution of MYO1e in antigen processing events in DCs. 
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Figure 29. Contribution of MYO1e in antigen processing by APCs. (a) MØ and (b) DCs were 
incubate with DQ-OVA (20 µg/ml) for indicated time points at 37°C or 4°C as control. Cells were 
fixed with 2%PFA/PBS to stop processing and subsequently analyzed by FACS. Shown are 
MEAN+SD of biological triplicates as ΔMFI (MFI of untreated cells subtracted from MFI of treated 
cells). Histogram overlay of DCs + DQ-OVA at 24h. WT DCs (blue line); Myo1e KO DCs (red line); 
n=1.   * p <0.05, ** p <0.001, *** p <0.0001. 
 
4.2.7 MYO1e in MHC-II surface expression on B-cells 
The third immune cell type expressing MHC-II and TLR4 are B-cells. Known from literature 
these cells only express MYO1e as a class I “long-tailed” myosin [118, 162] depending on 
their maturation stage [116]. Based on our previous findings regarding MØ and DCs, B-cells 
were an interesting target to investigate the contribution of MYO1e in MHC-II expression. 
Due to the fact that only bone marrow of WT and Myo1e KO mice was available to us, we 
generated bone marrow chimeras by reconstitution of RAG KO mice with WT or Myo1e KO 
bone marrow to finally obtain B-cells lacking MYO1e (Fig.30).  
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Figure 30. Confirmation of Myo1e KO in B-cells of 
RAG KO mice reconstituted with WT or Myo1e 
KO BM. B220
+
 B-cells were isolated via MACS 
from spleen of BM chimera mice. Cells were 
incubated with 10 µg/ml LPS and lysates were taken 
at indicated time points. Grb2: loading control. 
 
To simultaneously investigate whether the lack of MYO1e caused a change in B-cell 
distribution within the mice under basal condition we analyzed the ratio of CD19
+
 B220
+
 cells 
in different organs accompanied by analysis of their basal MHC-II expression. Started our 
analysis from bone marrow (BM) over blood (Bl) to the spleen (Sp) and the peritoneum (Pe) 
the ratio of CD19+B220+ cells strongly increase with highest amounts around  
45-50% detected in spleen. The bone marrow harbored only 5-10% of already differentiated 
CD19
+ 
B220
+
 B-cells but an equal, coexistent and clearly distinguishable population of 
CD19
+
B220
dim
 cells. Possibly caused by the high variance in B-cell ratios between 
reconstituted mice, a difference in cell distribution between the two genotypes could not be 
detected under basal conditions (Fig. 31a). Analysis of MHC-II revealed an already high 
expression on B220
+
 B-cells in all examined organs except of the CD19
+
 B220
dim
 population 
of the BM whereas highest amounts were measured on B-cells within the peritoneum 
(Fig.31b). To investigate whether B-cells are able to up-regulate MHC-II in response to LPS 
and if this is influenced by MYO1e, cell suspensions from the organs were stimulated and 
subsequently examined for MHC-II expression on CD19
+
 B220
+
 cells. B-cells of the bone 
marrow, spleen and peritoneum weakly elevated the expression of surface MHC-II after 24 h 
of LPS treatment but independent from the Myo1e KO (Fig. 31c-e). These results indicated 
that MYO1e does not contribute to MHC-II surface expression in B-cells.  
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Figure 31. MYO1e in organ specific MHC-II expression on B-cells. RAG KO mice reconstituted 
with either WT (black circles) or Myo1e KO (clear circles) bone marrow were analyzed for basal  
B-cell distribution and MHC-II expression. Dots represents MEAN of technical replicates from one 
mouse (7-10 mice per genotype) (a) Percentages of CD19
+
 B220
+
 or 
dim
 (intermediate) cells in bone 
marrow (BM), blood (Bl), spleen (Sp) and peritoneum (Pe) analyzed by FACS. (b) Basal MHC-II 
surface expression on B-cells from different organs. (c-e) Cell suspensions of BM, Sp and Pe were 
stimulated with LPS [10 µg/ml] for indicated time points. MHC-II expression on CD19
+
 B220
+
 cells 
was analyzed by FACS. Bars represents MEAN+SEM. 
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5 Discussion 
A global and quantitative phosphoproteome analysis of LPS-activated MØ, performed in our 
lab, identified 1800 phosphoproteins with around 7000 regulated phosphosites. Among these, 
bioinformatic analysis revealed the cytoskeleton as a hotspot of TLR4-driven protein 
phosphorylation [30]. Quantitative analysis of MØ spreading was validated and utilized as a 
measurable and cytoskeleton-dependent readout to investigate the impact of genetic or 
pharmacological inhibition of known TLR signaling components. We identified an essential 
but time-dependent requirement for MYD88 and the MAPK p38 and ERK1/2 in early and late 
TRL4-driven spreading. A siRNA knock down (KD) screen for selected cytoskeletal 
phosphoproteins identified the two class I myosins MYO1e and MYO1f as important 
contributors to LPS-triggered macrophage spreading. Further investigations on primary MØ 
and DC lacking MYO1e showed a selectively increased secretion of the chemokine CCL2 as 
well as a reduced basal and LPS-induced MHC-II surface expression on both antigen 
presenting cell types. The capacity of macrophages and DC lacking MYO1e to stimulate 
antigen-specific CD4+ T cell proliferation was remarkably impaired. Our results provide 
evidence for a non-redundant function of the motor protein MYO1e in the regulation of 
TLR4-controlled, cytoskeleton-associated functional properties of macrophages and DC, and 
in the induction of a full MHC-II restricted adaptive immune response. 
 
5.1  Quantitative analysis of cell spreading 
In order to better understand the contribution of the cytoskeleton in the control of TLR4 
induced immune cell response, we validated macrophage spreading as measurable readout. 
This important cell function is strongly dependent on actin dynamics regulated by signaling 
molecules and cytoskeletal associated proteins, and reflects the adherence process at the site 
of infection. To measure TLR4-driven spreading in vitro, BMM were stimulated with LPS in 
a kinetic manner up to 24 h and finally visualized by fluorescence microscopy. The change in 
contact area between cell and surface material was determined, compared to unstimulated 
control conditions and defined as spreading. A manual quantification of the spreading 
response was possible by using ImageJ [163, 164] or tools provided by the fluorescence 
microscope software AxioVision 4.8.2 from Carl Zeiss MicroImaging. However, these 
approaches had the disadvantage of being labor-intensive and time consuming. In addition the 
manual delineation of the cell borders potentially introduces bias. Hence, analysis of multiple 
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images within an acceptable time frame and a constantly accurate annotation quality was 
infeasible. Utilization of automatic image analysis software provided the possibility to 
circumvent these drawbacks. To this end, freeware software packages like CellProfiler [165, 
166] are available which can be adapted to the image content by adjusting several parameters, 
e.g. minimum and maximum cell diameter, threshold selection methods or pre-processing 
methods. However, adjustment of all these parameters to obtain sufficient results is as well 
very time-consuming for researchers not familiar with image processing. Thus, in cooperation 
with the group of PD Dr. Wittenberg from the Fraunhofer-Institut in Erlangen, we developed 
and optimized a two-step algorithm to segment nuclei and subsequently to determine cell size 
and contact area [154, 167]. This automated segmentation routine gave us the opportunity for 
a rapid acquisition of quantitative and reliable data from microscopy images without pre-
processing procedures done by the user. Comparison of automated to manual annotation 
demonstrated a good concordance in resting macrophages and early after stimulation. The 
observed increase in variation at later time points resulted from overlapping cells based on the 
spreading behavior of macrophages. An occasional manual editing of the contact area 
annotation was required at the late time points. Overall very similar results were obtained in 
several experiments investigating the cell spreading (Fig 7). Thus, our two-step algorithm was 
used in a semi-automated procedure, combining automated annotation with manual 
correction, to quantify TLR4 induced macrophage spreading with a tremendous reduction in 
time and labor [147]. To improve the performance of the automatic annotation tool the quality 
of the input data is very critical. The quality of fluorescence microscopy pictures, in terms of 
staining intensity and signal-to-noise ratio of the cells versus slide background is one of the 
pivotal parameters. In our hands staining of the macrophage surface marker CD11b with 
APC-labeled antibodies reached the best signal, compared to cytosolic CFSE or membrane 
lipid PKH staining. The reduced accuracy of the annotation tool at later time points after 
stimulation might be explained by the localization of CD11b. Continuing LPS stimulation can 
cause changes in redistribution or clustering of CD11b in different cellular compartments, 
creating local maxima that are falsely recognized as cell boarders. Hence, staining of surface 
markers like MHC-I, CD45 or Fc receptor which are also highly expressed independent of the 
activation status or the use of antibodies labeled with stronger fluorescent dyes could improve 
the tool performance. In the future, the development of automatic segmentation algorithms the 
annotation of overlapping cells remains an issue that must be solved by computer scientists.  
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5.2 Contribution of TLR4 signaling in macrophage spreading 
Convinced by the potential of our quantitative readout system and the advantage to interfere 
by utilization of specific pharmacological inhibitors and selected knockout (KO) cells, we 
further analyzed the contribution of TLR4 signaling molecules in the control of macrophage 
spreading. The LPS-triggered spreading observed first after 1 h and increasing continuously 
until 8-24 h (Fig. 6) could be caused by direct TLR4-driven signaling inducing actin 
polymerization or cytoskeleton rearrangement, or it could depend on indirect effects of TLR-
driven cytokine release, e.g. TNF. Compared to the cytokines IL-6 and  
IL-12p40, TNF is the only pro-inflammatory cytokine secreted early enough to potentially 
cause initial spreading (Fig. 8). In our experiments we have not excluded this possibility. 
Feasible experiments to address this issue will require the use of selected KO macrophages or 
application of inhibitors off protein biosynthesis (e.g. Cycloheximide), transport and secretion 
(e.g. Brefeldin A) or specific inhibitors of the metalloprotease ADAM17 (TACE) responsible 
for TNF shedding and release. Strong evidence that LPS directly induces a rapid actin 
rearrangement in macrophages was already described in peritoneal macrophages of C3H/HeN 
mice, where an assembling and disassembling within the first 6 minutes after LPS stimulation 
was observed in contrast to macrophages of LPS non-responder C3H/HeJ mice [69]. 
Comparable observations were made on the macrophage cell line J774, where TLR4 
activation induced a rapid morphological change within 20 minutes accompanied by an 
enrichment of actin filaments in ruffles at the leading edge [73]. To address this issue in 
murine bone marrow macrophages, shorter LPS stimulation time points are required to 
observe initial changes in actin dynamics. To determine the cytoskeletal rearrangement 
processes, fluorescence microscopy or FACS analysis of cells stained with phalloidin for 
polymerized actin filaments would be necessary. Furthermore, the fractionation of the actin 
cytoskeleton by high-speed centrifugation from cell lysates of activated MØ can give 
information on dynamic changes. This method allows the densitometric quantification of 
separated monomeric G-actin and filamentous F-actin. The ratio of G- to F-actin indicates 
alterations in assembling or disassembling dynamics [73].  
An essential adapter protein of TLR4 signaling is MYD88, required for transduction of 
intracellular signaling. The use of KO macrophages confirmed its crucial role in  
LPS-induced cytokine production. Thus, cells lacking the molecule entirely failed to produce 
TNF, IL-6 or IL-10. Interestingly Myd88 KO macrophages, compared to Myd88 heterozygous 
control cells, exhibited a normal spreading response to LPS during the initial phase until 2 h. 
Only under longer lasting LPS stimulation from 8 – 24 h, Myd88 KO macrophages showed a 
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reduced spreading, indicating a crucial role of MYD88 mediated signaling during late phase 
adherence (Fig. 8). To our knowledge, a role of MYD88 in LPS-induced actin rearrangement 
has not been described before. The normal TLR4-driven initial spreading of Myd88 KO MØ 
is supposed to be mediated via the MYD88 independent pathway, including the second 
adaptor protein TRIF. To examine this assumption, the use of macrophages lacking TRIF or 
both adaptors MYD88/TRIF will be useful. Furthermore, to distinguish between direct effects 
of MYD88 on macrophage spreading and secondary effects mediated by secreted cytokines, 
transfer of supernatant from WT MØ onto Myd88 KO was performed. Macrophages lacking 
the TLR4 adaptor protein did not increase their contact area in response to the supernatants 
(data not shown). The results suggested a direct induction of macrophage spreading and 
cytoskeleton rearrangement by LPS and less through the secreted cytokines.  
Central mediators regulated in response to TLR4 activation are the MAPK p38 and ERK1/2 
and thus became focus of our following investigations. Both MAPKs were necessary for a full 
cytokine production of primary macrophages in response to TLR4 activation. Interestingly a 
time-dependent requirement for p38 and ERK1/2 for early and late spreading responses, 
respectively, was found (Fig. 9 and 10). In the absence of p38 a significantly reduced early, 
but intact late spreading was observed. P38-deficient macrophages, compared to cells lacking 
Myd88, exhibited a slightly reduced basal contact area, which could also indicate differences 
in differentiation caused by the lack of these molecules (Fig. 8 and 9). The use of specific 
pharmacological inhibitors for p38 would be helpful to confirm the p38-dependent early LPS-
induced spreading. The approach was used to reveal the contribution of the MAPK ERK1/2 in 
this context. Macrophages treated with the MEK1 inhibitor PD184352 showed a similar 
spreading response to Myd88 KO cells, with intact early spreading but a strongly reduced 
response after 8 h and 24 h (Fig. 8 und 10). Thus, ERK1/2 appears to be the main kinase of 
the MYD88-dependent spreading response. However, the utilization of this pharmacological 
inhibitor entailed some limitations. First, a strongly diminished basal and LPS-induced 
phosphorylation of ERK1/2 was observed, but a complete suppression was not obtained. 
Second, the PD184352 treatment may have additional effects aside MEK1 inhibition, which 
can contribute to the observed spreading phenotype although a variation in p38 activation 
could not be observed (Fig. 10). To definitively confirm the role of ERK1/2 in the  
TLR4-driven late spreading response, experiments with respective KO macrophages are 
necessary. With these experiments we revealed a dichotomy of p38 and ERK1/2 in TLR4-
induced spreading, where the late spreading response is mediated by MYD88 and ERK1/2, 
while early spreading in contrast is dependent on p38 signaling. With respect to the normal 
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early spreading of Myd88 KO MØ, the early activation of p38 should be MYD88 
independent. In fact, the LPS-induced phosphorylation of both MAPK is only delayed in 
Myd88-deficient macrophages [28]. Experiments performed in the macrophage cell line J774 
also showed a contribution of p38 in early LPS-induced spreading by activation of β2-
integrins via the Ras-like GTPase RAP1 [140].  
The regulation of MAPK activity is crucial to control the response of innate immune cells. 
Endogenous regulators expressed by macrophages are dual-specificity phosphatases (DUSPs), 
known to be involved in p38 and ERK1/2 regulation [37, 168]. The use of specific KO 
macrophages for DUSP1 and DUSP16 confirmed their differential role in the regulation of 
LPS-induced production of IL-10 and IL-12p40 (Fig. 11). A contribution of  
DUSP1 to cytoskeleton-dependent cell functions has been described. Macrophages lacking 
DUSP1 showed an impaired spreading under resting conditions [38] and monocytes of 
diabetic mice express only low levels of DUSP1, leading to a hyperactivation of p38 and 
ERK1/2 in response to CCL2 and an increased chemotaxis and adhesion [168]. Interestingly, 
we observed that macrophages lacking either DUSP1 or DUSP16 showed a similar reduction 
in spreading at 8-24 h. Mechanisms behind the DUSP depend spreading phenotype are 
currently unknown. However, it is worth noting that 18 of 44 cytoskeletal phosphoproteins 
detected in our phosphoproteome analysis contains a MAPK binding motif, corroborating 
their importance as potential cytoskeleton regulators (Fig. 5).  
Furthermore, the expression and activation of integrins controlled by MAPK [139, 140] and 
possibly regulated through DUSPs, might be involved in TLR4-induced macrophage 
spreading. To address this question, inhibitor-treated or specific MAPK and DUSP KO 
macrophages can be screened for basal and LPS-induced integrin surface expression by FACS 
analysis. In addition to macrophage spreading on plastic slides, in this context it would be 
informative to determine the spreading response on slides coated with integrin ligands, e.g. 
fibronectin, collagen or ICAM-1. Aside surface expression, MYD88, MAPK and DUSPs 
might be involved in activation of integrins by controlling the inside-out signal. For the β2-
integrin CD18, the most prominent subunit on innate immune cells, specific antibodies exist 
which recognize epitopes formed during the activation process by conformational changes. 
Their application allows to distinguish between the “bent, inactive”, “extended, intermediate 
affinity” and “extended, high affinity” conformation of the integrin and whether this process 
is influenced by TLR4 activation and signaling components [138].  
One established pathway from TLR4 to integrin activation is transmitted by the  
focal-adhesion kinase-related PYK2 and the adaptor protein paxillin (PXN) [169]. The 
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phosphorylation of paxillin on Ser130, mediated by ERK1/2 in response to LPS, is required 
for GSK3-dependent phosphorylation of Ser126 [170]. All members of the described 
ERK1/2-GSK3-PYK2-PXN pathway were found strongly phosphorylated after LPS at several 
sites in our phosphoproteome analysis [30]. Interestingly, in Myd88 KO macrophages the 
activation of PXN and PYK2 were just weakly reduced [171], which might explain the intact 
initial spreading in Myd88-deficient cells observed in our experiments. Another potential 
mechanism involved in MYD88-independent macrophage spreading is provided by an early 
activation of the small GTPases CDC42 and RAC in response to LPS, known to be important 
in actin rearrangements [81].  
5.3 Cytoskeletal phosphoproteins in LPS-induced macrophage spreading 
Although some of the molecules in macrophage spreading are well described, the fact that 44 
cytoskeletal proteins were regulated by TLR4-driven phosphorylation in our 
phosphoproteome analysis [30] indicates that multiple proteins contribute to the changes in 
macrophage spreading, motility or other cytoskeletal cell functions. To elucidate the 
functional role of chosen candidate proteins we established a siRNA knock down (KD) in 
primary mouse macrophages, based on a protocol developed by the group of Jonathan Jantsch 
[146]. The delivery of small interference RNA (siRNA) into the cells for selective gene 
silencing occurs via electroporation. Compared to other transfection methods with DEAE-
dextran, calcium phosphate or lipofectamine, this procedure possesses a high efficiency with 
more than 95% transfected cells. Importantly, the electroporation did not impair the viability 
and immunological functions of macrophages, e.g. phagocytosis, expression of cytokines and 
NO production. To avoid cell stress by accutase treatment or mechanical detachment from 
plates in advance to electroporation, the differentiation of primary MØ was performed in 
hydrophobic teflon bags, yielded more than 90% macrophages (CD11b
high
 F4/80
high
) within 
the culture population after 8 days [146]. This culture condition was critical for the survival 
rate of macrophages after electroporation and siRNA treatment. The development of 
macrophages under non-adherent conditions seemed normal, however the surface attachment 
and activation of integrins is required for a complementary and optimal TLR4 response, 
leading to a full ERK1/2 and JNK activation and induction of an entire TNFα production 
[136]. In respect to cytokine secretion and up-regulation of surface molecules, MØ 
differentiated in teflon bags and petri dishes respond in similar kinetics and in same extent to 
LPS, in our hands. However, cells derived from the two differentiation approaches showed 
occasional differences in their spreading response. For this reason it was indispensable to 
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compare control and treated cells differentiated under same conditions. Cells treated with 
siRNA were rested 48 h to develop the full siRNA effect before LPS stimulation. The KD 
efficiencies measured on mRNA level by quantitative real-time PCR showed a high 
variability from 50-90% (Fig. 12). This high variability depends on the amount of the target 
mRNA expressed under basal condition and the inducibility of the respective gene expression 
in response to the stimulus. Target mRNAs available in larger quantity require enough time to 
get eliminated by the RNAi machinery, while mRNAs with low basal expression provide less 
possibility for target interaction. Thus, the cells get cleared from free siRNA molecules by 
nucleases [172]. Furthermore, the KD success depends on the dose of the delivered siRNA as 
well as its stability. The best results for the majority of the cytoskeletal proteins were obtained 
48 h after siRNA treatment. In case of proteins with low KD efficiency a shorter siRNA 
incubation period of 24 h may obtain better results. To confirm the KD also on protein level, 
Western blot analysis of cell lysates for the respective proteins are necessary in future 
experiments.  
Measurements on TLR4-induced spreading indeed revealed a contribution for some of the 
selected proteins in primary macrophages (Fig. 12). The most striking effects were observed 
in response to the KD of the actin polymerization factor (APF) ARP3 and its antagonist 
CORO1b. ARP3 is part of the multi protein complex ARP2/3, which is composed of seven 
subunits including ARP2 and ARPC1-5. It is the best described APF in lower and higher 
eukaryotes and its activity is essential to form branch-ends on existing actin filaments 
required for lamellipodia formation [88]. Furthermore, it plays a central role in macrophage 
chemotaxis and receptor-mediated phagocytosis [14]. First studies linking specific 
phosphorylation events of this protein complex to its functional control were done in lysates 
of human neutrophils. Here, the phosphorylation of ARPC5 was mediated by the MAPK p38 
and thus the authors speculate that it activates the ARP2/3 complex [92]. Furthermore, the 
phosphorylation of the subunit ARP2 in Dictyostelium was also shown to regulate the  
multi-protein complex activity [89, 90]. In our phosphoproteome studies of TLR4 activated 
primary macrophages a strong and consistent phosphorylation of the ARP3 subunit was 
identified, whose function is still unknown. However, biochemical studies identified a crucial 
role for the ARP3 subunit in actin polymerization, linking the whole complex to the site of 
actin filaments [173]. For these reasons we expected to observe a change in the LPS-induced 
spreading phenotype in macrophages treated with the specific ARP3 siRNA. Indeed, an 
initially reduced contact area as well as a strong impaired spreading response throughout LPS 
stimulation was measured. Macrophages manipulated in the synthesis of ARP3 protein 
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presumably failed to form the functional ARP2/3 complex and thus lose their ability to 
increase the contact area. The initial early spreading upon stimulation might be due to a high 
protein expression of all ARP2/3 subunits under basal conditions and enables the cells to 
rapidly adapt its morphology in response to a trigger. These results indicated an essential role 
for ARP3 in formation of a functional ARP2/3 complex, required in primary macrophage 
spreading.  
Although the KD efficiency for CORO1b was only 50%, its down regulation on mRNA level 
resulted in a strong alteration in macrophage spreading. Cells treated with specific siRNA 
showed a similar initial contact size but a significantly reduced early spreading up to 8 h upon 
stimulation. However, these cells subsequently enhanced their spreading until 24 h and ended 
up in a significantly strong increase in contact size compared to control cells. This 
cytoskeletal protein inhibits ARP2/3 activity by replacing it from actin filaments and 
additionally coordinates the activity of the actin depolymerization factor cofilin [160, 174]. In 
fibroblasts the CORO1b/ARP2/3 interaction is regulated by phosphorylation of CORO1b by 
the protein kinase C (PKC) in response to PMA [175]. PKC isoforms are well known to be 
activated in response to TLR4 activation [176] and a modest but consistent phosphorylation of 
PKC-β and PKC-δ was also detected in our phosphoproteome analysis. This might provide 
evidence for a PKC/CORO1b regulation of actin dynamics in response to TLR4 activation in 
primary macrophages. The down regulation of CORO1b by siRNA treatment might cause a 
hyperactive ARP2/3 complex dissipating the majority of monomeric G-actin for F-actin 
formation. It is possible that the disruption in disassembling processes inhibits the constant 
supply with G-actin and thus results in a reduced early spreading. To compensate or 
overwhelm the defect, macrophages might then activate additional depolymerization factors 
or increase the expression of actin, resulting in a stronger increase in contact area until 24 h, 
caused by the hyperactive ARP2/3 complex.  
The KD of other phosphorylated actin polymerization factors FMN1 and FHOD1, which 
belong to the formin family, did not show a change in the spreading behavior of macrophages. 
A possible explanation might be the difference in the procedure of actin polymerization. 
While ARP2/3 activation induces actin branching to build a dense network required in 
lamellipodia formation, formins interact with the tip of actin filaments and elongate them 
linear to form filopodia structures [84, 88, 177]. In contrast to ARP2/3, macrophages express 
several types of formins [178], which might be able to act redundantly. In further experiments 
a simultaneous double or multiple siRNA KD of selected formins can reduce this risk and 
might reveal a possible role of these APF in TLR4 induced macrophage spreading. 
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Furthermore, fluorescence microscopy can be utilized to focus on morphological changes 
caused by the formin KD. Their down regulation might reveal a contribution in TLR4-driven 
filopodia formation. These finger-like structures of macrophages are known to be critical in 
phagocytosis processes [179] and thus FMN1 and FHOD1 should be examined in uptake 
processes.  
The KD of the cytoskeletal adaptor protein missing-in-metastasis 1 (MTSS1) revealed a 
minor but biphasic alteration in spreading, with a significantly reduced early spreading and 
increased late spreading in response to LPS. The protein contains independent F- and G-actin 
binding domains and is thus believed to recruit actin monomers or other proteins to specific 
cytoskeletal networks [180]. Furthermore, redistribution in fibroblasts from the cytoplasm to 
membrane ruffles, dependent on Tyr-397 and Tyr-398 phosphorylation, is described in 
response to platelet-derived growth factor (PDGF) [181]. Interestingly, MTSS1 KO 
fibroblasts display a reduced spreading within 2 h in response to adherence as well as a 
distinct morphology and altered cytoskeleton reorganization after PDGF stimulation. The cell 
motility and endocytosis is also impaired [182]. The strong phosphorylation of MTSS1 in 
LPS-stimulated macrophages was detected on several serine residues from position 348 to 
355, the approximate position compared to fibroblasts. Our results together with observations 
on murine fibroblasts indicate an important role for the phosphorylation within this range, and 
thus might be essential to control murine MTSS1 function.  
The siRNA KD of LSP1 and EPS8 caused only minor changes in macrophage spreading; 
although the respective mRNA in challenged MØ was reduced from 60-85 %. LSP1 is 
expressed in all human and murine leukocytes [93] and described to be involved in regulation 
of the actin cytoskeleton structure and motile function of neutrophils by mediating MAPK 
signaling to the cytoskeleton [93-95, 183, 184]. Its activity is regulated by p38/MK2-mediated 
phosphorylation on Ser243 within its C-terminal F-actin binding region and thus stabilizing F-
actin polymerization during neutrophils chemotaxis [94, 183, 184]. Furthermore, confocal 
microscopy analysis showed that LSP1 targets MEK1 and ERK2 to peripheral actin filaments 
in a B-lymphoma cell line [95]. TLR4-driven phosphorylation of several residues within the 
C-terminal region of LSP1, even Ser242, was detected in LPS-activated macrophages; some 
of them identified within a MAPK substrate motif [30]. The obtained results suppose that 
LSP1 does not contribute to LPS-induced macrophage spreading, but it may be involved in 
chemotaxis as described for neutrophils. The same might be true for the signal adaptor EPS8, 
also functional as capping protein and described to be essential in DC migration [185]. Recent 
studies identified a contribution of EPS8 in macrophage phagocytosis and bacterial killing. 
Discussion  86 
 
Here, LPS induced EPS8 expression followed by its interaction with TLR4-MYD88 in the 
cytosol and at the phagosomes, and is necessary to fully activate SRC, focal adhesion kinase 
(FAK), and p38 MAPK [186]. A requirement of MTSS1, LSP1and EPS8 in TLR4-driven 
macrophage spreading is not as obvious as in case of ARP3 and CORO1b. Thus, macrophage 
spreading seems not to be the main cell function controlled by these proteins. Investigations 
of further cytoskeleton-associated cell functions are necessary to rule out an essential function 
for the respective phosphoproteins. Phagocytosis assays with fluorescent labeled beads or 
pathogens such as E.coli can be used to identify a possible contribution in uptake processes. 
To examine the pathogen killing capacity of the macrophages, a gentamicin protection assay 
can be utilized. Fluorescence microscopy in combination with phalloidin staining for F-actin 
filaments might be a feasible approach to determine the polarization potential of the cells in 
response to the trigger. Leading edge formation accompanied with F-actin enrichment might 
also be useful. To clearly identify the leading edge, an additional paxillin, talin or vinculin 
staining would be necessary to visualize podosomes. These short lived, punctate structures are 
concurrently formed and recruited to membrane protrusions of motile cells, and are thought to 
be involved in tissue invasion and matrix remodeling, but also can be found ex vivo [187]. 
Utilization of wound healing and trans-well assays can be used to determine the role of 
selected cytoskeletal phosphoproteins in LPS-induced motility or respectively migration 
towards stimuli gradients. Altogether, the technique of specific siRNA KD in combination 
with the automated annotation software proved to be a promising approach to screen for 
phosphoproteins involved in TLR4-driven cytoskeletal rearrangements and select candidate 
proteins for further investigations. 
 
5.4 Class I myosins MYO1e and MYO1f are required for efficient MØ 
spreading 
MYO1e and MYO1f belong to the group of class I myosins composed of eight members, who 
are able to interact with actin filaments and lipid membranes through distinct regions in their 
C-terminal tail domain. Both proteins are so-called long-tailed class I myosins based on the 
presence of three tail homology domains (TH1, TH2 and a SH3 domain termed TH3) [99]. A 
strong and consistent phosphorylation of both motor proteins was found in TLR4-activated 
primary macrophages (Fig. 13). The majority of the identified LPS-regulated phosphosites are 
located within the TH2 domain and one threonine within the pleckstrin homology (PH) 
domain. The TH2 domain of long-tailed myosin is required for microtubule – F-actin 
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interaction [188, 189] and as well mediates an ATP-independent actin binding of the myosins 
[108]. Furthermore, the prolin-rich TH2-domain allows the oligomerization of long-tailed 
myosins critical for movement and cargo binding [130]. The PH domain is necessary for 
anionic phospholipid binding and membrane localization [125]. In previous studies a motility 
defect of murine neutrophils lacking MYO1f was described. This phenotype results from an 
abnormal increase in exocytosis of β2-integrin containing granules, leading to an enhanced 
adherence [118].  
The specific siRNA KD for Myo1f in primary macrophages resulted in a reduced basal 
contact area and an impaired LPS-induced spreading (Fig. 14). Given the observed MYO1f 
effect, we also examined the contribution of MYO1e, which showed considerably stronger 
phosphorylation after LPS stimulation (Fig. 13). In Myo1e KO macrophages, qRT-PCR 
analysis confirmed the lack of Myo1e transcripts, but in Western blots a faint band of the 
expected molecular weight (MW) was still observed (Fig. 15). We assume that this band is 
caused by cross reactivity of the antibody with MYO1f of the same MW of 125kDa. 
However, Myo1e KO MØ showed only a moderately reduced spreading response to LPS after 
2 h and 8 h. Due to the high structural homology of both class I myosins we performed siRNA 
KD of Myo1f in Myo1e KO macrophages to generate “double-deficient” macrophages. 
MYO1e and MYO1f collaborated for efficient LPS-induced spreading in macrophages, as 
demonstrated by our experiment. FACS analysis of Myo1f KD macrophages should reveal 
whether the change in spreading phenotype is also caused by an altered integrin surface 
expression, as already described for neutrophils [118]. The expression of adhesion molecules 
on Myo1e KO macrophages was not influenced by the genetic deletion of the protein. All 
analyzed integrins were expressed comparable to WT control cells (Fig. 16).  
However, recent studies provide evidence that MYO1e contributes in cytoskeleton 
rearrangement and cell adhesion. MYO1e in human umbilical vein endothelial cells 
(HUVEC) was identified to co-localize with CARMIL, FHOD1, ARP3 and β3-intergins in 
early adhesion sites, suggested to transport the actin polymerization proteins to these 
structures and additionally be involved in its stabilization. The localization of MYO1e 
depends on its SH3 domain, which is not present in short tailed class I myosin isoforms [130]. 
Furthermore, proteomic studies identified MYO1e as a component of macrophage podosomes 
[190] and fibroblast integrin adhesome [191]. In fibroblasts the invadosome localization of 
MYO1e was identified to be dependent on its TH1 and TH2 domain [192] and in renal 
podocytes colocalizes with actin filaments at the site of newly established cell-cell contacts 
[135]. Fluorescence microscopy analysis of MYO1e in primary macrophages can be used to 
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examine the localization or TLR4-driven redistribution of the motor protein. The observation 
of an altered spreading phenotype of Myo1e KO macrophages led us to the question whether 
the migration of immune cells in vivo is influenced by the deletion of the motor protein. An in 
vivo model was utilized, where Myo1e-deficient immune cell recruitment in response to 
intraperitoneally injected, heat killed E. coli (as source of LPS) was studied (Fig. 17). 
Interestingly, analysis of the total cell influx at the site of injection revealed a significantly 
elevated cell number. The increased total cell number was not caused by the enhanced 
recruitment of a specific immune cell subset. Even cell types, such as neutrophils which do 
not express MYO1e under WT condition [118] were found enriched in the peritoneum. This 
indicates that MYO1e contributes in an immune response, which alters cell migration in a 
secondary way, leading to general enhanced immune cell recruitment. To further address this 
issue the distribution of immune cell subsets in different organs such as bone marrow, blood 
or spleen should be analyzed to determine a possible difference already under basal conditions 
in the utilized mouse model. Furthermore, the measurement of cytokines and chemokines in 
the peritoneum and in serum of mice can give a hint whether a possible alteration in their 
content is responsible for the increased cell influx in response to heat killed E. coli. 
Since MYO1e and its SH3 domain was reported to be involved in receptor-mediated 
endocytosis [121], we investigated the contribution of MYO1e and MYO1f in TLR4-driven 
macrophage phagocytosis (data not shown). Application of an unspecific bead and E. coli 
phagocytosis assay showed a comparable uptake of particles or pathogens independent on the 
KO or siRNA KD of the motor proteins. In our hands, the uptake of fluorescent latex beads 
and GFP-expressing E. coli similarly increased over the time, even in Myo1e KO 
macrophages additionally treated with Myo1f siRNA. These results indicate that MYO1e and 
MYO1f are not involved in macrophage phagocytosis. Myo1e-deficient macrophages were 
utilized in a gentamicin protection assay to examine a possible role of the protein in pathogen 
killing. Incubation of macrophages with E. coli, S. aureus or Salmonella up to 20 h upon 
antibiotic treatment revealed no difference in pathogen killing dependent on the macrophage 
genotype. Thus, MYO1e also did not contribute in intracellular pathogen killing (data not 
shown).  
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5.5 MYO1e selectively regulates the release of the chemokine CCL2 from 
macrophages and DCs 
Activation of TLR4 by LPS induces rapid and massive induction of pro-inflammatory gene 
expression as well as secretion of cytokines and chemokines known from quantitative 
proteome, transcriptome and secretome analysis, which are involved in cellular 
communication, adhesion and migration [193, 194]. An example is TNF, which may induce a 
spreading response in leukocytes [195]. Thus we examined whether the reduced spreading 
phenotype observed in Myo1e KO macrophages was related to TLR4-driven cytokines release 
(Fig. 18). The kinetic and amounts of TNF, IL-6, IL-12p40 and IL-10 were unaltered in 
macrophages lacking MYO1e. However, a significantly increased release of the chemokine 
CCL2/MCP-1 was detected in the supernatant of LPS-stimulated KO macrophages compared 
to WT cells at the 8 h and 24 h time points. This effect was specific for CCL2, as alterations 
in the secretion of other chemokines like IP-10 and CCL3 was not detected. A transiently 
higher release for CCL4 was observed in WT macrophages. Interestingly, an increased 
secretion of CCL2 was also measured when Myo1e
-/-
 bone marrow-derived dendritic cells 
were stimulated with LPS (Fig. 21). Thus MYO1e, which is expressed in MØ and DCs [118], 
regulates TLR4-driven CCL2 release in both cell types. Recent studies showed that CCL2 
causes cytoskeletal rearrangements and morphological changes in macrophages [196]. 
Blocking the CCL2 receptor CCR2 on macrophages with specific antibodies prior to LPS 
stimulation might reveal whether the reduced spreading observed in KO cells results from the 
elevated CCL2 in the supernatant or occurs as direct effect of the motor protein KO. The 
increased secretion of CCL2 is presumably caused by altered transport and release from the 
cells, because the downstream signaling measured by MAPK phosphorylation of p38 and 
ERK1/2 (Fig. 19 and 22) and expression on mRNA level (Fig. 20) was not altered in MYO1e 
MØ. A regulatory role of MYO1e in vesicular trafficking of the chemokine CCL2 seems 
therefore likely. Interestingly an involvement of the long-tailed class I myosins and their 
regulatory function in exocytosis processes was already observed. MYO1e is involved in 
granule release in Xenopus oocytes [127] and granulocytes deficient in MYO1f showed an 
increased CD18 surface expression [118]. To confirm the contribution of class I myosins in 
this context, the application of the pharmacological myosin 1 inhibitor PCIP can be useful 
[130]. These results indicate a conserved mechanism for the long-tailed myosins MYO1e in 
vesicle trafficking and exocytosis processes. Intracellular staining of CCL2 combined with 
FACS analysis can give additional information. Thus, cells lacking MYO1e should harbor 
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less intracellular CCL2 in response to LPS, on grounds of the increased release and unaltered 
biosynthesis of the chemokine. Due to the fact that no interaction partner for class I myosins 
in response to TLR4 activation is identified to explain this mechanism, immunoprecipitation 
experiments with a subsequent mass spectrometry analysis for co-precipitated proteins might 
be helpful. 
5.6 MYO1e is required for optimal MHC-II surface expression on 
macrophages and DCs 
Previous studies on Myo1f-deficient neutrophils demonstrated an increased surface expression 
of β2-integrins, and thus the functional regulation of an endocytosis processes by a long-tailed 
myosin [118]. Therefore, we addressed the question whether MYO1e also contributes in 
expression of surface molecules on TLR4-activated MØ. FACS analysis of LPS-stimulated 
macrophages for surface molecules including integrins and co-stimulatory molecules revealed 
no obvious alterations in that expression, except of CD80, which was weakly but significantly 
reduced on LPS-activated MØ (Fig. 16 and 25). A surprising finding in Myo1e-deficient 
macrophages was the selective reduction in MHC-II surface expression levels under basal and 
LPS-induced conditions. Suggestions that MYO1e regulates the intracellular transport of 
MHC-II were corroborated by the unchanged mRNA transcription of the molecule in Myo1e 
KO cells (Fig. 24). Also in DCs, which expressed much higher levels of MHC-II, a MYO1e-
dependent reduction of MHC-II 24h after LPS stimulation was observed (Fig. 26). A 
contribution of the motor protein in MHC-II expression on B-cells, which exclusively express 
MYO1e [118], was not detected in our hands (Fig. 31). Interestingly, recent system biology 
studies of pathways controlling antigen presentation described a function for MYO1e in the 
regulation of intracellular MHC-II transport to the plasma membrane [132, 197]. In a genome-
wide RNAi screen the authors found the GTPase ARL14/ARF7 to be involved in MHC-II 
expression, followed by yeast-2-hybrid-based identification of its effector protein ARF7EP. 
Subsequent pulldown experiments with GST-tagged ARF7EP in cytosolic extracts of human 
PBMCs identified MYO1e by mass spectrometry analysis and finally confirmed this 
interaction by co-immunoprecipitation. Based on their findings the researchers postulated that 
ARF7 connects to the actin network by ARF7-MYO1e interaction and thus controls the 
redistribution of MHC-II [132, 197]. Whether the same or comparable interactions in murine 
macrophages or DCs are responsible in regulation of MYO1e-dependent MHC-II surface 
expression is currently unknown. Specific siRNA KD experiments in murine MØ and DC for 
the GTPase ARF7 or its effector protein ARF7EP can give first indications, if resulting in 
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comparable MHC-II surface expression patterns as observed in Myo1e KO cells. Furthermore, 
co-localization studies by fluorescence microscopy for intracellular MHC-II and MYO1e in 
WT and KO cells can be used to visualize the interaction and motor protein-dependent 
redistribution in response to LPS. In addition to the Myo1e KO, the global class I myosin 
inhibitor PCIP [130, 198, 199] can be utilized to reveal a possible contribution of other class I 
myosins such as MYO1f in MHC-II surface expression. To examine the role of MYO1f in 
this context we already applied MYO1f KD in MYO1e KO MØ (data not shown). However, 
cells treated either with specific or non-targeting control siRNA showed an increase in MHC-
II surface expression throughout TLR4 activation, comparable to IFNγ stimulation. This 
indicates that siRNA treatment may activate oligonucleotide recognition receptors, induce an 
IFN response and thus may influence the sensible and IFN-dependent MHC expression. To 
address this issue the employment of Myo1e/Myo1f double KO cells will be essential. 
 
5.7 Myo1e-deficient antigen-presenting cells are impaired in eliciting  
T-cell activation  
The surprising finding that MYO1e selectively regulates MHC-II surface protein in murine 
macrophages and DCs indicated a possible effect on antigen presentation and elicitation of  
T-cell responses. Whether the MYO1e-dependent MHC-II phenotype is functional relevant 
was analyzed in an OT-II system. Hence, purified CD4 T-cells from OT-II transgenic mice 
which carry a T-cell receptor (TCR) specific for MHC-II-bound ovalbumin (OVA) peptide 
were co-cultured with APCs pre-incubated with whole OVA protein, and antigen-specific  
T-cell activation was analyzed (Fig. 27 and 28). In case of macrophages only a high number 
of Myo1e KO cells within the co-culture results in the same T-cell proliferation comparable to 
WT conditions, although T-cells still produced significantly less amounts of IFNγ (Fig. 27). 
DCs lacking MYO1e showed an impaired activation capacity under high DC-OT-II ratio 
observed by reduced antigen-specific T-cell proliferation, and IFNγ production (Fig. 28). This 
indicates that the absence of MYO1e in macrophages and DC led to a significant reduction in 
the capacity of APCs to induce an antigen-specific cytokine-production and CD4 T-cell 
proliferation. Interestingly, a participation of a class I myosin in MHC-II mediated  
T-cell activation has also been described in B-cells. Here the short-tailed myosin MYO1c was 
shown to interact with MHC-II and contribute in antigen-specific CD4 T-cell stimulation. 
Overexpression of a dominant-negative MYO1c version or specific siRNA knockdown led to 
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reduced T-cell activation and IL-2 secretion induced by B lymphocytes [162]. Our results 
showed that MYO1e in MØ and DC is essential to induce a full MHC-II response.  
However, the OT-II approach used in our experiments did not offer the information whether 
the impaired T-cell activation was directly caused by the decrease in MHC-II surface 
expression or additionally through an alteration in endocytosis or antigen processing. To 
address this issue, a possible change in antigen processing caused by the Myo1e KO was 
analyzed by utilization of DQ-OVA, a fluorescently labeled OVA which illuminates upon 
proteolytical cleavage. To simulate conditions comparable to the OT-II assay, the DQ-OVA 
was kept within the APC culture until 24 h instead of a short pulse period (Fig. 29). In MØ 
the antigen processing throughout the whole kinetic was not influenced by the Myo1e-
deficiency, and thus also an alteration in endocytosis can be excluded. Hence, the impaired T-
cell activation capacity of Myo1e KO macrophages most likely derived from the reduced 
MHC-II surface expression in combination with a weak reduction in CD80. DCs are not as 
fast in antigen processing as MØ, caused by the lower protease content within their lysosomes 
[200, 201]. This behavior was also observed in our experiments, confirming the properness of 
the applied DQ-OVA assay. However, DC lacking MYO1e showed a constantly enhanced 
antigen processing compared to WT cells. This raises the question whether MYO1e 
contributes in the regulation of antigen processing in murine DC or whether it influences 
endocytosis. A contribution of MYO1e in endocytosis processes was already described in 
fibroblasts [121, 122] Application of fluorescently labeled OVA, able to illuminate without 
previous cleavage, additionally to DQ-OVA should dissect the role for MYO1e in the 
different processes.  
To investigate the issue in the OT-II system it is necessary to use the OVA323-339 peptide [202] 
instead of whole OVA protein to circumvent the need for intracellular antigen processing. The 
slow antigen processing capacity of DC under WT conditions is advantageous for a better  
T-cell activation. In contrast, the rapid proteolytical cleavage in MØ causes an excess of 
antigens followed by degradation for the majority of the processed peptides. This 
characteristic prevents a strong T-cell activation by macrophages. The enhanced antigen 
processing in Myo1e KO DC might cause a comparable effect, and thus, additionally to a 
reduced MHC-II surface expression, lead to the impaired T-cell activation.  
 
Since in this thesis exclusively MYO1e-dependent phenotypes were described, the challenge 
for future experiments will be to determine the mechanisms by which the motor protein 
controls spreading, chemokine secretion and MHC-II presentation in macrophages and DC. In 
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addition to the analysis of the cell biology of MYO1e, the regulation of its localization and 
interaction with binding partners by site-specific phosphorylation needs to be studied in detail. 
The involvement of Myo1e in several key functional aspects of macrophage and DC biology 
(such as cell spreading and motility, chemokine secretion and antigen presentation), shown 
here in vitro, suggests that this motor protein may also play an important role in innate 
immune cell recruitment and function during inflammatory and infectious disease processes  
in vivo.  
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